8-K - JATT - Equibles

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIESEXCHANGE ACT OF 1934

Date of Report (Date of earliest event reported):April 20, 2026

JATT II ACQUISITION CORP

(Exact name of registrant as specified in its charter)

Cayman Islands	001-43237	N/A
(State or other jurisdiction	(Commission File Number)	(I.R.S. Employer
of incorporation)		Identification No.)

153Central Avenue C/O 56 Westfield, ### NJ07091

(Address of principal executive offices, including zip code)

201-688-0364

(Registrant’s telephone number, including area code)

Not Applicable

(Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐	Written communications pursuant to Rule 425 under the Securities<br>Act (17 CFR 230.425)
☐	Soliciting material pursuant to Rule 14a-12 under the Exchange<br>Act (17 CFR 240.14a-12)
---	---
☐	Pre-commencement communications pursuant to Rule 14d-2(b) under<br>the Exchange Act (17 CFR 240.14d-2(b))
---	---
☐	Pre-commencement communications pursuant to Rule 13e-4(c) under<br>the Exchange Act (17 CFR 240.13e-4(c))
---	---

Securities registered pursuant to Section 12(b) of the Act:

Title of each class	Trading Symbol(s)	Name of each exchange on<br><br> <br>which registered
ordinary shares, par value $0.0001 per share	JATT	The Nasdaq Stock Market LLC

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

☒ Emerging growth company

☐	If an emerging growth company, indicate by check mark if the<br>registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards<br>provided pursuant to Section 13(a) of the Exchange Act.

Item 1.01. Entry into Material Definitive Agreement.

On April 20, 2026, JATT II Acquisition Corp (the “Company”) consummated its initial public offering (the “IPO”) of 6,000,000 ordinary shares, par value $0.0001 per share (the “Ordinary Shares”). The Ordinary Shares were sold at a price of $10.00 per share, generating gross proceeds to the Company of $60,000,000. The underwriters for the IPO have a 45 day over-allotment option to purchase up to an additional 900,000 Ordinary Shares at a price of $10.00 per share.

In connection with the IPO, the Company entered into the following agreements, forms of which were previously filed as exhibits to the Company’s Registration Statement on Form S-1 (File No. 333-294294) for the IPO, originally filed with the U.S. Securities and Exchange Commission (the “Commission”) on March 13, 2026 (as amended, the “Registration Statement”):

●	An Underwriting Agreement, dated April 16, 2026, between the<br>Company and Guggenheim Securities, LLC, a copy of which is attached as Exhibit 1.1 hereto and incorporated herein by reference.
●	A Letter Agreement, dated April 16, 2026 (“Letter Agreement”), among the Company, the Company’s sponsor, JATT Ventures II L.P. (the “Sponsor”) and each of the officers and directors of the Company, a copy of which is attached as Exhibit 10.1 hereto and incorporated herein by reference.
---	---
●	An Investment Management Trust Agreement, dated April 16, 2026, between the Company and Continental Stock Transfer & Trust Company, as trustee, a copy of which is attached as Exhibit 10.2 hereto and incorporated herein by reference.
---	---
●	A Registration Rights Agreement, dated April 16, 2026, among the Company, the Sponsor and the Holders signatory thereto, a copy of which is attached as Exhibit 10.3 hereto and incorporated herein by reference.
---	---
●	A Private Placement Shares Purchase Agreement, dated April 16, 2026 (the “Private Placement Shares Purchase Agreement”), between the Company and the Sponsor, a copy of which is attached as Exhibit 10.4 hereto and incorporated herein by reference.
---	---
●	An Administrative Services and Indemnification Agreement, dated April 16, 2026, between the Company and the Sponsor, a copy of which is attached as Exhibit 10.5 hereto and incorporated herein by reference.
---	---
●	Indemnity Agreements, each dated April 16, 2026 (each, an “Indemnity Agreement”), between the Company and each of its officers and directors, substantially in the form attached hereto as Exhibit 10.6.

The material terms of such agreements are fully described in the Company’s final prospectus, dated April 17, 2026, as filed with the Commission on April 17, 2026 (the “Prospectus”) and are incorporated herein by reference.

Item 3.02. Unregistered Sales of Equity Securities.

Simultaneously with the closing of the IPO, pursuant to the Private Placement Shares Purchase Agreement, the Company completed the private sale of 300,000 Ordinary Shares (the “Private Placement Shares”) at a purchase price of $10.00 per Private Placement Share, to the Sponsor, generating gross proceeds to the Company of $3,000,000. The Private Placement Shares are identical to the Ordinary Shares sold in the IPO, except that, so long as they are held by the Sponsor and its permitted transferees: (i) they may not, subject to certain limited exceptions, be transferred, assigned or sold until 30 days after the completion of a business combination and (ii) they are entitled to registration rights.

In addition, the Sponsor has agreed to waive its redemption rights with respect to the Private Placement Shares in connection with (i) the consummation of the Company’s initial business combination, or (ii) a shareholder vote to approve an amendment to the Company’s amended and restated memorandum and articles of association to modify the substance or timing of the Company’s obligation to redeem 100% of the Ordinary Shares sold in the IPO if the Company has not consummated a business combination within 24 months of the closing of the IPO (or such other time period pursuant to an amendment to the Amended Charter (as defined below)) or with respect to any other material provisions relating to shareholders’ rights or pre-initial business combination activity.

Item 5.02. Departure of Directors or CertainOfficers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

On April 16, 2026, in connection with the IPO, Mr. Verender S. Badial, Mr. Christopher Staral, Dr. Dr. Arjun Goyal, and Dr. Jonathon Kluft (the “Directors”) were appointed to the board of directors of the Company (the “Board”). The Directors are independent directors. Effective April 16, 2026, the Directors were also appointed to the Board’s (i) Audit Committee, with Mr. Badial serving as chair of the Audit Committee, (ii) Compensation Committee, with Dr. Kluft serving as chair of the Compensation Committee and (iii) Nominating and Corporate Governance Committee, with Mr. Staral serving as chair of the Nominating and Corporate Governance Committee.

In connection with their appointments to the Board, each Director entered into the Letter Agreement as well as an Indemnity Agreement with the Company.

Other than the foregoing, none of the Directors are party to any arrangement or understanding with any person pursuant to which they were appointed as directors, nor are they party to any transactions required to be disclosed under Item 404(a) of Regulation S-K involving the Company.

The foregoing descriptions of the Letter Agreement and the form of indemnity agreement do not purport to be complete and are qualified in their entireties by reference to the Letter Agreement and form of indemnity agreement, copies of which are attached as Exhibits 10.1 and 10.6 hereto, respectively, and are incorporated herein by reference.

Item 5.03. Amendments to Articles of Incorporationor Bylaws; Change in Fiscal Year

On April 16, 2026, in connection with the IPO, the Company filed its amended and restated memorandum and articles of association (the “Amended Charter”) with the Cayman Islands General Registry, effective the same day. The terms of the Amended Charter are set forth in the Registration Statement on pages 142 to 144 and are incorporated herein by reference. A copy of the Amended Charter is attached as Exhibit 3.1 hereto and incorporated herein by reference.

Item 8.01. Other Events.

A total of $60,000,000 comprised of the net proceeds from the IPO and the sale of the Private Placement Shares were placed in a U.S.-based trust account maintained by Continental Stock Transfer & Trust Company, acting as trustee. Except with respect to interest earned on the funds in the trust account that may be released to the Company to pay its taxes and up to $100,000 of interest to pay dissolution expenses, the funds held in the trust account will not be released from the trust account until the earliest of (i) the completion of the Company’s initial business combination, (ii) the redemption of the Ordinary Shares sold in the IPO (the “public shares”) if the Company is unable to complete its initial business combination within 24 months from the closing of the IPO, subject to applicable law or (iii) the redemption of any of the Company’s public shares properly tendered in connection with a shareholder vote to amend the Amended Charter (A) to modify the substance or timing of its obligation to allow redemption in connection with the Company’s initial business combination or to redeem 100% of the Company’s public shares if it does not complete its initial business combination within 24 months from the closing of the IPO or (B) with respect to any other provision relating to shareholders’ rights or pre-business combination activity.

On April 16, 2026, the Company issued a press release announcing the pricing of the IPO, a copy of which is attached as Exhibit 99.1 to this Current Report on Form 8-K.

On April 20, 2026, the Company issued a press release announcing the closing of the IPO, a copy of which is attached as Exhibit 99.2 to this Current Report on Form 8-K.

Item 9.01. Financial Statements and Exhibits.

(d) Exhibits

EXHIBIT INDEX

Exhibit No.	Description
1.1	Underwriting Agreement, dated April 16, 2026, between the Company and Guggenheim Securities, LLC.
3.1	Amended and Restated Memorandum and Articles of Association.
10.1	Letter Agreement, dated April 16, 2026, among the Company, JATT Ventures II L.P. and each of the officers and directors of the Company.
10.2	Investment Management Trust Agreement, dated April 16, 2026, between the Company and Continental Stock Transfer & Trust Company, as trustee.
10.3	Registration Rights Agreement, dated April 16, 2026, among the Company, JATT Ventures II L.P. and the Holders signatory thereto.
10.4	Private Placement Shares Purchase Agreement, dated April 16, 2026, between the Company and JATT Ventures II L.P.
10.5	Administrative Services and Indemnification Agreement, dated April 16, 2026, between the Company and JATT Ventures II L.P..
10.6	Form of Indemnity Agreement (incorporated by reference to Exhibit 10.8 to the Company’s Registration Statement on Form S-1 (File No. 333-294294), filed with the Securities and Exchange Commission on March 13, 2026).
99.1	Press Release, dated April 16, 2026.
99.2	Press Release, dated April 20, 2026.
104	Cover Page Interactive Data File (embedded within the Inline XBRL document)

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

	JATT II Acquisition Corp
Date: April 20, 2026	By:	/s/ Someit Sidhu
	Name:	Someit Sidhu
	Title:	Chief Executive Officer

Exhibit 1.1

6,000,000 Ordinary Shares

JATT II Acquisition Corp

UNDERWRITING AGREEMENT

April 16, 2026

Guggenheim Securities, LLC

330 Madison Avenue

New York, NY 10017

As representative (the “Representative”) of the several Underwriters named in Schedule I hereto

Ladies and Gentlemen:

JATT II Acquisition Corp, a Cayman Islands exempted company (the “Company”), proposes to sell to you and, as applicable, to the several underwriters named in Schedule I hereto (collectively, the “Underwriters”), for whom you (the “Representative”) are acting as representative, 6,000,000 ordinary shares, par value $0.0001 per share, of the Company (the “Ordinary Shares”) (said Ordinary Shares to be issued and sold by the Company being hereinafter called the “Underwritten Securities”). The Company also proposes to grant to the Underwriters an option to purchase up to 900,000 additional Ordinary Shares to cover over-allotments, if any (the “Option Securities”; the Option Securities, together with the Underwritten Securities, being hereinafter called the “Securities”). To the extent there are no additional Underwriters listed on Schedule I other than you, the term Representative as used herein shall mean you, as Underwriter, and the term Underwriter shall mean either the singular or plural as the context requires. Certain capitalized terms used herein and not otherwise defined are defined in Section 21 hereof.

As used herein, the term “BusinessCombination” (as described more fully in the Registration Statement) shall mean a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses.

The Company has entered into an Investment Management Trust Agreement, effective as of April 16, 2026, with Continental Stock Transfer & Trust Company (“CST”), as trustee, in substantially the form filed as Exhibit 10.2 to the Registration Statement (the “Trust Agreement”), pursuant to which certain proceeds from the sale of the Private Placement Shares (as defined below) and certain proceeds of the Offering will be deposited and held in a trust account (the “Trust Account”) for the benefit of the Company, the Underwriters and the holders of the Underwritten Securities and the Option Securities, if and when issued.

The Company has entered into a Securities Subscription Agreement, dated as of February 13, 2026 (the “Securities Subscription Agreement”), with JATT Ventures II L.P., a Cayman Islands exempted limited partnership (the “Sponsor”), in substantially the form filed as Exhibit 10.7, pursuant to which the Sponsor purchased an aggregate of 1,725,000 Ordinary Shares of the Company (the “FounderShares”) for an aggregate purchase price of $25,000.

The Company has entered into a Private Placement Shares Purchase Agreement, effective as of April 16, 2026 (the “Private Placement Agreement”), with the Sponsor, in substantially the form filed as Exhibit 10.4 to the Registration Statement, pursuant to which the Sponsor agreed to purchase 300,000 Ordinary Shares (or 309,000 Ordinary Shares if the Underwriters’ over-allotment option is exercised in full) (the “Private Placement Shares”) at a price of $10.00 per Private Placement Share.

The Company has entered into a Registration Rights Agreement, dated as of April 16, 2026, with the Sponsor and the shareholders signatory thereto, in substantially the form filed as Exhibit 10.3 to the Registration Statement (the “Registration Rights Agreement”), pursuant to which the Company has granted certain registration rights in respect of the Founder Shares and Private Placement Shares as described in the Prospectus.

The Company has caused to be duly executed and delivered a letter agreement, dated April 16, 2026, by and among the Sponsor and each of the Company’s officers, directors and director nominees, in substantially the form filed as Exhibit 10.1 to the Registration Statement (the “Letter Agreement”).

The Company has entered into an Administrative Services and Indemnification Agreement, dated as of April 16, 2026, with an affiliate of the Sponsor, in substantially the form filed as Exhibit 10.8 to the Registration Statement (the “Administrative Services Agreement”), pursuant to which the Company will pay to such affiliate of the Sponsor an aggregate monthly fee of $20,000 for certain office space, utilities and secretarial and administrative support.

1. REPRESENTATIONS AND WARRANTIES.

The Company represents and warrants to, and agrees with, each Underwriter as set forth below in this Section 1.

(a)	The Company has prepared and filed with the Commission the Registration Statement (file number 333-294294)<br>on Form S-1, including the related Preliminary Prospectus, for registration under the Act of the offering and sale of the Securities.<br>Such Registration Statement, including any amendments thereto filed prior to the Execution Time, has become effective. The Company has<br>filed one or more amendments thereto, including the related Preliminary Prospectus, each of which has previously been furnished to you.<br>The Company will file with the Commission the Prospectus in accordance with Rule 424(b). As filed, such Prospectus shall contain all information<br>required by the Act and, except to the extent the Representative shall agree in writing to a modification, shall be in all substantive<br>respects in the form furnished to you prior to the Execution Time or, to the extent not completed at the Execution Time, shall contain<br>only such specific additional information and other changes (beyond that contained in the latest Preliminary Prospectus) as the Company<br>has advised you, prior to the Execution Time, will be included or made therein. The Company has complied to the Commission’s satisfaction<br>with all requests of the Commission for additional or supplemental information.
(b)	On the Effective Date, the Registration Statement did, and when the Prospectus is first filed in accordance<br>with Rule 424(b) and on the Closing Date (as defined herein) and on any date on which Option Securities are purchased, if such date is<br>not the Closing Date (a “settlement date”), the Prospectus (and any supplement thereto) will comply in all material<br>respects with the applicable requirements of the Act; on the Effective Date and at the Execution Time, the Registration Statement did<br>not and will not contain any untrue statement of a material fact or omit to state any material fact required to be stated therein or necessary<br>in order to make the statements therein, in light of the circumstances under which they were made, not misleading; as of the Applicable<br>Time and on the Closing Date and any settlement date, any individual Written Testing-the-Waters Communication (as defined herein) did<br>not conflict with the information contained in the Registration Statement or the Statutory Prospectus, complied in all material respects<br>with the Act, when considered together with the Statutory Prospectus, and did not and will not contain any untrue statement of a material<br>fact or omit to state any material fact required to be stated therein or necessary in order to make the statements therein, in light of<br>the circumstances under which they were made, not misleading; and on the date of any filing pursuant to Rule 424(b) and on the Closing<br>Date and any settlement date, the Prospectus (together with any supplement thereto) will not include any untrue statement of a material<br>fact or omit to state a material fact necessary in order to make the statements therein, in the light of the circumstances under which<br>they were made, not misleading; provided, however, that the Company makes no representations or warranties as to the information<br>contained in or omitted from the Registration Statement or the Prospectus (or any supplement thereto) in reliance upon and in conformity<br>with information furnished in writing to the Company by or on behalf of any Underwriter through the Representative specifically for inclusion<br>in the Registration Statement or the Prospectus (or any supplement thereto), it being understood and agreed that the only such information<br>furnished by any Underwriter consists of the information described as such in Section 8(b) hereof.
---	---
(c)	The Statutory Prospectus, as of the Applicable Time and on the Closing Date and any settlement date, did<br>not and will not contain any untrue statement of a material fact or omit to state any material fact necessary in order to make the statements<br>therein, in the light of the circumstances under which they were made, not misleading; provided, however, that the Company<br>makes no representations or warranties as to the information contained in or omitted from the Statutory Prospectus in reliance upon and<br>in conformity with written information furnished to the Company by or on behalf of any Underwriter through the Representative specifically<br>for use therein, it being understood and agreed that the only such information furnished by or on behalf of any Underwriter consists of<br>the information described as such in Section 8(b) hereof.
---	---

(d)	The Company has filed with the Commission a Form 8-A (file number 001-43237) providing for the registration<br>under the Exchange Act of the Securities, which registration is currently effective on the date hereof. The Securities have been authorized<br>for listing, subject to official notice of issuance and evidence of satisfactory distribution, on the Nasdaq Global Market (“Nasdaq”),<br>and the Company knows of no reason or set of facts that is likely to adversely affect such authorization.
(e)	The Commission has not issued any order or, to the Company’s knowledge, threatened to issue any<br>order preventing or suspending the effectiveness of the Registration Statement or the use of any Preliminary Prospectus, the Prospectus<br>or any part thereof, and has not instituted or, to the Company’s knowledge, threatened to institute any proceedings with respect<br>to such an order.
---	---
(f)	(i) At the time of filing the Registration Statement and (ii) as of the Execution Time (with such date<br>being used as the determination date for purposes of this clause (ii)), the Company was and is an Ineligible Issuer (as defined in Rule<br>405).
---	---
(g)	The Company has not prepared or used a Free Writing Prospectus.
---	---
(h)	The Company has been duly incorporated and is validly existing as an exempted company in the Cayman Islands<br>and is in good standing under the laws of the Cayman Islands with full corporate power and authority to own or lease, as the case may<br>be, and to operate its properties and conduct its business as described in the Statutory Prospectus and the Prospectus and to enter into<br>this Agreement, the Trust Agreement, the Securities Subscription Agreement, the Private Placement Agreement, the Registration Rights Agreement,<br>the Letter Agreement and the Administrative Services Agreement and to carry out the transactions contemplated hereby and thereby, and<br>is duly qualified to do business as a foreign corporation and is in good standing under the laws of each jurisdiction that requires such<br>qualification.
---	---
(i)	There is no franchise, contract or other document of a character required to be described in the Registration<br>Statement or Prospectus, or to be filed as an exhibit thereto, which is not described or filed as required (and the Statutory Prospectus<br>contains in all material respects the same description of the foregoing matters contained in the Prospectus); and the statements in the<br>Statutory Prospectus and the Prospectus under the headings “Principal Shareholders,” “Certain Relationshipsand Related Party Transactions,” and “Description of Securities” insofar as such statements summarize legal<br>matters, agreements, documents or proceedings discussed therein, are accurate and fair summaries of such legal matters, agreements, documents<br>or proceedings. There are no business relationships or related party transactions involving the Company or any other person required by<br>the Act to be described in the Registration Statement or Prospectus that have not been described as required.
---	---
(j)	The Company’s authorized share capital is as set forth in the Statutory Prospectus, the Prospectus<br>and the Amended and Restated Memorandum and Articles of Association of the Company (the “Amended and Restated Memorandum andArticles of Association”).
---	---
(k)	All issued and outstanding shares of the Company have been duly and validly authorized and issued and<br>are fully paid and non-assessable (meaning that the holder thereof shall not, solely by virtue of its status as a shareholder, be liable<br>for additional assessments or calls on such shares by the Company or its creditors (except in exceptional circumstances, such as involving<br>fraud, the establishment of an agency relationship or an illegal or improper purpose or other circumstance in which a court may be prepared<br>to pierce or lift the corporate veil)); and none of such shares were issued in violation of the preemptive rights of any holders of any<br>security of the Company or similar contractual rights granted by the Company. The offers and sales of the Founder Shares and Private Placement<br>Shares were at all relevant times either registered under the Act, the applicable state securities and blue sky laws or, based in part<br>on the representations and warranties of the purchasers of such Founder Shares and Private Placement Shares, exempt from such registration<br>requirements. The holders of outstanding shares or other securities of the Company are not entitled to preemptive or other rights to subscribe<br>for the Securities arising by operation of law or under the Amended and Restated Memorandum and Articles of Association; and, except as<br>set forth in the Statutory Prospectus and the Prospectus, no options, warrants or other rights to purchase, agreements or other obligations<br>to issue, or rights to convert any obligations into or exchange any securities for, shares of capital stock of or other ownership interests<br>in the Company are outstanding.
---	---

(l)	The Securities have been duly authorized and reserved for issuance and when issued and delivered against<br>payment for the Securities by the Underwriters pursuant to this Agreement (including the registration of the share issuance in the Company’s<br>register of members as fully paid), will be validly issued, fully paid and non-assessable (meaning that the holder thereof shall not,<br>solely by virtue of its status as a shareholder, be liable for additional assessments or calls on such shares by the Company or its creditors<br>(except in exceptional circumstances, such as involving fraud, the establishment of an agency relationship or an illegal or improper purpose<br>or other circumstance in which a court may be prepared to pierce or lift the corporate veil)).
(m)	Except as set forth in the Statutory Prospectus, the Prospectus and the Amended and Restated Memorandum<br>and Articles of Association, no holders of any securities of the Company or any rights exercisable for or convertible or exchangeable<br>into securities of the Company have the right to require the Company to register any such securities of the Company under the Act or to<br>include any such securities in a registration statement to be filed by the Company.
---	---
(n)	No securities of the Company have been sold by the Company or by or on behalf of, or for the benefit of,<br>any person or persons controlling, controlled by, or under common control with the Company from its inception through and including the<br>date hereof, except as disclosed in the Registration Statement, the Statutory Prospectus and the Prospectus.
---	---
(o)	Neither the Company nor any of its affiliates has, prior to the date hereof, made any offer or sale of<br>any securities that are required to be “integrated” pursuant to the Act with the offer and sale of the Underwritten Securities<br>pursuant to the Registration Statement.
---	---
(p)	The Founder Shares are duly authorized, validly issued, fully paid non-assessable (meaning that the holder<br>thereof shall not, solely by virtue of its status as a shareholder, be liable for additional assessments or calls on such shares by the<br>Company or its creditors (except in exceptional circumstances, such as involving fraud, the establishment of an agency relationship or<br>an illegal or improper purpose or other circumstance in which a court may be prepared to pierce or lift the corporate veil)).
---	---
(q)	The Private Placement Shares have been duly authorized and, when executed by the Company and countersigned,<br>and issued and delivered against payment for the Private Placement Shares by the Sponsor pursuant to the Private Placement Agreement (including<br>the registration of the share issuance in the Company’s register of members as fully paid), will be validly issued, fully paid and<br>non-assessable (meaning that the holder thereof shall not, solely by virtue of its status as a shareholder, be liable for additional assessments<br>or calls on such shares by the Company or its creditors (except in exceptional circumstances, such as involving fraud, the establishment<br>of an agency relationship or an illegal or improper purpose or other circumstance in which a court may be prepared to pierce or lift the<br>corporate veil)).
---	---
(r)	This Agreement has been duly authorized, executed and delivered by the Company and is a valid and binding<br>agreement of the Company, enforceable against the Company in accordance with its terms except as the enforceability thereof may be limited<br>by bankruptcy, insolvency, or similar laws affecting creditors’ rights generally from time to time in effect and by equitable principles<br>of general applicability.
---	---
(s)	The Trust Agreement has been duly authorized, executed and delivered by the Company, and is a valid and<br>binding agreement of the Company, enforceable against the Company, in accordance with its terms except as the enforceability thereof may<br>be limited by bankruptcy, insolvency, or similar laws affecting creditors’ rights generally from time to time in effect and by equitable<br>principles of general applicability.
---	---

(t)	The Securities Subscription Agreement has been duly authorized, executed and delivered by the Company<br>and the Sponsor, and is a valid and binding agreement of the Company and the Sponsor, enforceable against the Company and the Sponsor<br>in accordance with its terms except as the enforceability thereof may be limited by bankruptcy, insolvency, or similar laws affecting<br>creditors’ rights generally from time to time in effect and by equitable principles of general applicability.
(u)	The Private Placement Agreement has been duly authorized, executed and delivered by the Company, and is<br>a valid and binding agreement of the Company, enforceable against the Company and the Sponsor in accordance with its terms except as the<br>enforceability thereof may be limited by bankruptcy, insolvency, or similar laws affecting creditors’ rights generally from time<br>to time in effect and by equitable principles of general applicability.
---	---
(v)	[Intentionally omitted.]
---	---
(w)	The Registration Rights Agreement has been duly authorized, executed and delivered by the Company and<br>is a valid and binding agreement of the Company, enforceable against the Company in accordance with its terms except as the enforceability<br>thereof may be limited by bankruptcy, insolvency, or similar laws affecting creditors’ rights generally from time to time in effect<br>and by equitable principles of general applicability.
---	---
(x)	The Letter Agreement executed by the Company, the Sponsor and, to the Company’s knowledge, each<br>executive officer, director and director nominee of the Company, has been duly authorized, executed and delivered by the Company, the<br>Sponsor and, to the Company’s knowledge, each such executive officer, director and director nominee, respectively, and is a valid<br>and binding agreement of the Company, the Sponsor and, to the Company’s knowledge, each such executive officer, director and director<br>nominee, respectively, enforceable against the Company, the Sponsor and, to the Company’s knowledge, each such executive officer,<br>director and director nominee, respectively, in accordance with its terms except as the enforceability thereof may be limited by bankruptcy,<br>insolvency or similar laws affecting creditors’ rights generally from time to time in effect and by equitable principles of general<br>applicability.
---	---
(y)	The Administrative Services Agreement has been duly authorized, executed and delivered by the Company<br>and, assuming the due authorization, execution and delivery thereof by the affiliate of the Sponsor party thereto, is a valid and binding<br>agreement of the Company, enforceable against the Company in accordance with its terms except as the enforceability thereof may be limited<br>by bankruptcy, insolvency or similar laws affecting creditors’ rights generally from time to time in effect and by equitable principles<br>of general applicability.
---	---
(z)	The Company is not and, after giving effect to the offering and sale of the Securities and the application<br>of the proceeds thereof as described in the Statutory Prospectus and the Prospectus, will not be an “investment company” as<br>defined in the Investment Company Act of 1940, as amended.
---	---
(aa)	No consent, approval, authorization, filing with or order of any court or governmental agency or body<br>is required in connection with the transactions contemplated herein or in the Trust Agreement, the Securities Subscription Agreement,<br>the Private Placement Agreement, the Registration Rights Agreement, the Letter Agreement or the Administrative Services Agreement, except<br>for the registration under the Act and the Exchange Act of the Securities and such as may be required under state securities or blue sky<br>laws of any jurisdiction in connection with the purchase and distribution of the Securities by the Underwriters in the manner contemplated<br>herein and in the Statutory Prospectus and the Prospectus.
---	---

(bb)	The Company is not in violation or default of (i) any provision of its Amended and Restated Memorandum<br>and Articles of Association, (ii) the terms of any indenture, contract, lease, mortgage, deed of trust, note agreement, loan agreement<br>or other agreement, obligation, condition, covenant or instrument to which it is a party or bound or to which its property is subject,<br>or (iii) any (x) statute, law, rule, regulation, or (y) judgment, order or decree of any court, regulatory body, administrative agency,<br>governmental body, arbitrator or other authority having jurisdiction over the Company; except in the case of clauses (ii) and (iii) above<br>for any such conflict, breach or violation that would not, individually or in the aggregate, be reasonably expected to have a material<br>adverse effect on the financial condition, prospects, earnings, business or properties of the Company, taken as a whole, whether or not<br>arising from transactions in the ordinary course of business (a “Material Adverse Effect”).
(cc)	Neither the issue and sale of the Securities nor the consummation of any other of the transactions herein<br>contemplated nor the fulfillment of the terms hereof or of the Trust Agreement, the Securities Subscription Agreement, the Private Placement<br>Agreement, the Registration Rights Agreement, the Letter Agreement or the Administrative Services Agreement will conflict with, result<br>in a breach or violation of, or imposition of any lien, charge or encumbrance upon any property or assets of the Company pursuant to,<br>(i) the Amended and Restated Memorandum and Articles of Association, (ii) the terms of any indenture, contract, lease, mortgage, deed<br>of trust, note agreement, loan agreement or other agreement, obligation, condition, covenant or instrument to which the Company is a party<br>or bound or to which the Company’s property is subject, or (iii) any statute, law, rule, or regulation, judgment, order or decree<br>applicable to the Company of any court, regulatory body, administrative agency, governmental body, arbitrator or other authority having<br>jurisdiction over the Company or any of its respective properties.
---	---
(dd)	No holders of securities of the Company have rights to the registration of such securities under the Registration<br>Statement.
---	---
(ee)	The historical financial statements, including the notes thereto and the supporting schedules, if any,<br>of the Company included in the Registration Statement, the Statutory Prospectus and the Prospectus present fairly the financial condition,<br>results of operations and cash flows of the Company as of the dates and for the periods indicated, comply as to form with the applicable<br>accounting requirements of the Act and have been prepared in conformity with generally accepted accounting principles applied on a consistent<br>basis throughout the periods involved (except as otherwise noted therein). The Company is not party to any off-balance sheet transactions,<br>arrangements, obligations (including contingent obligations), or other relationships with unconsolidated entities or other persons that<br>may have a material current or future effect on the Company’s financial condition, changes in financial condition, results of operations,<br>liquidity, capital expenditures, capital resources, or significant components of revenues or expenses. The statistical, industry-related<br>and market-related data included in the Registration Statement, the Statutory Prospectus and the Prospectus are based on or derived from<br>sources that the Company reasonably and in good faith believes are reliable and accurate, and such data agree with the sources from which<br>they are derived.
---	---
(ff)	No action, suit or proceeding by or before any court or governmental agency, authority or body or any<br>arbitrator involving the Company or the Sponsor, or the property of either of them is pending or, to the knowledge of the Company, threatened<br>that (i) could reasonably be expected to have a material adverse effect on the performance of this Agreement or the consummation of any<br>of the transactions contemplated hereby by the Company or (ii) could reasonably be expected to have a Material Adverse Effect, except<br>as set forth in or contemplated in the Statutory Prospectus and the Prospectus (exclusive of any supplement thereto).
---	---
(gg)	The Company owns or leases all such properties as are necessary to the conduct of its operations as presently<br>conducted.
---	---
(hh)	WithumSmith+Brown, PC (“WithumSmith”), who have certified certain financial statements<br>of the Company and delivered their report with respect to the audited financial statements and schedules included in the Registration<br>Statement, Statutory Prospectus and the Prospectus, is a registered public accounting firm that is independent with respect to the Company<br>within the meaning of the Act and the Exchange Act and the applicable published rules and regulations thereunder.
---	---

(ii)	The Company maintains effective “disclosure controls and procedures” (as defined under Rule<br>13a-15(e) under the Exchange Act to the extent required by such rule).
(jj)	Solely to the extent that the Sarbanes Oxley Act of 2002, as amended, and the rules and regulations promulgated<br>by the Commission thereunder (the “Sarbanes Oxley Act”) have been applicable to the Company, there is and has been<br>no failure on the part of the Company to comply in all material respects with the applicable provisions of the Sarbanes Oxley Act.
---	---
(kk)	There is and has been no failure on the part of the Company or, to the knowledge of the Company, any of<br>the Company’s officers or directors, in their capacities as such, to comply with (as and when applicable), and immediately following<br>the Effective Date the Company will be in compliance with, Nasdaq rules. Further, there is and has been no failure on the part of the<br>Company or, to the knowledge of the Company, any of the Company’s officers or directors, in their capacities as such, to comply<br>with (as and when applicable), and immediately following the Effective Date the Company will be in compliance with, the phase-in requirements<br>and all other provisions of Nasdaq’s corporate governance requirements set forth in the Nasdaq rules.
---	---
(ll)	There are no transfer, stamp, issue, registration, documentary or other similar taxes, duties, fees or<br>charges under U.S. federal law or the laws of any state, or any political subdivision thereof, or under the laws of any non-U.S. jurisdiction,<br>required to be paid in connection with the execution and delivery of this Agreement or the issuance or sale by the Company of the Securities.
---	---
(mm)	The Company has filed all tax returns (including U.S. federal, state and non-U.S.) that are required to<br>be filed by it or has requested extensions thereof (except in any case in which the failure so to file would not have a Material Adverse<br>Effect) through the date hereof and has paid all taxes required to be paid by it and any other assessment, fine or penalty levied against<br>it, to the extent that any of the foregoing is due and payable, except for any such tax, assessment, fine or penalty that is currently<br>being contested in good faith and for which adequate reserves required by generally accepted accounting principles have been created with<br>respect thereto or as would not have a Material Adverse Effect, except as set forth in or contemplated in the Registration Statement,<br>Statutory Prospectus and the Prospectus (exclusive of any supplement thereto).
---	---
(nn)	The Company possesses all licenses, certificates, permits and other authorizations issued by the appropriate<br>federal, state or foreign regulatory authorities necessary to conduct its business, and the Company has not received any notice of proceedings<br>relating to the revocation or modification of any such license, certificate, authorization or permit that, singly or in the aggregate,<br>if the subject of an unfavorable decision, ruling or finding, would have a Material Adverse Effect, except as set forth in or contemplated<br>in the Statutory Prospectus and the Prospectus (exclusive of any supplement thereto).
---	---
(oo)	None of the Company, the Sponsor or, to the knowledge of the Company, any director, director nominee,<br>officer, agent, employee, affiliate or other person associated with or acting on behalf of the Company: (i) has used any corporate funds<br>for any unlawful contribution, gift, entertainment or other unlawful expense relating to political activity; (ii) has made any direct<br>or indirect unlawful contribution or payment to any official of, or candidate for, or any employee of, any federal, state or foreign office<br>from corporate funds; (iii) has made any bribe, unlawful rebate, payoff, influence payment, kickback or other unlawful payment; or (iv)<br>is aware of or has taken any action, directly or indirectly, that would result in a violation by such persons of the OECD Convention on<br>Bribery of Foreign Public Officials in International Business Transactions, the Foreign Corrupt Practices Act of 1977, as amended, and<br>the rules and regulations thereunder (collectively, the “FCPA”) or any similar law or regulation to which the Company,<br>any director, director nominee, officer, agent, employee, affiliate or other person associated with or acting on behalf of the Company<br>is subject. The Company, the Sponsor and, to the knowledge of the Company, its directors, director nominees, officers, agents, employees<br>and affiliates have each conducted the business of the Company and their own businesses on behalf of the Company in compliance with the<br>FCPA and any applicable similar law or regulation and have instituted and maintain policies and procedures designed to ensure, and which<br>are reasonably expected to continue to ensure, continued compliance therewith.
---	---

(pp)	The operations of the Company are and have been conducted at all times in compliance with applicable financial<br>record-keeping and reporting requirements, including those of the Bank Secrecy Act, as amended by Title III of the Uniting and Strengthening<br>America by Providing Appropriate Tools Required to Intercept and Obstruct Terrorism Act of 2001 (USA PATRIOT Act), the Currency and Foreign<br>Transactions Reporting Act of 1970, as amended, the applicable money laundering statutes of jurisdictions where the Company conducts business,<br>the applicable rules and regulations thereunder and any related or similar rules, regulations or guidelines, issued, administered or enforced<br>by any governmental agency (collectively, the “Money Laundering Laws”) and no action, suit or proceeding by or before<br>any court or governmental agency, authority or body or any arbitrator involving the Company with respect to the Money Laundering Laws<br>is pending or, to the knowledge of the Company, threatened.
(qq)	None of the Company, the Sponsor or, to the knowledge of the Company, any director, director nominee,<br>officer, agent or affiliate of the Company is currently subject to any sanctions administered by the Office of Foreign Assets Control<br>of the U.S. Treasury Department (“OFAC”), the U.S. Department of State, the United Nations Security Council (“UNSC”),<br>the European Union (the “EU”), His Majesty’s Treasury (“HMT”) or any similar sanctions imposed<br>by any other body, governmental or other, to which any of such persons is subject (collectively, “other economic sanctions”);<br>and the Company will not directly or indirectly use the proceeds of the Offering, or lend, contribute or otherwise make available such<br>proceeds to any subsidiary, joint venture partner or other person or entity, for the purpose of financing the activities of any person<br>currently subject to any sanctions administered by OFAC or other economic sanctions.
---	---
(rr)	Except as disclosed in the Registration Statement, the Statutory Prospectus and the Prospectus, the Company<br>(i) does not have any material lending or other relationship with any bank or lending affiliate of any of the Underwriters and (ii) does<br>not intend to use any of the proceeds from the sale of the Securities hereunder to repay any outstanding debt owed to any affiliate of<br>any of the Underwriters.
---	---
(ss)	All information contained in the questionnaires (the “Questionnaires”) completed by<br>the Sponsor and, to the knowledge of the Company, the Company’s officers, directors and director nominees and provided to the Representative,<br>is true and correct and the Company has not become aware of any information that would cause the information disclosed in the Questionnaires<br>completed by the Sponsor or the Company’s officers, directors and director nominees to become inaccurate and incorrect.
---	---
(tt)	Except as disclosed in the Registration Statement, the Statutory Prospectus and the Prospectus, prior<br>to the date hereof, the Company has not selected any business combination target and has not, nor has anyone on its behalf, initiated<br>any substantive discussions, directly or indirectly, with any business combination target.
---	---
(uu)	Except as would not, individually or in the aggregate, reasonably be expected to result in a Material<br>Adverse Effect, and except as described in the Registration Statement, the Statutory Prospectus and the Prospectus, to the knowledge of<br>the Company, (i) there has been no security breach or other security compromise of or relating to any of the Company’s information<br>technology and computer systems, networks, hardware, software, data, trade secrets, or equipment; and (ii) the Company is presently in<br>compliance with all applicable laws, regulations, contractual obligations and internal policies relating to data privacy and security<br>or personally identifiable information.
---	---
(vv)	Except as described in the Registration Statement, the Statutory Prospectus and the Prospectus, there<br>are no claims, payments, arrangements, contracts, agreements or understandings relating to the payment of a brokerage commission or finder’s,<br>consulting, origination or similar fee by the Company or the Sponsor with respect to the sale of the Securities hereunder or any other<br>arrangements, agreements, or understandings of the Company, the Sponsor or any officer or director of the Company, or their respective<br>affiliates, that may affect the Underwriters’ compensation, as determined by the Financial Industry Regulatory Authority, Inc. (“FINRA”).
---	---
(ww)	Except as described in the Registration Statement, the Statutory Prospectus and the Prospectus, the Company<br>has not made any direct or indirect payments (in cash, securities or any other “item of value” as defined in Rule 5110(c)(3)<br>of FINRA’s Conduct Rules): (i) to any person, as a finder’s fee, consulting fee, or otherwise, in consideration of such person<br>raising capital for the Company or introducing to the Company persons who raised or provided capital to the Company; (ii) to any person<br>that, to the Company’s knowledge, has been accepted by FINRA as a member of FINRA (a “Member”); or (iii) to any<br>person or entity that, to the Company’s knowledge, has any direct or indirect affiliation or association with any Member, within<br>the twelve months prior to the Effective Date, other than payments to the Underwriters pursuant to this Agreement.
---	---

(xx)	Except as described in the Registration Statement, the Statutory Prospectus and the Prospectus, during<br>the period beginning 180 days prior to the initial filing of the Registration Statement and ending on the Effective Date, no Member and/or<br>any person associated or affiliated with a Member has provided any investment banking, financial advisory and/or consulting services to<br>the Company.
(yy)	Except as disclosed in the FINRA questionnaires provided to the Representative (the “FINRA Questionnaires”),<br>to the Company’s knowledge no officer, director, or beneficial owner of any class of the Company’s securities (whether debt<br>or equity, registered or unregistered, regardless of the time acquired or the source from which derived) (any such individual or entity,<br>a “Company Affiliate”) is a Member or a person associated or affiliated with a Member.
---	---
(zz)	Except as disclosed in the FINRA Questionnaires, to the Company’s knowledge, no Company Affiliate<br>is an owner of shares or other securities of any Member (other than securities purchased on the open market).
---	---
(aaa)	No Company Affiliate has made a subordinated loan to any Member.
---	---
(bbb)	Except as described in the Registration Statement, the Statutory Prospectus and the Prospectus, no proceeds<br>from the sale of the Underwritten Securities (excluding underwriting compensation as disclosed in the Registration Statement, Statutory<br>Prospectus and the Prospectus) will be paid by the Company to any Member, or any persons associated or affiliated with a Member.
---	---
(ccc)	The Company has not issued any warrants or other securities, or granted any options, directly or indirectly,<br>to anyone who is a potential underwriter in the Offering or a related person (as defined by FINRA rules) of such an underwriter within<br>the earliest of the 180-day period prior to the initial filing date and the initial confidential submission date of the Registration Statement.
---	---
(ddd)	No person to whom securities of the Company have been privately issued within the 180-day period prior<br>to the initial filing date of the Registration Statement has to the Company’s knowledge any relationship or affiliation or association<br>with any Member.
---	---
(eee)	To the Company’s knowledge, no Member intending to participate in the Offering has a conflict of<br>interest with the Company. For this purpose, a “conflict of interest” means, if at the time of the Member’s participation<br>in the Offering, any of the following applies: (A) the securities are to be issued by the Member; (B) the Company controls, is controlled<br>by or is under common control with the Member or the Member’s associated persons; (C) at least 5% of the net offering proceeds,<br>not including underwriting compensation, are intended to be: (i) used to reduce or retire the balance of a loan or credit facility extended<br>by the Member, its affiliates and its associated persons, in the aggregate; or (ii) otherwise directed to the Member, its affiliates and<br>its associated persons, in the aggregate; or (D) as a result of the Offering and any transactions contemplated at the time of the Offering:<br>(i) the Member will be an affiliate of the Company; (ii) the Member will become publicly owned; or (iii) the Company will become a Member<br>or form a broker-dealer subsidiary. “Member intending to participate in the Offering” includes any associated person of a<br>Member that is participating in the Offering, any members of such associated person’s immediate family, and any affiliate of a Member<br>that is participating in the Offering.
---	---
(fff)	The Company has not taken, directly or indirectly, any action designed to or that would constitute or<br>that might reasonably be expected to cause or result in, under the Exchange Act or otherwise, stabilization or manipulation of the price<br>of any security of the Company to facilitate the sale or resale of the Securities.
---	---
(ggg)	The Company does not own an interest in any corporation, partnership, limited liability company, joint<br>venture, trust or other entity.
---	---

(hhh)	No relationship, direct or indirect, exists between or among any of the Company or any affiliate of the<br>Company, on the one hand, and any director, director nominee, officer, shareholder, special advisor, customer or supplier of the Company<br>or any affiliate of the Company, on the other hand, which is required by the Act or the Exchange Act to be described in the Registration<br>Statement, Statutory Prospectus or the Prospectus that is not described as required. There are no outstanding loans, advances (except<br>normal advances for business expenses in the ordinary course of business) or guarantees of indebtedness by the Company to or for the benefit<br>of any of the officers, directors or director nominees of the Company or any of their respective family members, except as disclosed in<br>the Registration Statement, Statutory Prospectus and the Prospectus. The Company has not extended or maintained credit, arranged for the<br>extension of credit, or renewed an extension of credit, in the form of a personal loan to or for any director or officer of the Company.
(iii)	The Company has not offered, or caused the Underwriters to offer, the Underwritten Securities to any person<br>or entity with the intention of unlawfully influencing: (a) a customer or supplier of the Company or any affiliate of the Company to alter<br>the customer’s or supplier’s level or type of business with the Company or such affiliate or (b) a journalist or publication<br>to write or publish favorable information about the Company or any such affiliate.
---	---
(jjj)	Upon delivery and payment for the Ordinary Shares on the Closing Date, the Company will not be subject<br>to Rule 419 under the Act and none of the Company’s outstanding securities will be deemed to be a “penny stock” as defined<br>in Rule 3a51-1 under the Exchange Act.
---	---
(kkk)	From the time of the initial confidential submission of the Registration Statement to the Commission (or,<br>if earlier, the first date on which the Company engaged, directly or through any person authorized to act on its behalf, in any Testing-the-Waters<br>Communication) through the Execution Time, the Company has been and is an “emerging growth company,” as defined in Section<br>2(a) of the Act (an “Emerging Growth Company”). “Testing-the-Waters Communication” means any oral<br>or written communication with potential investors undertaken in reliance on Section 5(d) of the Act.
---	---
(lll)	The Company (i) has not alone engaged in any Testing-the-Waters Communication other than Testing-the-Waters<br>Communications with the consent of the Representative with entities that are qualified institutional buyers within the meaning of Rule<br>144A under the Act or institutions that are accredited investors within the meaning of Rule 501 under the Act and (ii) has not authorized<br>anyone other than the Representative to engage in Testing-the-Waters Communications. The Company reconfirms that the Representative has<br>been authorized to act on its behalf in undertaking Testing-the-Waters Communications. The Company has not distributed any Written Testing-the-Waters<br>Communications other than those listed on Schedule III hereto. “Written Testing-the-Waters Communication” means<br>any Testing-the-Waters Communication that is a written communication within the meaning of Rule 405 under the Act.
---	---
(mmm)	Except as disclosed in the Registration Statement, the Statutory Prospectus and the Prospectus, under<br>current laws and regulations of the Cayman Islands and any political subdivision thereof, all dividends and other distributions declared<br>and payable on the Securities may be paid by the Company to the holder thereof in United States dollars and all such payments made to<br>holders thereof or therein who are non-residents of the Cayman Islands will not be subject to income, withholding or other taxes under<br>laws and regulations of the Cayman Islands or any political subdivision or taxing authority thereof or therein and will otherwise be free<br>and clear of any other tax, duty, withholding or deduction in the Cayman Islands or any political subdivision or taxing authority thereof<br>or therein and without the necessity of obtaining any governmental authorization in the Cayman Islands or any political subdivision or<br>taxing authority thereof or therein.
---	---
(nnn)	Except as expressly set forth in that certain letter agreement, dated March 6, 2026, among the Company,<br>the Sponsor and the Representative, and as described in the Registration Statement, the Statutory Prospectus and the Prospectus, the Company<br>does not have any expectation, understanding or agreement with any Underwriter for such Underwriter to provide any additional services<br>to the Company after the consummation of the Offering relating to the initial Business Combination, the financing thereof or other related<br>transactions. Any Underwriter’s provision of any such additional services in connection with the initial Business Combination will<br>require the Company’s separate engagement of such Underwriter in connection with the initial Business Combination and the entry<br>into a related written engagement agreement between such Underwriter and the Company setting forth the terms and conditions of the additional<br>services to be provided by such Underwriter to the Company.
---	---

Any certificate signed by any officer of the Company and delivered to the Representative or counsel for the Underwriters in connection with the Offering shall be deemed a representation and warranty by the Company, as to matters covered thereby, to each Underwriter.

2. PURCHASE AND SALE.

(a)	Subject to the terms and conditions and in reliance upon the representations and warranties herein set<br>forth, the Company agrees to sell to each Underwriter, and each Underwriter agrees, severally and not jointly, to purchase from the Company,<br>at a purchase price of $9.90 per Underwritten Security, the amount of the Underwritten Securities set forth opposite such Underwriter’s<br>name in Schedule I hereto.
(b)	Subject to the terms and conditions and in reliance upon the representations and warranties herein set<br>forth, the Company hereby grants an option to the several Underwriters to purchase, severally and not jointly, up to 900,000 Option Securities<br>at $9.90 per Option Security. Said option may be exercised only to cover over-allotments in the sale of the Underwritten Securities by<br>the Underwriters. Said option may be exercised in whole or in part at any time on or before the 45th day after the date of the Prospectus<br>upon written notice by the Representative to the Company setting forth the number of Option Securities as to which the several Underwriters<br>are exercising the option and the settlement date. The number of Option Securities to be purchased by each Underwriter shall be based<br>upon the same percentage of the total number of the Option Securities to be purchased by the several Underwriters as such Underwriter<br>is purchasing of the Underwritten Securities, subject to such adjustments as the Representative in its absolute discretion shall make<br>to eliminate any fractional shares.
---	---
(c)	In addition to the discount from the public offering price represented by the purchase price set forth<br>in the first sentence of Section 2(a) of this Agreement, the Company hereby agrees to pay to the Underwriters a deferred discount of $0.30<br>per Ordinary Share (including both Underwritten Securities and Option Securities) purchased hereunder (the “Deferred Discount”).<br>The Underwriters agree that, at the Company’s sole and absolute discretion, up to $500,000 of the Deferred Discount may be paid<br>to third parties not participating in this offering that assist the Company in consummating its initial Business Combination. The Underwriters<br>hereby agree that if no Business Combination is consummated within the time period provided in the Amended and Restated Memorandum and<br>Articles of Association and the funds held under the Trust Agreement are distributed to the holders of the Ordinary Shares included in<br>the Securities sold pursuant to this Agreement (the “Public Shareholders”), (i) the Underwriters will forfeit any rights<br>or claims to the Deferred Discount and (ii) the trustee under the Trust Agreement is authorized to distribute the Deferred Discount to<br>the Public Shareholders on a pro rata basis.
---	---
(d)	Notwithstanding anything to the contrary in this Agreement, each Underwriter may at any time prior to<br>an initial Business Combination and in its sole and absolute discretion, by written notice to the Company, elect to forfeit any right<br>or claim to its Deferred Discount, in which case the Company agrees to instruct the trustee not to pay such Underwriter its Deferred Discount<br>upon the consummation of an initial Business Combination. For the avoidance of doubt, any such election by an Underwriter shall be without<br>prejudice to any right or claim of any other Underwriter to its respective portion of the Deferred Discount or to any other right such<br>Underwriter may have under this Agreement. In addition, for the avoidance of doubt, the obligations of the Underwriters under this Agreement<br>shall be fully satisfied upon the payment of the purchase price for the Ordinary Shares purchased by the Underwriters on the date of the<br>closing of the Offering without any further conditions.
---	---

3. DELIVERY AND PAYMENT.

Delivery of and payment for the Underwritten Securities and the Option Securities (if the option provided for in Section 2(b) hereof shall have been exercised on or before the second Business Day prior to the Closing Date) shall be made at 9:00 a.m., New York City time, on April 20, 2026, or at such time on such later date at least two Business Days after the foregoing date as the Representative shall designate, which date and time may be postponed by agreement between the Representative and the Company or as provided in Section 9 hereof (such date and time of delivery and payment for the Securities being herein called the “Closing Date”). Delivery of the Securities shall be made to the Representative for the respective accounts of the several Underwriters against payment by the several Underwriters through the Representative of the purchase price thereof by wire transfer payable in same-day funds to account specified by the Company and to the Trust Account as described below in this Section 3. Delivery of the Underwritten Securities and the Option Securities shall be made through the facilities of The Depository Trust Company (“DTC”) unless the Representative shall otherwise instruct.

(a)	Payment for the Underwritten Securities shall be made as follows: $59,400,000 of the net proceeds for<br>the Underwritten Securities (including $1,800,000 of Deferred Discount) shall be deposited in the Trust Account pursuant to the terms<br>of the Trust Agreement along with such portion of the gross proceeds from the sale of the Private Placement Shares (the “BasePrivate Placement Portion”) in order for the Trust Account to equal the product of the number of Underwritten Securities sold<br>and the Public Offering price per Ordinary Share as set forth on the cover of the Prospectus upon delivery to the Representative of the<br>Underwritten Securities through the facilities of DTC or, if the Representative has otherwise instructed, upon delivery to the Representative<br>of certificates (in form and substance satisfactory to the Representative) representing the Underwritten Securities, in each case for<br>the account of the Underwriters. The Underwritten Securities shall be registered in such name or names and in such authorized denominations<br>as the Representative may request in writing at least two Business Days prior to the Closing Date. If delivery is not made through the<br>facilities of DTC, the Company will permit the Representative to examine and package the Underwritten Securities for delivery, at least<br>one Business Day prior to the Closing Date. The Company shall not be obligated to sell or deliver the Underwritten Securities except upon<br>tender of payment by the Representative for all the Underwritten Securities. Payment by the Underwriters for the Underwritten Securities<br>is contingent on the (i) payment by the Sponsor to the Company for the Private Placement Shares and (ii) deposit of the Base Private Placement<br>Portion by or at the direction of the Company into the Trust Account, in each case at least one Business Day prior to the Closing Date.
(b)	Payment for the Option Securities shall be made as follows: $9.90 per Option Security (including $0.30<br>per Option Security of Deferred Discount) shall be deposited in the Trust Account pursuant to the terms of the Trust Agreement along with<br>such portion of the gross proceeds from the sale of the applicable number of over-allotment Private Placement Shares (the “Over-AllotmentPrivate Placement Portion”) in order for the Trust Account to equal the product of the number of Option Securities sold and<br>the Public Offering price per Ordinary Share as set forth on the cover of the Prospectus upon delivery to the Representative of the Option<br>Securities through the facilities of DTC or, if the Representative has otherwise instructed, upon delivery to the Representative of certificates<br>(in form and substance satisfactory to the Representative) representing the Option Securities (or through the facilities of DTC), in each<br>case for the account of the Underwriters. The Option Securities shall be registered in such name or names and in such authorized denominations<br>as the Representative may request in writing at least two Business Days prior to the Closing Date. If delivery is not made through the<br>facilities of DTC, the Company will permit the Representative to examine and package the Option Securities for delivery, at least one<br>Business Day prior to the Closing Date. The Company shall not be obligated to sell or deliver the Option Securities except upon tender<br>of payment by the Representative for all the Option Securities. Payment by the Underwriters for the Option Securities is contingent on<br>the (i) payment by the Sponsor to the Company for the applicable number of over-allotment Private Placement Shares and (ii) deposit of<br>the Over-Allotment Private Placement Portion by or at the direction of the Company into the Trust Account, in each case at least one Business<br>Day prior to the Closing Date.
---	---

(a)

Payment for the Underwritten Securities shall be made as follows: $59,400,000 of the net proceeds for the Underwritten Securities (including $1,800,000 of Deferred Discount) shall be deposited in the Trust Account pursuant to the terms of the Trust Agreement along with such portion of the gross proceeds from the sale of the Private Placement Shares (the “BasePrivate Placement Portion”) in order for the Trust Account to equal the product of the number of Underwritten Securities sold and the Public Offering price per Ordinary Share as set forth on the cover of the Prospectus upon delivery to the Representative of the Underwritten Securities through the facilities of DTC or, if the Representative has otherwise instructed, upon delivery to the Representative of certificates (in form and substance satisfactory to the Representative) representing the Underwritten Securities, in each case for the account of the Underwriters. The Underwritten Securities shall be registered in such name or names and in such authorized denominations as the Representative may request in writing at least two Business Days prior to the Closing Date. If delivery is not made through the facilities of DTC, the Company will permit the Representative to examine and package the Underwritten Securities for delivery, at least one Business Day prior to the Closing Date. The Company shall not be obligated to sell or deliver the Underwritten Securities except upon tender of payment by the Representative for all the Underwritten Securities. Payment by the Underwriters for the Underwritten Securities is contingent on the (i) payment by the Sponsor to the Company for the Private Placement Shares and (ii) deposit of the Base Private Placement Portion by or at the direction of the Company into the Trust Account, in each case at least one Business Day prior to the Closing Date.

(b)

Payment for the Option Securities shall be made as follows: $9.90 per Option Security (including $0.30 per Option Security of Deferred Discount) shall be deposited in the Trust Account pursuant to the terms of the Trust Agreement along with such portion of the gross proceeds from the sale of the applicable number of over-allotment Private Placement Shares (the “Over-AllotmentPrivate Placement Portion”) in order for the Trust Account to equal the product of the number of Option Securities sold and the Public Offering price per Ordinary Share as set forth on the cover of the Prospectus upon delivery to the Representative of the Option Securities through the facilities of DTC or, if the Representative has otherwise instructed, upon delivery to the Representative of certificates (in form and substance satisfactory to the Representative) representing the Option Securities (or through the facilities of DTC), in each case for the account of the Underwriters. The Option Securities shall be registered in such name or names and in such authorized denominations as the Representative may request in writing at least two Business Days prior to the Closing Date. If delivery is not made through the facilities of DTC, the Company will permit the Representative to examine and package the Option Securities for delivery, at least one Business Day prior to the Closing Date. The Company shall not be obligated to sell or deliver the Option Securities except upon tender of payment by the Representative for all the Option Securities. Payment by the Underwriters for the Option Securities is contingent on the (i) payment by the Sponsor to the Company for the applicable number of over-allotment Private Placement Shares and (ii) deposit of the Over-Allotment Private Placement Portion by or at the direction of the Company into the Trust Account, in each case at least one Business Day prior to the Closing Date.

---

If the option provided for in Section 2 hereof is exercised after the second Business Day prior to the Closing Date, the Company will deliver the Option Securities (at the expense of the Company) to the Representative, at 330 Madison Avenue, New York, NY 10017, on the date specified by the Representative (which shall be at least three Business Days after exercise of said option) for the respective accounts of the several Underwriters, against payment by the several Underwriters through the Representative of the purchase price thereof to the Trust Account as described above in Section 3(b). If settlement for the Option Securities occurs after the Closing Date, the Company will deliver to the Representative on the settlement date for the Option Securities, and the obligation of the Underwriters to purchase the Option Securities shall be conditioned upon receipt of, supplemental opinions, certificates and letters confirming as of such date the opinions, certificates and letters delivered on the Closing Date pursuant to Section 6 hereof.

4. OFFERING BY UNDERWRITERS.

It is understood that the several Underwriters propose to offer the Securities for sale to the public as set forth in the Prospectus (the “Offering”).

5. AGREEMENTS.

The Company agrees with the several Underwriters that:

(a)	Prior to the termination of the Offering, the Company will not file any amendment to the Registration<br>Statement or supplement to the Prospectus or any Rule 462(b) Registration Statement unless the Company has furnished you a copy for your<br>review prior to filing and will not file any such proposed amendment, supplement or Rule 462(b) Registration Statement to which you reasonably<br>object. The Company will cause the Prospectus, properly completed, and any supplement thereto, to be filed in a form approved by the Representative<br>with the Commission pursuant to the applicable paragraph of Rule 424(b) within the time period prescribed and will provide evidence satisfactory<br>to the Representative of such timely filing. The Company will promptly advise the Representative (i) when the Prospectus, and any supplement<br>thereto, shall have been filed (if required) with the Commission pursuant to Rule 424(b) or when any Rule 462(b) Registration Statement<br>or any Written Testing-the-Waters Communication shall have been filed with the Commission, (ii) when, prior to termination of the Offering,<br>any amendment to the Registration Statement shall have been filed or become effective, (iii) of any request by the Commission or its staff<br>for any amendment of the Registration Statement, any Rule 462(b) Registration Statement or any Written Testing-the-Waters Communication<br>or for any supplement to the Prospectus or for any additional information, (iv) of the issuance by the Commission of any stop order suspending<br>the effectiveness of the Registration Statement or any order preventing or suspending the use of the Preliminary Prospectus, the Prospectus<br>or any Written Testing-the-Waters Communication, or of the institution of any proceedings for that purpose or pursuant to Section 8A of<br>the Act and (v) of the receipt by the Company of any notification with respect to the suspension of the qualification of the Securities<br>for sale in any jurisdiction or the institution or threatening of any proceeding for such purpose. The Company shall use its best efforts<br>to prevent the issuance of any such stop order or the occurrence of any such suspension or objection to the use of the Registration Statement<br>and, upon such issuance, occurrence or notice of objection, to obtain as soon as possible the withdrawal of such stop order or relief<br>from such occurrence or objection, including, if necessary, by filing an amendment to the Registration Statement or a new registration<br>statement and using its best efforts to have such amendment or new registration statement declared effective as soon as practicable.
(b)	If, at any time prior to the filing of the Prospectus pursuant to Rule 424(b), any event or development<br>occurs as a result of which the Statutory Prospectus would include any untrue statement of a material fact or omit to state any material<br>fact necessary in order to make the statements therein in the light of the circumstances under which they were made at such time not misleading,<br>the Company will (i) notify promptly the Representative so that any use of the Statutory Prospectus may cease until it is amended or supplemented;<br>(ii) amend or supplement the Statutory Prospectus to correct such statement or omission; and (iii) supply any amendment or supplement<br>to you in such quantities as you may reasonably request.
---	---

(a)

Prior to the termination of the Offering, the Company will not file any amendment to the Registration Statement or supplement to the Prospectus or any Rule 462(b) Registration Statement unless the Company has furnished you a copy for your review prior to filing and will not file any such proposed amendment, supplement or Rule 462(b) Registration Statement to which you reasonably object. The Company will cause the Prospectus, properly completed, and any supplement thereto, to be filed in a form approved by the Representative with the Commission pursuant to the applicable paragraph of Rule 424(b) within the time period prescribed and will provide evidence satisfactory to the Representative of such timely filing. The Company will promptly advise the Representative (i) when the Prospectus, and any supplement thereto, shall have been filed (if required) with the Commission pursuant to Rule 424(b) or when any Rule 462(b) Registration Statement or any Written Testing-the-Waters Communication shall have been filed with the Commission, (ii) when, prior to termination of the Offering, any amendment to the Registration Statement shall have been filed or become effective, (iii) of any request by the Commission or its staff for any amendment of the Registration Statement, any Rule 462(b) Registration Statement or any Written Testing-the-Waters Communication or for any supplement to the Prospectus or for any additional information, (iv) of the issuance by the Commission of any stop order suspending the effectiveness of the Registration Statement or any order preventing or suspending the use of the Preliminary Prospectus, the Prospectus or any Written Testing-the-Waters Communication, or of the institution of any proceedings for that purpose or pursuant to Section 8A of the Act and (v) of the receipt by the Company of any notification with respect to the suspension of the qualification of the Securities for sale in any jurisdiction or the institution or threatening of any proceeding for such purpose. The Company shall use its best efforts to prevent the issuance of any such stop order or the occurrence of any such suspension or objection to the use of the Registration Statement and, upon such issuance, occurrence or notice of objection, to obtain as soon as possible the withdrawal of such stop order or relief from such occurrence or objection, including, if necessary, by filing an amendment to the Registration Statement or a new registration statement and using its best efforts to have such amendment or new registration statement declared effective as soon as practicable.

(b)

If, at any time prior to the filing of the Prospectus pursuant to Rule 424(b), any event or development occurs as a result of which the Statutory Prospectus would include any untrue statement of a material fact or omit to state any material fact necessary in order to make the statements therein in the light of the circumstances under which they were made at such time not misleading, the Company will (i) notify promptly the Representative so that any use of the Statutory Prospectus may cease until it is amended or supplemented; (ii) amend or supplement the Statutory Prospectus to correct such statement or omission; and (iii) supply any amendment or supplement to you in such quantities as you may reasonably request.

---

(c)	If, at any time when a prospectus relating to the Securities is required to be delivered under the Act<br>(including in circumstances where such requirement may be satisfied pursuant to Rule 172), any event or development occurs as a result<br>of which the Prospectus as then supplemented would include any untrue statement of a material fact or omit to state any material fact<br>necessary in order to make the statements therein in the light of the circumstances under which they were made at such time not misleading,<br>or if it shall be necessary to amend the Registration Statement or supplement the Prospectus to comply with the Act or the rules thereunder,<br>the Company promptly will (i) notify the Representative of any such event; (ii) prepare and file with the Commission, subject to the second<br>sentence of paragraph (a) of this Section 5, an amendment or supplement that will correct such statement or omission or effect such compliance;<br>and (iii) supply any supplemented Prospectus to you in such quantities as you may reasonably request.
(d)	As soon as practicable, the Company will make generally available to its security holders and to the Representative<br>an earnings statement or statements of the Company and its subsidiaries that will satisfy the provisions of Section 11(a) of the Act and<br>Rule 158; provided, that the Company will be deemed to have furnished such statements to its security holders and the Representative<br>to the extent they are filed on the Commission’s Electronic Data Gathering, Analysis, and Retrieval system (“EDGAR”)<br>or any successor system.
---	---
(e)	The Company will not make any offer relating to the Ordinary Shares that constitutes or would constitute<br>a Free Writing Prospectus or a portion thereof required to be filed by the Company with the Commission or retained by the Company under<br>Rule 433 of the Act.
---	---
(f)	The Company will furnish to the Representative and counsel for the Underwriters, without charge, signed<br>copies of the Registration Statement (including exhibits thereto) and to each other Underwriter a copy of the Registration Statement (without<br>exhibits thereto) and, so long as delivery of a prospectus by an Underwriter or dealer may be required by the Act (including in circumstances<br>where such requirement may be satisfied pursuant to Rule 172), as many copies of each Preliminary Prospectus, the Prospectus and any supplement<br>thereto as the Representative may reasonably request. The Company will pay the expenses of printing or other production of all documents<br>relating to the Offering.
---	---
(g)	The Company will arrange, if necessary, for the qualification of the Securities for sale under the laws<br>of such jurisdictions as the Representative may designate and will maintain such qualifications in effect so long as required for the<br>distribution of the Securities; provided, however, that in no event shall the Company be obligated to qualify to do business<br>in any jurisdiction where it is not now so qualified or to take any action that would subject it to service of process in suits, other<br>than those arising out of the offering or sale of the Securities, in any jurisdiction where it is not now so subject.
---	---
(h)	The Company will not, without the prior written consent of the Representative, (x) offer, sell, contract<br>to sell, pledge or otherwise dispose of (or enter into any transaction that is designed to, or might reasonably be expected to, result<br>in the disposition (whether by actual disposition or effective economic disposition due to cash settlement or otherwise) by the Company<br>or any affiliate of the Company or any person in privity with the Company or any affiliate of the Company), directly or indirectly, including<br>the filing (or participation in the filing) of a registration statement with the Commission in respect of, or establish or increase a<br>put equivalent position or liquidate or decrease a call equivalent position within the meaning of Section 16 of the Exchange Act with<br>respect to, any other Ordinary Shares or any securities convertible into, or exercisable, or exchangeable for, Ordinary Shares or publicly<br>announce an intention to effect any such transaction during the period commencing on the date hereof and ending 180 days after the date<br>of this Agreement; provided, however, that the Company may (1) issue and sell the Private Placement Shares, (2) issue and<br>sell the Option Securities on exercise of the option provided for in Section 2 hereof, (3) register with the Commission pursuant to the<br>Registration Rights Agreement, in accordance with the terms of the Registration Rights Agreement, the resale of the securities covered<br>thereby, and (4) issue securities in connection with a Business Combination or (y) release the Sponsor or any officer, director or director<br>nominee from the 180-day lock-up contained in the Letter Agreement; provided, that the foregoing restrictions shall not apply to<br>the forfeiture of any Founder Shares pursuant to the terms of the Letter Agreement or any transfer of Founder Shares to a current or future<br>independent director of the Company (as long as such current or future independent director is subject to the terms of the Letter Agreement<br>with respect to such Founder Shares at the time of such transfer).
---	---
(i)	The Company will not take, directly or indirectly, any action designed to or that would constitute or<br>that might reasonably be expected to cause or result in, under the Exchange Act or otherwise, stabilization or manipulation of the price<br>of any security of the Company to facilitate the sale or resale of the Securities.
---	---

(j)	The Company agrees to pay the costs and expenses relating to the following matters: (i) the preparation,<br>printing or reproduction and filing with the Commission of the Registration Statement (including financial statements and exhibits thereto),<br>each Preliminary Prospectus, the Prospectus and each amendment or supplement to any of them; (ii) the printing (or reproduction) and delivery<br>(including postage, air freight charges and charges for counting and packaging) of such copies of the Registration Statement, each Preliminary<br>Prospectus, the Prospectus and all amendments or supplements to any of them, as may, in each case, be reasonably requested for use in<br>connection with the offering and sale of the Securities; (iii) the preparation, printing, authentication, issuance and delivery of certificates<br>for the Securities, including any stamp or transfer taxes (but, in no event, taxes imposed on the net income of an Underwriter) in connection<br>with the original issuance and sale of the Securities; (iv) the printing (or reproduction) and delivery of this Agreement and all other<br>agreements or documents printed (or reproduced) and delivered in connection with the Offering; (v) the registration of the Securities<br>under the Exchange Act and the listing of the Securities on Nasdaq; (vi) the printing and delivery of a preliminary blue sky memorandum,<br>any registration or qualification of the Securities for offer and sale under the securities or blue sky laws of the several states, and<br>any filings required to be made with FINRA (including filing fees and the reasonable and documented fees and expenses of counsel for the<br>Underwriters relating to such filings, memorandum, registration and qualification in an aggregate amount of up to $25,000); (vii) the<br>transportation and other expenses incurred by or on behalf of the Company (and not the Underwriters) in connection with presentations<br>to prospective purchasers of the Securities; (viii) the fees and expenses of the Company’s accountants and the fees and expenses<br>of counsel for the Company; and (ix) all other costs and expenses incident to the performance by the Company of its obligations hereunder.
(k)	For a period of at least five (5) years from the Effective Date or until such earlier time at which the<br>Liquidation occurs, the Company shall use its commercially reasonable efforts to maintain the registration of the Ordinary Shares (or<br>such other security into which such Ordinary Shares may be exchanged in connection with an initial Business Combination) under the Exchange<br>Act, except after giving effect to a going private transaction after the completion of a Business Combination. The Company will not deregister<br>the Ordinary Shares under the Exchange Act (except in connection with a going private transaction after the completion of a Business Combination)<br>without the prior consent of the Representative.
---	---
(l)	The Company shall, on the date hereof, retain its independent registered public accounting firm to audit<br>the balance sheet of the Company as of the Closing Date (the “Audited Balance Sheet”) reflecting the receipt by the<br>Company of the proceeds of the Offering on the Closing Date. As soon as the Audited Balance Sheet becomes available, the Company shall<br>promptly, but not later than four Business Days after the Closing Date, file a Current Report on Form 8-K with the Commission, which Report<br>shall contain the Audited Balance Sheet. Additionally, upon the Company’s receipt of the proceeds from the exercise of all or any<br>portion of the option provided for in Section 2 hereof, the Company shall promptly, but not later than four Business Days after the receipt<br>of such proceeds, file a Current Report on Form 8-K with the Commission, which report shall disclose the Company’s sale of the Option<br>Securities and its receipt of the proceeds therefrom.
---	---
(m)	For a period of at least five (5) years from the Effective Date or until such earlier time at which the<br>Liquidation occurs or the Ordinary Shares cease to be publicly traded, the Company, at its expense, shall cause its regularly engaged<br>independent registered public accounting firm to review (but not audit) the Company’s financial statements for each of the first<br>three fiscal quarters prior to the announcement of quarterly financial information, the filing of the Company’s Form 10-Q quarterly<br>report and the mailing, if any, of quarterly financial information to shareholders.
---	---
(n)	For a period of at least five (5) years from the Effective Date or until such earlier time at which the<br>Liquidation occurs, the Company shall, to the extent such information or documents are not otherwise publicly available, upon written<br>request from the Representative, furnish to the Representative copies of such financial statements and other periodic and special reports<br>as the Company from time to time furnishes generally to holders of any class of securities, and, to the extent such information or documents<br>are not otherwise publicly available, upon written request from the Representative promptly furnish to the Representative: (i) a copy<br>of such registration statements, financial statements and periodic and special reports as the Company shall be required to file with the<br>Commission and from time to time furnishes generally to holders of any such class of its securities; and (ii) such additional documents<br>and information with respect to the Company and the affairs of any future subsidiaries of the Company as the Representative may from time<br>to time reasonably request, all subject to the execution of a satisfactory confidentiality agreement. Any registration statements, financial<br>statements, periodic and special reports or other additional documents referred to in the preceding sentence filed on the Commission’s<br>EDGAR website will be considered furnished for the purposes of this section.
---	---

(o)	For a period of at least five (5) years from the Effective Date or until such earlier time at which the<br>Liquidation occurs or the Ordinary Shares cease to be publicly traded, the Company shall retain a transfer agent.
(p)	In no event will the amounts payable by the Company for office space, utilities and secretarial and administrative<br>support exceed $20,000 per month in the aggregate until the earlier of the date of the consummation of the Business Combination or the<br>Liquidation.
---	---
(q)	In the event the Company seeks to enter into a Business Combination with an entity that is affiliated<br>with the Sponsor and/or any directors or officers of the Company, the Company, or a committee of independent directors, will obtain an<br>opinion from an independent investment banking firm or another independent entity that commonly renders valuation opinions stating that<br>the consideration to be paid by the Company in such Business Combination is fair to the Company from a financial point of view.
---	---
(r)	The Company will apply the net proceeds from the Offering and the sale of the Private Placement Shares<br>received by it in a manner consistent in all material respects with the applications described under the caption “Use of Proceeds”<br>in the Registration Statement, Statutory Prospectus and the Prospectus.
---	---
(s)	For a period of 60 days following the Effective Date, in the event any person or entity (regardless of<br>any FINRA affiliation or association) is engaged to assist the Company in its search for a merger candidate or to provide any other merger<br>and acquisition services, or has provided or will provide any investment banking, financial, advisory and/or consulting services to the<br>Company, the Company agrees that it shall promptly provide to FINRA (via a FINRA submission), and to the Representative and its counsel,<br>a notification prior to entering into the agreement or transaction relating to a potential Business Combination including: (i) the identity<br>of the person or entity providing any such services; (ii) complete details of all such services and copies of all agreements governing<br>such services prior to entering into the agreement or transaction; and (iii) justification as to why the value received by any person<br>or entity for such services is not underwriting compensation for the Offering. The Company also agrees that proper disclosure of such<br>arrangement or potential arrangement will be made in the tender offer materials or proxy statement, as applicable, which the Company may<br>file in connection with the Business Combination for purposes of offering redemption of shares held by its shareholders or for soliciting<br>shareholder approval, as applicable.
---	---
(t)	The Company shall advise FINRA, the Representative and its counsel, if it is aware that any 10% or greater<br>shareholder of the Company becomes an affiliate or associated person of a Member participating in the distribution of the Securities.
---	---
(u)	The Company shall cause the proceeds of the Offering and certain of the proceeds from the sale of the<br>Private Placement Shares to be held in the Trust Account to initially be invested only in United States government treasury obligations<br>with a maturity of 185 days or less or in money market funds meeting certain conditions under Rule 2a-7 under the Investment Company Act<br>which invest only in direct U.S. government treasury obligations; the holding of these assets in this form is intended to be temporary<br>and for the sole purpose of facilitating the intended business combination, and may at any time be held as cash or cash items, including<br>in demand deposit accounts at a bank. The Company will otherwise conduct its business in a manner so that it will not become subject to<br>the Investment Company Act. Furthermore, once the Company consummates a Business Combination, it will not be required to register as an<br>investment company under the Investment Company Act.
---	---

(v)	During the period prior to the Company’s initial Business Combination or Liquidation, the Company<br>may instruct the trustee under the Trust Agreement to release interest from the Trust Account in such amounts necessary to pay the Company’s<br>taxes; provided that such withdrawals may not be made from the principal held in the Trust Account (the “Permitted Withdrawals”).<br>Otherwise, all funds held in the Trust Account (including any interest income earned on the amounts held in the Trust Account (net of<br>Permitted Withdrawals)) will remain in the Trust Account until the earlier of the consummation of the Company’s initial Business<br>Combination or the Liquidation; provided, however, that in the event of the Liquidation, up to $100,000 of interest income<br>may be released to the Company if the proceeds of the Offering held outside of the Trust Account are not sufficient to cover the costs<br>and expenses associated with the liquidation and dissolution of the Company.
(w)	Prior to the consummation of a Business Combination or the Liquidation, the Company shall not issue any<br>Ordinary Shares, warrants or any options or other securities convertible into Ordinary Shares, or any shares of preferred stock, in each<br>case, that participate in any manner in the Trust Account or that vote as a class with the Ordinary Shares on a Business Combination.
---	---
(x)	Prior to the consummation of a Business Combination or the Liquidation, the Company’s audit committee<br>will review on a quarterly basis all payments made to the Sponsor, to the Company’s officers or directors, or to the Company’s<br>or any of such other persons’ respective affiliates.
---	---
(y)	The Company agrees that it shall use commercially reasonable efforts to prevent the Company from becoming<br>subject to Rule 419 prior to the consummation of any Business Combination, including, but not limited to, using commercially reasonable<br>efforts to prevent any of the Company’s outstanding securities from being deemed to be a “penny stock” as defined in<br>Rule 3a51-1 under the Exchange Act during such period.
---	---
(z)	To the extent required by Rule 13a-15(e) under the Exchange Act, the Company shall maintain “disclosure<br>controls and procedures” (as defined under Rule 13a-15(e) under the Exchange Act) and a system of internal accounting controls sufficient<br>to provide reasonable assurances that (i) transactions are executed in accordance with management’s general or specific authorization,<br>(ii) transactions are recorded as necessary in order to permit preparation of financial statements in accordance with GAAP and to maintain<br>accountability for assets, (iii) access to assets is permitted only in accordance with management’s general or specific authorization,<br>and (iv) the recorded accountability for assets is compared with existing assets at reasonable intervals and appropriate action is taken<br>with respect to any differences.
---	---
(aa)	The Company will use commercially reasonable efforts to effect and, for a period of at least five (5)<br>years from the Effective Date or until such earlier time at which Liquidation occurs, maintain the listing of the Ordinary Shares on Nasdaq<br>(or another national securities exchange).
---	---
(bb)	As soon as legally required to do so, the Company and its directors and officers, in their capacities<br>as such, shall take all actions necessary to comply with any applicable provisions of the Sarbanes-Oxley Act, including Section 402 related<br>to loans and Sections 302 and 906 related to certifications, and to comply with the Nasdaq Listing Rules.
---	---
(cc)	The Company shall not take any action or omit to take any action that would cause the Company to be in<br>breach or violation of its Amended and Restated Memorandum and Articles of Association.
---	---

(dd)	The Company shall seek to have all vendors, service providers (other than independent accountants), prospective<br>target businesses, lenders or other entities with which it does business enter into agreements waiving any right, title, interest or claim<br>of any kind in or to any monies held in the Trust Account for the benefit of the Public Shareholders. If any third party refuses to execute<br>an agreement waiving such claims to the monies held in the Trust Account, the Company will perform an analysis of the alternatives available<br>to it and will only enter into an agreement with a third party that has not executed a waiver if the Company’s Chief Executive Officer<br>believes that such third party’s engagement would be significantly more beneficial to the Company than any alternative.
(ee)	The Company may consummate the initial Business Combination and conduct redemptions of Ordinary Shares<br>for cash upon consummation of such Business Combination without a shareholder vote pursuant to Rule 13e-4 and Regulation 14E under the<br>Exchange Act, including the filing of tender offer documents with the Commission. Such tender offer documents will contain substantially<br>the same financial and other information about the initial Business Combination and the redemption rights as is required under the Commission’s<br>proxy rules and will provide each shareholder of the Company with the opportunity prior to the consummation of the initial Business Combination<br>to redeem the Ordinary Shares held by such shareholder for an amount of cash equal to (A) the aggregate amount then on deposit in the<br>Trust Account as of two business days prior to the consummation of the initial Business Combination, representing (x) certain of the proceeds<br>held in the Trust Account from the Offering and the sale of the Private Placement Shares and (y) any interest income earned on the funds<br>held in the Trust Account not previously released for Permitted Withdrawals, divided by (B) the total number of Ordinary Shares sold as<br>part of the Offering (the “Public Shares”) then outstanding. If, however, a shareholder vote is required by law or<br>stock exchange listing requirement in connection with the initial Business Combination or the Company decides to hold a shareholder vote<br>for business or other legal reasons, the Company will submit such Business Combination to the Company’s shareholders for their approval<br>(“Business Combination Vote”). With respect to the initial Business Combination Vote, if any, the Sponsor, and its<br>officers and directors, have agreed to vote all of their Founder Shares and any other Ordinary Shares purchased during or after the Offering<br>in favor of the Company’s initial Business Combination. If the Company seeks shareholder approval of the initial Business Combination,<br>the Company will offer to each Public Shareholder holding Ordinary Shares the right to have its shares redeemed in conjunction with a<br>proxy solicitation pursuant to the proxy rules of the Commission at a per share redemption price (the “Redemption Price”)<br>equal to (I) the aggregate amount then on deposit in the Trust Account as of two business days prior to the consummation of the initial<br>Business Combination, representing (1) certain of the proceeds held in the Trust Account from the Offering and the sale of the Private<br>Placement Shares and (2) any interest income earned on the funds held in the Trust Account not previously released for Permitted Withdrawals,<br>divided by (II) the total number of Public Shares then outstanding. If the Company seeks shareholder approval of the initial Business<br>Combination, the Company may proceed with such Business Combination only if a majority of the outstanding Ordinary Shares voted by the<br>shareholders at a duly held shareholders meeting are voted to approve such Business Combination. If, after seeking and receiving such<br>shareholder approval, the Company elects to so proceed, it will redeem shares, at the Redemption Price, from those Public Shareholders<br>who affirmatively requested such redemption. Only Public Shareholders holding Ordinary Shares who properly exercise their redemption rights,<br>in accordance with the applicable tender offer or proxy materials related to such Business Combination and the Amended and Restated Memorandum<br>and Articles of Association, shall be entitled to receive distributions from the Trust Account in connection with an initial Business<br>Combination, and the Company shall pay no distributions with respect to any other holders of shares in the capital of the Company in connection<br>therewith. In the event that the Company does not effect a Business Combination by twenty-four (24) months from the closing of the Offering<br>or such earlier date as the directors may approve in accordance with the Amended and Restated Memorandum and Articles of Association,<br>or such later time as the shareholders of the Company may approve in accordance with the Amended and Restated Memorandum and Articles<br>of Association, or a resolution of the Company’s shareholders is passed pursuant to the Companies Act (Revised) of the Cayman Islands<br>to commence the voluntary liquidation of the Company prior to the consummation of an initial Business Combination for any reason (the<br>“Completion Window”), the Company will (i) cease all operations except for the purpose of winding up, (ii) as promptly<br>as reasonably possible but not more than ten (10) business days thereafter, redeem 100% of the Public Shares, at a per-share price, payable<br>in cash, equal to the aggregate amount then on deposit in the Trust Account (including interest not previously released to the Company<br>for Permitted Withdrawals, and less up to $100,000 of interest to pay dissolution expenses), divided by the number of then outstanding<br>Public Shares, which redemption will completely extinguish Public Shareholders’ rights as shareholders (including the right to receive<br>further liquidation distributions, if any), subject to applicable law, and (iii) as promptly as reasonably possible following such redemption,<br>subject to the approval of the Company’s remaining Shareholders and the Company’s board of directors, liquidate and dissolve,<br>subject in each case to the Company’s obligations under Cayman Islands law to provide for claims of creditors and the requirements<br>of other applicable law. Only Public Shareholders holding Ordinary Shares included in the Securities will be entitled to receive such<br>redemption amounts and the Company shall pay no such redemption amounts or any distributions in liquidation with respect to any other<br>shares of the Company. The Sponsor and the Company’s officers and directors have agreed that they will not propose any amendment<br>to the Amended and Restated Memorandum and Articles of Association that would affect the substance or timing of the Company’s obligation<br>to redeem 100% of the outstanding Public Shares if the Company has not consummated a Business Combination within the Completion Window<br>unless the Company offers to redeem the Public Shares in connection with such amendment, as described in the Statutory Prospectus and<br>Prospectus.
---	---

(dd)

The Company shall seek to have all vendors, service providers (other than independent accountants), prospective target businesses, lenders or other entities with which it does business enter into agreements waiving any right, title, interest or claim of any kind in or to any monies held in the Trust Account for the benefit of the Public Shareholders. If any third party refuses to execute an agreement waiving such claims to the monies held in the Trust Account, the Company will perform an analysis of the alternatives available to it and will only enter into an agreement with a third party that has not executed a waiver if the Company’s Chief Executive Officer believes that such third party’s engagement would be significantly more beneficial to the Company than any alternative.

(ee)

The Company may consummate the initial Business Combination and conduct redemptions of Ordinary Shares for cash upon consummation of such Business Combination without a shareholder vote pursuant to Rule 13e-4 and Regulation 14E under the Exchange Act, including the filing of tender offer documents with the Commission. Such tender offer documents will contain substantially the same financial and other information about the initial Business Combination and the redemption rights as is required under the Commission’s proxy rules and will provide each shareholder of the Company with the opportunity prior to the consummation of the initial Business Combination to redeem the Ordinary Shares held by such shareholder for an amount of cash equal to (A) the aggregate amount then on deposit in the Trust Account as of two business days prior to the consummation of the initial Business Combination, representing (x) certain of the proceeds held in the Trust Account from the Offering and the sale of the Private Placement Shares and (y) any interest income earned on the funds held in the Trust Account not previously released for Permitted Withdrawals, divided by (B) the total number of Ordinary Shares sold as part of the Offering (the “Public Shares”) then outstanding. If, however, a shareholder vote is required by law or stock exchange listing requirement in connection with the initial Business Combination or the Company decides to hold a shareholder vote for business or other legal reasons, the Company will submit such Business Combination to the Company’s shareholders for their approval (“Business Combination Vote”). With respect to the initial Business Combination Vote, if any, the Sponsor, and its officers and directors, have agreed to vote all of their Founder Shares and any other Ordinary Shares purchased during or after the Offering in favor of the Company’s initial Business Combination. If the Company seeks shareholder approval of the initial Business Combination, the Company will offer to each Public Shareholder holding Ordinary Shares the right to have its shares redeemed in conjunction with a proxy solicitation pursuant to the proxy rules of the Commission at a per share redemption price (the “Redemption Price”) equal to (I) the aggregate amount then on deposit in the Trust Account as of two business days prior to the consummation of the initial Business Combination, representing (1) certain of the proceeds held in the Trust Account from the Offering and the sale of the Private Placement Shares and (2) any interest income earned on the funds held in the Trust Account not previously released for Permitted Withdrawals, divided by (II) the total number of Public Shares then outstanding. If the Company seeks shareholder approval of the initial Business Combination, the Company may proceed with such Business Combination only if a majority of the outstanding Ordinary Shares voted by the shareholders at a duly held shareholders meeting are voted to approve such Business Combination. If, after seeking and receiving such shareholder approval, the Company elects to so proceed, it will redeem shares, at the Redemption Price, from those Public Shareholders who affirmatively requested such redemption. Only Public Shareholders holding Ordinary Shares who properly exercise their redemption rights, in accordance with the applicable tender offer or proxy materials related to such Business Combination and the Amended and Restated Memorandum and Articles of Association, shall be entitled to receive distributions from the Trust Account in connection with an initial Business Combination, and the Company shall pay no distributions with respect to any other holders of shares in the capital of the Company in connection therewith. In the event that the Company does not effect a Business Combination by twenty-four (24) months from the closing of the Offering or such earlier date as the directors may approve in accordance with the Amended and Restated Memorandum and Articles of Association, or such later time as the shareholders of the Company may approve in accordance with the Amended and Restated Memorandum and Articles of Association, or a resolution of the Company’s shareholders is passed pursuant to the Companies Act (Revised) of the Cayman Islands to commence the voluntary liquidation of the Company prior to the consummation of an initial Business Combination for any reason (the “Completion Window”), the Company will (i) cease all operations except for the purpose of winding up, (ii) as promptly as reasonably possible but not more than ten (10) business days thereafter, redeem 100% of the Public Shares, at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the Trust Account (including interest not previously released to the Company for Permitted Withdrawals, and less up to $100,000 of interest to pay dissolution expenses), divided by the number of then outstanding Public Shares, which redemption will completely extinguish Public Shareholders’ rights as shareholders (including the right to receive further liquidation distributions, if any), subject to applicable law, and (iii) as promptly as reasonably possible following such redemption, subject to the approval of the Company’s remaining Shareholders and the Company’s board of directors, liquidate and dissolve, subject in each case to the Company’s obligations under Cayman Islands law to provide for claims of creditors and the requirements of other applicable law. Only Public Shareholders holding Ordinary Shares included in the Securities will be entitled to receive such redemption amounts and the Company shall pay no such redemption amounts or any distributions in liquidation with respect to any other shares of the Company. The Sponsor and the Company’s officers and directors have agreed that they will not propose any amendment to the Amended and Restated Memorandum and Articles of Association that would affect the substance or timing of the Company’s obligation to redeem 100% of the outstanding Public Shares if the Company has not consummated a Business Combination within the Completion Window unless the Company offers to redeem the Public Shares in connection with such amendment, as described in the Statutory Prospectus and Prospectus.

---

(ff)	In the event that the Company desires or is required by an applicable law or regulation to cause an announcement<br>(“Business Combination Announcement”) to be placed in The Wall Street Journal, The New York Times or any other news<br>or media publication or outlet or to be made via a public filing with the Commission announcing the consummation of the Business Combination<br>that indicates that the Underwriters were the underwriters in the Offering, the Company shall supply the Representative with a draft of<br>the Business Combination Announcement and provide the Representative with a reasonable advance opportunity to comment thereon, subject<br>to the agreement of the Underwriters to keep confidential such draft announcement in accordance with the Representative’s standard<br>policies regarding confidential information.
(gg)	Subject to the provisions of this paragraph, upon the consummation of the initial Business Combination,<br>the Company and the Representative will jointly direct the trustee to pay the Representative, on behalf of the Underwriters, the Deferred<br>Discount out of the proceeds of the Offering held in the Trust Account. The Underwriters shall have no claim to payment of any interest<br>earned on the portion of the proceeds held in the Trust Account representing the Deferred Discount. If the Company fails to consummate<br>its initial Business Combination within the Completion Window, the Deferred Discount will not be paid to the Representative and will,<br>instead, be included in the Liquidation distribution of the proceeds held in the Trust Account made to the Public Shareholders. In connection<br>with any such Liquidation, the Underwriters forfeit any rights or claims to the Deferred Discount.
---	---
(hh)	The Company will endeavor in good faith, and in cooperation with the Representative, to qualify the Securities<br>for offering and sale under the securities laws of such jurisdictions as the Representative may reasonably designate; provided<br>that no such qualification shall be required in any jurisdiction where, as a result thereof, the Company would be subject to service of<br>general process or to taxation as a foreign corporation doing business in such jurisdiction. Until the earliest of (i) the date on which<br>all Underwriters shall have ceased to engage in market-making activities in respect of the Securities, (ii) the date on which the Securities<br>are listed on Nasdaq (or any successor thereto), (iii) a going private transaction after the completion of a Business Combination, and<br>(iv) the date of the liquidation of the Company, in each jurisdiction where such qualification shall be effected, the Company will, unless<br>the Representative agrees that such action is not at the time necessary or advisable, use all reasonable efforts to file and make such<br>statements or reports at such times as are or may be required to qualify the Securities for offering and sale under the securities laws<br>of such jurisdiction.
---	---
(ii)	If at any time following the distribution of any Written Testing-the-Waters Communication, there occurred<br>or occurs an event or development as a result of which such Written Testing-the-Waters Communication included or would include any untrue<br>statement of a material fact or omitted or would omit to state any material fact necessary to make the statements therein in light of<br>the circumstances under which they were made at such time, not misleading, the Company will promptly (i) notify the Representative so<br>that use of the Written Testing-the-Waters Communication may cease until it is amended or supplemented; (ii) amend or supplement, at its<br>own expense, such Written Testing-the-Waters Communication to eliminate or correct such untrue statement or omission; and (iii) supply<br>any amendment or supplement to the Representative in such quantities as may be reasonably requested.
---	---
(jj)	The Company will promptly notify the Representative if the Company ceases to be an Emerging Growth Company<br>at any time prior to the later of completion of the distribution of the Securities within the meaning of the Act and completion of the<br>180-day restricted period referred to in Section 5(h) hereof.
---	---
(kk)	[Intentionally omitted.]
---	---
(ll)	Upon the earlier to occur of the expiration or termination of the Underwriters’ over-allotment option,<br>the Company shall cancel or otherwise effect the forfeiture/surrender for no consideration of Founder Shares from the Sponsor in an aggregate<br>amount equal to the number of Founder Shares determined by multiplying (a) 1,725,000 by (b) a fraction, (i) the numerator of which is<br>900,000 minus the number of Option Securities purchased by the Underwriters upon the exercise of their over-allotment option, and (ii)<br>the denominator of which is 900,000. For the avoidance of doubt, if the Underwriters exercise their over-allotment option in full, the<br>Company shall not cancel or otherwise effect the forfeiture/surrender for no consideration of the Founder Shares pursuant to this subsection.
---	---

6. CONDITIONS TO THE OBLIGATIONS OF THE UNDERWRITERS.

The obligations of the Underwriters to purchase the Underwritten Securities and the Option Securities, as the case may be, shall be subject to the accuracy of the representations and warranties on the part of the Company contained herein as of the Execution Time, the Closing Date and any settlement date pursuant to Section 3 hereof, to the accuracy of the statements of the Company made in any certificates pursuant to the provisions hereof, to the performance by the Company of its obligations hereunder and to the following additional conditions:

(a)	The Prospectus, and any supplement thereto, have been filed in the manner and within the time period required<br>by Rule 424(b); and no stop order suspending the effectiveness of the Registration Statement or any notice objecting to its use shall<br>have been issued and no proceedings for that purpose shall have been instituted or threatened.
(b)	The Company shall have requested and caused Loeb & Loeb LLP, counsel for the Company, to have furnished<br>to the Representative its opinions and negative assurance letter, each dated the Closing Date or settlement date (as applicable) and addressed<br>to the Representative, in a form reasonably acceptable to the Representative.
---	---
(c)	The Company shall have requested and caused Appleby (Cayman) Ltd., Cayman Islands counsel for the Company,<br>to have furnished to the Representative its opinions, dated the Closing Date and any settlement date, as applicable, and addressed to<br>the Representative, in form and substance reasonably acceptable to the Representative.
---	---
(d)	The Representative shall have received from Davis Polk & Wardwell LLP, counsel for the Underwriters,<br>such opinion or opinions and negative assurance letter, each dated the Closing Date or settlement date (as applicable) and addressed to<br>the Representative, with respect to the issuance and sale of the Securities, the Registration Statement, the Statutory Prospectus, the<br>Prospectus (together with any supplement thereto) and other related matters as the Representative may reasonably require, and the Company<br>shall have furnished to such counsel such documents as they request for the purpose of enabling them to pass upon such matters.
---	---
(e)	The Company shall have furnished to the Representative a certificate of the Company, signed by the Chief<br>Executive Officer and the principal financial or accounting officer of the Company, dated the Closing Date or settlement date (as applicable),<br>to the effect that the signers of such certificate have carefully examined the Registration Statement, each Preliminary Prospectus, the<br>Prospectus and any amendment or supplement thereto, and this Agreement and that:
---	---
i.	the representations and warranties of the Company in this Agreement are true and correct on and as of<br>the Closing Date or settlement date (as applicable) with the same effect as if made on the Closing Date or settlement date (as applicable)<br>and the Company has complied with all the agreements and satisfied all the conditions on its part to be performed or satisfied at or prior<br>to the Closing Date or settlement date (as applicable);
---	---
ii.	no stop order suspending the effectiveness of the Registration Statement or any notice objecting to its<br>use has been issued and no proceedings for that purpose have been instituted or, to the Company’s knowledge, threatened; and
---	---
iii.	since the date of the most recent financial statements included in the Statutory Prospectus and the Prospectus<br>(exclusive of any supplement thereto), there has been no Material Adverse Effect, except as set forth in or contemplated by the Statutory<br>Prospectus and the Prospectus (exclusive of any supplement thereto).
---	---

(f)	The Company shall have furnished to the Representative a certificate signed by a director or officer of<br>the Company, dated the Closing Date or settlement date (as applicable), certifying (i) that the Amended and Restated Memorandum and Articles<br>of Association is true and complete, has not been modified and is in full force and effect, (ii) that the resolutions relating to the<br>Offering contemplated by this agreement are in full force and effect and have not been modified, (iii) copies of all correspondence between<br>the Company or its counsel and the Commission, and (iv) as to the incumbency of the officers of the Company. The documents referred to<br>in such certificate shall be attached to such certificate.
(g)	The Company shall have requested and caused WithumSmith to have furnished to the Representative, at the<br>Execution Time and at the Closing Date or settlement date (as applicable), letters, dated respectively as of the Execution Time and as<br>of the Closing Date or settlement date (as applicable), in form and substance satisfactory to the Representative, confirming that they<br>are a registered public accounting firm that is independent with respect to the Company within the meaning of the Act and the Exchange<br>Act and the applicable rules and regulations adopted by the Commission thereunder and that they have performed a review of the audited<br>financial statements of the Company for the period from January 13, 2026 (inception) through February 13, 2026, provided, however,<br>that the cutoff date shall not be more than two business days prior to such Execution Time or Closing Date or settlement date, as applicable,<br>and stating in effect that:
---	---
i.	in their opinion the audited financial statements, the unaudited financial statements and any financial<br>statement schedules included in the Registration Statement, the Statutory Prospectus and the Prospectus and reported on by them comply<br>as to form in all material respects with the applicable accounting requirements of the Act and the related rules and regulations adopted<br>by the Commission; and
---	---
ii.	they have performed certain other specified procedures as a result of which they determined that certain<br>information of an accounting, financial or statistical nature (which is limited to accounting, financial or statistical information derived<br>from the general accounting records of the Company) set forth in the Registration Statement, the Statutory Prospectus and the Prospectus,<br>including the information set forth under the captions “Dilution” and “Capitalization” in the Statutory<br>Prospectus and the Prospectus, agrees with the accounting records of the Company, excluding any questions of legal interpretation.
---	---

References to the Prospectus in this paragraph (f) include any supplement thereto at the date of the letter.

(h)

Subsequent to the Execution Time or, if earlier, the dates as of which information is given in the Registration Statement (exclusive of any amendment thereof), the Statutory Prospectus and the Prospectus (exclusive of any supplement thereto), there shall not have been any change or decrease specified in the letter or letters referred to in paragraph (g) of this Section 6 or any change, or any development involving a prospective change, in or affecting the earnings, business, management, properties, assets, rights, operations, condition (financial or otherwise) or prospects of the Company, whether or not arising from transactions in the ordinary course of business, except as set forth in or contemplated in the Statutory Prospectus and the Prospectus (exclusive of any supplement thereto) the effect of which, in any case referred to in clause (i) or (ii) in paragraph (g) above, is, in the sole judgment of the Representative, so material and adverse as to make it impractical or inadvisable to proceed with the offering or delivery of the Securities as contemplated by the Registration Statement (exclusive of any amendment thereof), the Statutory Prospectus and the Prospectus (exclusive of any supplement thereto).

(i)	Prior to the Closing Date or settlement date (as applicable), the Company shall have furnished to the<br>Representative such further information, certificates and documents as the Representative may reasonably request.
(j)	FINRA shall not have raised any objection with respect to the fairness or reasonableness of the underwriting<br>or other arrangements of the transactions contemplated hereby.
---	---
(k)	The Securities shall be duly listed subject to notice of issuance on Nasdaq, satisfactory evidence of<br>which shall have been provided to the Representative.
---	---
(l)	On the Effective Date, the Company shall have delivered to the Representative executed copies of the Trust<br>Agreement, the Securities Subscription Agreement, the Private Placement Agreement, the Registration Rights Agreement, the Letter Agreement<br>and the Administrative Services Agreement.
---	---
(m)	[Intentionally omitted.]
---	---
(n)	At least one Business Day prior to the Closing Date or settlement date (as applicable), the Company shall<br>have caused the applicable purchase price for the Private Placement Shares to be deposited into the Trust Account so that together with<br>the net proceeds for the Ordinary Shares (including the Deferred Discount), or with respect to the Optional Securities, the net proceeds<br>from the Optional Securities (including the Deferred Discount), the Trust Account would equal the product of the number of Ordinary Shares<br>sold and the public offering price per Ordinary Share as set forth on the cover of the Prospectus. Notwithstanding the foregoing, in no<br>event will the Company take any action that would result in the Company receiving proceeds from the sale of the Private Placement Shares<br>in excess of the sum of: (i) the amount required to satisfy the obligation in the immediately preceding sentence; (ii) the amount of the<br>discount from the public offering price represented by the purchase price set forth in Section 2(a) of this Agreement, and (iii) the amount<br>of money to be held by the Company outside of the Trust Account, as disclosed in the Registration Statement, the Statutory Prospectus<br>and the Prospectus.
---	---
(o)	No order preventing or suspending the sale of the Ordinary Shares in any jurisdiction designated by the<br>Representative pursuant to Section 5(hh) hereof shall have been issued as of the Closing Date or settlement date (as applicable), and<br>no proceedings for that purpose shall have been instituted or shall have been threatened.
---	---

If any of the conditions specified in this Section 6 shall not have been fulfilled when and as provided in this Agreement, or if any of the opinions and certificates mentioned above or elsewhere in this Agreement shall not be reasonably satisfactory in form and substance to the Representative and counsel for the Underwriters, this Agreement and all obligations of the Underwriters hereunder may be canceled at, or at any time prior to, the Closing Date by the Representative. Notice of such cancellation shall be given to the Company in writing or by telephone or facsimile confirmed in writing.

The documents required to be delivered by this Section 6 shall be delivered at the office of Davis Polk & Wardwell LLP, counsel for the Underwriters, at 450 Lexington Avenue, New York, NY 10163, Attention: Derek Dostal and Robert Van de Mark, unless otherwise indicated herein, on the Closing Date or settlement date (as applicable).

7. REIMBURSEMENT OF UNDERWRITERS’ EXPENSES.

If the sale of the Securities provided for herein is not consummated because any condition to the obligations of the Underwriters set forth in Section 6 hereof is not satisfied, because of any termination pursuant to Section 10 hereof (other than clauses (ii), (iii) or (vi) thereof) or because of any refusal, inability or failure on the part of the Company to perform any agreement herein or comply with any provision hereof other than by reason of a default by any of the Underwriters, the Company will reimburse the Underwriters severally through the Representative on demand for all reasonable out-of-pocket expenses (including reasonable fees and disbursements of counsel, but, in no event, shall expenses exceed $25,000 or include taxes imposed on the net income of an Underwriter) that shall have been incurred by them in connection with the proposed purchase and sale of the Securities.

8. INDEMNIFICATION AND CONTRIBUTION.

(a)	The Company agrees to indemnify and hold harmless each Underwriter, the directors, officers, employees<br>and agents of each Underwriter, each person who controls any Underwriter within the meaning of either the Act or the Exchange Act and<br>each affiliate of each Underwriter against any and all losses, claims, damages or liabilities, joint or several, to which they or any<br>of them may become subject under the Act, the Exchange Act or other Federal or state statutory law or regulation, at common law or otherwise,<br>insofar as such losses, claims, damages or liabilities (or actions in respect thereof) arise out of or are based upon any untrue statement<br>or alleged untrue statement of a material fact contained in (i) the Registration Statement for the registration of the Securities as originally<br>filed or in any amendment thereof, or in any Preliminary Prospectus, the Statutory Prospectus, the Prospectus, any “road show”<br>as defined in Rule 433(h) of the Act or any Written Testing-the-Waters Communication or in any amendment thereof or supplement thereto,<br>or arise out of or are based upon the omission or alleged omission to state therein a material fact required to be stated therein or necessary<br>to make the statements therein not misleading, and (ii) any materials or information, including roadshow materials, provided to investors<br>by, or with the approval of, the Company in connection with obtaining stockholder approval of the Business Combination, including any<br>road show or investor presentations made to investors by the Company (whether in person or electronically), or in any proxy statement,<br>prospectus (or any amendment or supplement thereto), any preliminary prospectus, or any Written Testing-the-Waters Communication, in each<br>case used in connection with the initial Business Combination, and agrees to reimburse each such indemnified party, as incurred, for any<br>legal or other expenses reasonably incurred by them in connection with investigating or defending any such loss, claim, damage, liability<br>or action; provided, however, that the Company will not be liable in any such case to the extent that any such loss, claim,<br>damage or liability arises out of or is based upon any such untrue statement or alleged untrue statement or omission or alleged omission<br>made therein in reliance upon and in conformity with written information furnished to the Company by or on behalf of any Underwriter through<br>the Representative specifically for inclusion therein, it being understood and agreed that the only such information furnished by any<br>Underwriter consists of the information described in the last sentence of Section 8(b) hereof. This indemnity agreement will be in addition<br>to any liability that the Company may otherwise have.
(b)	Each Underwriter severally and not jointly agrees to indemnify and hold harmless the Company, each of<br>its directors, each of its officers who signs the Registration Statement, and each person who controls the Company within the meaning<br>of either the Act or the Exchange Act, to the same extent as the foregoing indemnity from the Company to each Underwriter, but only with<br>reference to written information relating to such Underwriter furnished to the Company by or on behalf of such Underwriter through the<br>Representative specifically for inclusion in the documents referred to in the foregoing indemnity. This indemnity agreement will be in<br>addition to any liability that any Underwriter may otherwise have. The Company acknowledges that the following statements set forth under<br>the heading “Underwriting” in the Preliminary Prospectus, the Statutory Prospectus and the Prospectus constitute the only<br>information furnished in writing by or on behalf of the several Underwriters for inclusion in the documents referred to in the foregoing<br>indemnity: (x) the list of Underwriters and their respective roles and participation in the sale of the Securities, (y) the sentences<br>related to concessions and reallowances and the Underwriter’s intention not to make sales to discretionary accounts, and (z) the<br>paragraphs related to stabilization, syndicate covering transactions and penalty bids.
---	---

(a)

The Company agrees to indemnify and hold harmless each Underwriter, the directors, officers, employees and agents of each Underwriter, each person who controls any Underwriter within the meaning of either the Act or the Exchange Act and each affiliate of each Underwriter against any and all losses, claims, damages or liabilities, joint or several, to which they or any of them may become subject under the Act, the Exchange Act or other Federal or state statutory law or regulation, at common law or otherwise, insofar as such losses, claims, damages or liabilities (or actions in respect thereof) arise out of or are based upon any untrue statement or alleged untrue statement of a material fact contained in (i) the Registration Statement for the registration of the Securities as originally filed or in any amendment thereof, or in any Preliminary Prospectus, the Statutory Prospectus, the Prospectus, any “road show” as defined in Rule 433(h) of the Act or any Written Testing-the-Waters Communication or in any amendment thereof or supplement thereto, or arise out of or are based upon the omission or alleged omission to state therein a material fact required to be stated therein or necessary to make the statements therein not misleading, and (ii) any materials or information, including roadshow materials, provided to investors by, or with the approval of, the Company in connection with obtaining stockholder approval of the Business Combination, including any road show or investor presentations made to investors by the Company (whether in person or electronically), or in any proxy statement, prospectus (or any amendment or supplement thereto), any preliminary prospectus, or any Written Testing-the-Waters Communication, in each case used in connection with the initial Business Combination, and agrees to reimburse each such indemnified party, as incurred, for any legal or other expenses reasonably incurred by them in connection with investigating or defending any such loss, claim, damage, liability or action; provided, however, that the Company will not be liable in any such case to the extent that any such loss, claim, damage or liability arises out of or is based upon any such untrue statement or alleged untrue statement or omission or alleged omission made therein in reliance upon and in conformity with written information furnished to the Company by or on behalf of any Underwriter through the Representative specifically for inclusion therein, it being understood and agreed that the only such information furnished by any Underwriter consists of the information described in the last sentence of Section 8(b) hereof. This indemnity agreement will be in addition to any liability that the Company may otherwise have.

(b)

Each Underwriter severally and not jointly agrees to indemnify and hold harmless the Company, each of its directors, each of its officers who signs the Registration Statement, and each person who controls the Company within the meaning of either the Act or the Exchange Act, to the same extent as the foregoing indemnity from the Company to each Underwriter, but only with reference to written information relating to such Underwriter furnished to the Company by or on behalf of such Underwriter through the Representative specifically for inclusion in the documents referred to in the foregoing indemnity. This indemnity agreement will be in addition to any liability that any Underwriter may otherwise have. The Company acknowledges that the following statements set forth under the heading “Underwriting” in the Preliminary Prospectus, the Statutory Prospectus and the Prospectus constitute the only information furnished in writing by or on behalf of the several Underwriters for inclusion in the documents referred to in the foregoing indemnity: (x) the list of Underwriters and their respective roles and participation in the sale of the Securities, (y) the sentences related to concessions and reallowances and the Underwriter’s intention not to make sales to discretionary accounts, and (z) the paragraphs related to stabilization, syndicate covering transactions and penalty bids.

---

(c)	Promptly after receipt by an indemnified party under this Section 8 of notice of the commencement of any<br>action, such indemnified party will, if a claim in respect thereof is to be made against the indemnifying party under this Section 8,<br>notify the indemnifying party in writing of the commencement thereof; but the failure so to notify the indemnifying party will not relieve<br>it from liability under paragraph (a) or (b) above unless and to the extent it did not otherwise learn of such action and such failure<br>results in the forfeiture by the indemnifying party of material rights and defenses and will not, in any event, relieve the indemnifying<br>party from any obligations to any indemnified party other than the indemnification obligation provided in paragraph (a) or (b) above.<br>The indemnifying party shall be entitled to appoint counsel of the indemnifying party’s choice at the indemnifying party’s<br>expense to represent the indemnified party in any action for which indemnification is sought (in which case the indemnifying party shall<br>not thereafter be responsible for the fees and expenses of any separate counsel retained by the indemnified party or parties except as<br>set forth below); provided, however, that such counsel shall be satisfactory to the indemnified party. Notwithstanding the<br>indemnifying party’s election to appoint counsel to represent the indemnified party in an action, the indemnified party shall have<br>the right to employ separate counsel (including local counsel), and the indemnifying party shall bear the reasonable fees, costs and expenses<br>of such separate counsel if (i) the use of counsel chosen by the indemnifying party to represent the indemnified party would present such<br>counsel with a conflict of interest, (ii) the actual or potential defendants in, or targets of, any such action include both the indemnified<br>party and the indemnifying party and the indemnified party shall have reasonably concluded that there may be legal defenses available<br>to it and/or other indemnified parties that are different from or additional to those available to the indemnifying party, (iii) the indemnifying<br>party shall not have employed counsel satisfactory to the indemnified party to represent the indemnified party within a reasonable time<br>after notice of the institution of such action or (iv) the indemnifying party shall authorize the indemnified party to employ separate<br>counsel at the expense of the indemnifying party. An indemnifying party will not, without the prior written consent of the indemnified<br>parties (which consent shall not be unreasonably withheld, delayed or conditioned), settle or compromise or consent to the entry of any<br>judgment with respect to any pending or threatened claim, action, suit or proceeding in respect of which indemnification or contribution<br>may be sought hereunder (whether or not the indemnified parties are actual or potential parties to such claim or action) unless (i) such<br>settlement, compromise or consent includes an unconditional release of each indemnified party from all liability arising out of such claim,<br>action, suit or proceeding and (ii) does not include a statement as to or an admission of fault, culpability or a failure to act by or<br>on behalf of any indemnified party. If at any time an indemnified party shall have requested an indemnifying party to reimburse the indemnified<br>party for fees and expenses of counsel, such indemnifying party agrees that it shall be liable for any settlement of any proceeding effected<br>without its written consent if (i) such settlement is entered into more than 45 days after receipt by such indemnifying party of the aforesaid<br>request, (ii) such indemnifying party shall have received notice of the terms of such settlement at least 45 days prior to such settlement<br>being entered into and (iii) such indemnifying party shall not have reimbursed such indemnified party in accordance with such request<br>prior to the date of such settlement.
(d)	In the event that the indemnity provided in paragraph (a) or (b) of this Section 8 is unavailable to or<br>insufficient to hold harmless an indemnified party for any reason, the Company and the Underwriters severally agree to contribute to the<br>aggregate losses, claims, damages and liabilities (including legal or other expenses reasonably incurred in connection with investigating<br>or defending the same) (collectively “Losses”) to which the Company and one or more of the Underwriters may be subject<br>in such proportion as is appropriate to reflect the relative benefits received by the Company on the one hand and by the Underwriters<br>on the other from the Offering; provided, however, that in no case shall any Underwriter (except as may be provided in any<br>agreement among underwriters relating to the Offering) be responsible for any amount in excess of the underwriting discount or commission<br>applicable to the Securities purchased by such Underwriter hereunder. If the allocation provided by the immediately preceding sentence<br>is unavailable for any reason, the Company and the Underwriters severally shall contribute in such proportion as is appropriate to reflect<br>not only such relative benefits but also the relative fault of the Company on the one hand and of the Underwriters on the other in connection<br>with the statements or omissions that resulted in such Losses as well as any other relevant equitable considerations. Benefits received<br>by the Company shall be deemed to be equal to the total net proceeds from the Offering (before deducting expenses) received by it, and<br>benefits received by the Underwriters shall be deemed to be equal to the total underwriting discounts and commissions, in each case as<br>set forth on the cover page of the Prospectus. Relative fault shall be determined by reference to, among other things, whether any untrue<br>or any alleged untrue statement of a material fact or the omission or alleged omission to state a material fact relates to information<br>provided by the Company on the one hand or the Underwriters on the other, the intent of the parties and their relative knowledge, access<br>to information and opportunity to correct or prevent such untrue statement or omission. The Company and the Underwriters agree that it<br>would not be just and equitable if contribution were determined by pro rata allocation or any other method of allocation that does not<br>take account of the equitable considerations referred to above. Notwithstanding the provisions of this paragraph (d), no person guilty<br>of fraudulent misrepresentation (within the meaning of Section 11(f) of the Act) shall be entitled to contribution from any person who<br>was not guilty of such fraudulent misrepresentation. For purposes of this Section 8, each person who controls an Underwriter within the<br>meaning of either the Act or the Exchange Act and each director, officer, employee and agent of an Underwriter shall have the same rights<br>to contribution as such Underwriter, and each person who controls the Company within the meaning of either the Act or the Exchange Act,<br>each officer of the Company who shall have signed the Registration Statement and each director of the Company shall have the same rights<br>to contribution as the Company, subject in each case to the applicable terms and conditions of this paragraph (d).
---	---

(c)

Promptly after receipt by an indemnified party under this Section 8 of notice of the commencement of any action, such indemnified party will, if a claim in respect thereof is to be made against the indemnifying party under this Section 8, notify the indemnifying party in writing of the commencement thereof; but the failure so to notify the indemnifying party will not relieve it from liability under paragraph (a) or (b) above unless and to the extent it did not otherwise learn of such action and such failure results in the forfeiture by the indemnifying party of material rights and defenses and will not, in any event, relieve the indemnifying party from any obligations to any indemnified party other than the indemnification obligation provided in paragraph (a) or (b) above. The indemnifying party shall be entitled to appoint counsel of the indemnifying party’s choice at the indemnifying party’s expense to represent the indemnified party in any action for which indemnification is sought (in which case the indemnifying party shall not thereafter be responsible for the fees and expenses of any separate counsel retained by the indemnified party or parties except as set forth below); provided, however, that such counsel shall be satisfactory to the indemnified party. Notwithstanding the indemnifying party’s election to appoint counsel to represent the indemnified party in an action, the indemnified party shall have the right to employ separate counsel (including local counsel), and the indemnifying party shall bear the reasonable fees, costs and expenses of such separate counsel if (i) the use of counsel chosen by the indemnifying party to represent the indemnified party would present such counsel with a conflict of interest, (ii) the actual or potential defendants in, or targets of, any such action include both the indemnified party and the indemnifying party and the indemnified party shall have reasonably concluded that there may be legal defenses available to it and/or other indemnified parties that are different from or additional to those available to the indemnifying party, (iii) the indemnifying party shall not have employed counsel satisfactory to the indemnified party to represent the indemnified party within a reasonable time after notice of the institution of such action or (iv) the indemnifying party shall authorize the indemnified party to employ separate counsel at the expense of the indemnifying party. An indemnifying party will not, without the prior written consent of the indemnified parties (which consent shall not be unreasonably withheld, delayed or conditioned), settle or compromise or consent to the entry of any judgment with respect to any pending or threatened claim, action, suit or proceeding in respect of which indemnification or contribution may be sought hereunder (whether or not the indemnified parties are actual or potential parties to such claim or action) unless (i) such settlement, compromise or consent includes an unconditional release of each indemnified party from all liability arising out of such claim, action, suit or proceeding and (ii) does not include a statement as to or an admission of fault, culpability or a failure to act by or on behalf of any indemnified party. If at any time an indemnified party shall have requested an indemnifying party to reimburse the indemnified party for fees and expenses of counsel, such indemnifying party agrees that it shall be liable for any settlement of any proceeding effected without its written consent if (i) such settlement is entered into more than 45 days after receipt by such indemnifying party of the aforesaid request, (ii) such indemnifying party shall have received notice of the terms of such settlement at least 45 days prior to such settlement being entered into and (iii) such indemnifying party shall not have reimbursed such indemnified party in accordance with such request prior to the date of such settlement.

(d)

In the event that the indemnity provided in paragraph (a) or (b) of this Section 8 is unavailable to or insufficient to hold harmless an indemnified party for any reason, the Company and the Underwriters severally agree to contribute to the aggregate losses, claims, damages and liabilities (including legal or other expenses reasonably incurred in connection with investigating or defending the same) (collectively “Losses”) to which the Company and one or more of the Underwriters may be subject in such proportion as is appropriate to reflect the relative benefits received by the Company on the one hand and by the Underwriters on the other from the Offering; provided, however, that in no case shall any Underwriter (except as may be provided in any agreement among underwriters relating to the Offering) be responsible for any amount in excess of the underwriting discount or commission applicable to the Securities purchased by such Underwriter hereunder. If the allocation provided by the immediately preceding sentence is unavailable for any reason, the Company and the Underwriters severally shall contribute in such proportion as is appropriate to reflect not only such relative benefits but also the relative fault of the Company on the one hand and of the Underwriters on the other in connection with the statements or omissions that resulted in such Losses as well as any other relevant equitable considerations. Benefits received by the Company shall be deemed to be equal to the total net proceeds from the Offering (before deducting expenses) received by it, and benefits received by the Underwriters shall be deemed to be equal to the total underwriting discounts and commissions, in each case as set forth on the cover page of the Prospectus. Relative fault shall be determined by reference to, among other things, whether any untrue or any alleged untrue statement of a material fact or the omission or alleged omission to state a material fact relates to information provided by the Company on the one hand or the Underwriters on the other, the intent of the parties and their relative knowledge, access to information and opportunity to correct or prevent such untrue statement or omission. The Company and the Underwriters agree that it would not be just and equitable if contribution were determined by pro rata allocation or any other method of allocation that does not take account of the equitable considerations referred to above. Notwithstanding the provisions of this paragraph (d), no person guilty of fraudulent misrepresentation (within the meaning of Section 11(f) of the Act) shall be entitled to contribution from any person who was not guilty of such fraudulent misrepresentation. For purposes of this Section 8, each person who controls an Underwriter within the meaning of either the Act or the Exchange Act and each director, officer, employee and agent of an Underwriter shall have the same rights to contribution as such Underwriter, and each person who controls the Company within the meaning of either the Act or the Exchange Act, each officer of the Company who shall have signed the Registration Statement and each director of the Company shall have the same rights to contribution as the Company, subject in each case to the applicable terms and conditions of this paragraph (d).

---

(e)	In any proceeding relating to the Registration Statement, the Preliminary Prospectus, the Statutory Prospectus,<br>any Written Testing-the-Waters Communication, the Prospectus or any supplement or amendment thereto, each party against whom contribution<br>may be sought under this Section 8 hereby consents to the exclusive jurisdiction of the federal courts of the United States of America<br>located in the City and County of New York, Borough of Manhattan and the courts of the State of New York located in the City and County<br>of New York, Borough of Manhattan (collectively, the “Specified Courts”), agrees that process issuing from such courts<br>may be served upon it by any other contributing party and consents to the service of such process and agrees that any other contributing<br>party may join it as an additional defendant in any such proceeding in which such other contributing party is a party.
(f)	Any losses, claims, damages, liabilities or expenses for which an indemnified party is entitled to indemnification<br>or contribution under this Section 8 shall be paid by the indemnifying party to the indemnified party as such losses, claims, damages,<br>liabilities or expenses are incurred. The indemnity and contribution agreements contained in this Section 8 and the representations and<br>warranties of the Company set forth in this Agreement shall remain operative and in full force and effect, regardless of (i) any investigation<br>made by or on behalf of any Underwriter, its directors or officers or any person controlling any Underwriter, the Company, its directors<br>or officers or any persons controlling the Company, (ii) acceptance of any Securities and payment therefor hereunder, and (iii) any termination<br>of this Agreement. A successor to any Underwriter, its directors or officers or any person controlling any Underwriter, or to the Company,<br>its directors or officers, or any person controlling the Company, shall be entitled to the benefits of the indemnity, contribution and<br>reimbursement agreements contained in this Section 8.
---	---

(e)

In any proceeding relating to the Registration Statement, the Preliminary Prospectus, the Statutory Prospectus, any Written Testing-the-Waters Communication, the Prospectus or any supplement or amendment thereto, each party against whom contribution may be sought under this Section 8 hereby consents to the exclusive jurisdiction of the federal courts of the United States of America located in the City and County of New York, Borough of Manhattan and the courts of the State of New York located in the City and County of New York, Borough of Manhattan (collectively, the “Specified Courts”), agrees that process issuing from such courts may be served upon it by any other contributing party and consents to the service of such process and agrees that any other contributing party may join it as an additional defendant in any such proceeding in which such other contributing party is a party.

(f)

Any losses, claims, damages, liabilities or expenses for which an indemnified party is entitled to indemnification or contribution under this Section 8 shall be paid by the indemnifying party to the indemnified party as such losses, claims, damages, liabilities or expenses are incurred. The indemnity and contribution agreements contained in this Section 8 and the representations and warranties of the Company set forth in this Agreement shall remain operative and in full force and effect, regardless of (i) any investigation made by or on behalf of any Underwriter, its directors or officers or any person controlling any Underwriter, the Company, its directors or officers or any persons controlling the Company, (ii) acceptance of any Securities and payment therefor hereunder, and (iii) any termination of this Agreement. A successor to any Underwriter, its directors or officers or any person controlling any Underwriter, or to the Company, its directors or officers, or any person controlling the Company, shall be entitled to the benefits of the indemnity, contribution and reimbursement agreements contained in this Section 8.

---

9. DEFAULT BY AN UNDERWRITER.

If any one or more Underwriters shall fail to purchase and pay for any of the Securities agreed to be purchased by such Underwriter or Underwriters hereunder and such failure to purchase shall constitute a default in the performance of its or their obligations under this Agreement, the remaining Underwriters shall be obligated severally to take up and pay for (in the respective proportions that the amount of Securities set forth opposite their names in Schedule I hereto bears to the aggregate amount of Securities set forth opposite the names of all the remaining Underwriters) the Securities that the defaulting Underwriter or Underwriters agreed but failed to purchase; provided, however, that in the event that the aggregate amount of Securities that the defaulting Underwriter or Underwriters agreed but failed to purchase shall exceed 10% of the Underwritten Securities, the remaining Underwriters shall have the right to purchase all, but shall not be under any obligation to purchase any, of the Securities. If within one Business Day after such default relating to more than 10% of the Underwritten Securities the remaining Underwriters do not arrange for the purchase of such Underwritten Securities, then the Company shall be entitled to a further period of one Business Day within which to procure another party or parties reasonably satisfactory to you to purchase said Underwritten Securities. In the event that neither the remaining Underwriters nor the Company purchase or arrange for the purchase of all of the Underwritten Securities to which a default relates as provided in this Section 9, this Agreement will terminate without liability to any nondefaulting Underwriter or the Company. In the event of a default by any Underwriter as set forth in this Section 9, the Closing Date shall be postponed for such period, not exceeding five Business Days, as the Representative shall determine in order that the required changes in the Registration Statement and the Prospectus or in any other documents or arrangements may be effected. Nothing contained in this Agreement shall relieve any defaulting Underwriter of its liability, if any, to the Company and any nondefaulting Underwriter for damages occasioned by its default hereunder.

10. TERMINATION.

This Agreement shall be subject to termination in the absolute discretion of the Representative, by notice given to the Company prior to delivery of and payment for the Securities, if at any time prior to such delivery and payment any of the following has occurred: (i) trading in the Company’s Ordinary Shares shall have been suspended by the Commission, or trading in securities generally on the NYSE or Nasdaq Stock Market LLC shall have been suspended or limited or minimum prices shall have been established on such exchange or trading market, (ii) a banking moratorium shall have been declared either by Federal or New York State authorities, (iii) there shall have occurred any outbreak or escalation of hostilities, declaration by the United States of a national emergency or war, or other national or international calamity or crisis (including, without limitation, an act of terrorism) or change in economic or political conditions the effect of which on financial markets is such as to make it, in the sole judgment of the Representative, impractical or inadvisable to proceed with the offering or delivery of the Securities as contemplated by the Statutory Prospectus or the Prospectus (exclusive of any supplement thereto), (iv) since the respective dates as of which information is given in the Registration Statement, the Statutory Prospectus and the Prospectus, any material adverse change or any development involving a prospective material adverse change in or affecting the earnings, business, management, properties, assets, rights, operations, condition (financial or otherwise) or prospects of the Company, whether or not arising in the ordinary course of business, (v) the enactment, publication, decree or other promulgation of any statute, regulation, rule or order of any court or other governmental authority which in your opinion materially and adversely affects or may materially and adversely affect the business or operations of the Company, or (vi) the taking of any action by any governmental body or agency in respect of its monetary or fiscal affairs which in your opinion has a material adverse effect on the securities markets in the United States.

11. REPRESENTATIONS AND INDEMNITIES TO SURVIVE.

The respective agreements, representations, warranties, indemnities and other statements of the Company or its officers and of the Underwriters set forth in or made pursuant to this Agreement will remain in full force and effect, regardless of any investigation made by or on behalf of any Underwriter or the Company or any of the officers, directors, employees, agents or controlling persons referred to in Section 8 hereof, and will survive delivery of and payment for the Securities. The provisions of Sections 7 and 8 hereof shall survive the termination or cancellation of this Agreement.

12. NOTICES.

All communications hereunder will be in writing and effective only on receipt, and will be mailed, delivered or e-mailed.

If to the Representative:

Guggenheim Securities, LLC

330 Madison Avenue New York, New York 10017

Attention: Michael Jiang, Senior Managing Director

Email: michael.jiang@guggenheimpartners.com.

If to the Company:

JATT II Acquisition Corp

153 Central Avenue

C/O 56

Westfield, NJ 07091

Attention: Nicholas Fernandez

Email: nicholas.fernandez@athanorcapital.com

Copy (which copy shall not constitute notice) to:

Loeb & Loeb LLP

345 Park Avenue

New York, NY 10154

Attention: Giovanni Caruso, Esq

Email: gcaruso@loeb.com

13. SUCCESSORS.

This Agreement will inure to the benefit of and be binding upon the parties hereto and their respective successors and the officers, directors, employees, agents and controlling persons referred to in Section 8 hereof, and no other person will have any right or obligation hereunder.

14. NO FIDUCIARY DUTY.

The Company hereby acknowledges that (a) the purchase and sale of the Securities pursuant to this Agreement is an arm’s-length commercial transaction between the Company, on the one hand, and the Underwriters and any affiliate through which any of them may be acting, on the other, (b) the Underwriters are each acting as principal and not as an agent or fiduciary of the Company and (c) the Company’s engagement of the Underwriters in connection with the Offering and the process leading up to the Offering is as independent contractors and not in any other capacity. Furthermore, the Company agrees that it is solely responsible for making its own judgments in connection with the Offering (irrespective of whether any of the Underwriters has advised or is currently advising the Company on related or other matters). The Company agrees that it will not claim that the Underwriters have rendered advisory services of any nature or respect, or owe an agency, fiduciary or similar duty to the Company, in connection with such transaction or the process leading thereto. None of the activities of the Underwriters in connection with the transactions contemplated herein constitutes a recommendation, investment advice, or solicitation of any action by the Underwriters with respect to any entity or natural person.

15. RECOGNITION OF THE U.S. SPECIAL RESOLUTION REGIMES.

(a)	In the event that any Underwriter that is a Covered Entity becomes subject to a proceeding under a U.S.<br>Special Resolution Regime, the transfer from such Underwriter of this Agreement, and any interest and obligation in or under this Agreement,<br>will be effective to the same extent as the transfer would be effective under the U.S. Special Resolution Regime if this Agreement, and<br>any such interest and obligation, were governed by the laws of the United States or a state of the United States.
(b)	In the event that any Underwriter that is a Covered Entity or a BHC Act Affiliate of such Underwriter<br>becomes subject to a proceeding under a U.S. Special Resolution Regime, Default Rights under this Agreement that may be exercised against<br>such Underwriter are permitted to be exercised to no greater extent than such Default Rights could be exercised under the U.S. Special<br>Resolution Regime if this Agreement were governed by the laws of the United States or a state of the United States.
---	---
(c)	For purposes of this Section 15: (A) a “BHC Act Affiliate” has the meaning assigned<br>to the term “affiliate” in, and shall be interpreted in accordance with, 12 U.S.C. § 1841(k); (B) “Covered Entity”<br>means any of the following: (i) a “covered entity” as that term is defined in, and interpreted in accordance with, 12 C.F.R.<br>§ 252.82(b); (ii) a “covered bank” as that term is defined in, and interpreted in accordance with, 12 C.F.R. § 47.3(b);<br>or (iii) a “covered FSI” as that term is defined in, and interpreted in accordance with, 12 C.F.R. § 382.2(b); (C) “DefaultRight” has the meaning assigned to that term in, and shall be interpreted in accordance with, 12 C.F.R. §§ 252.81,<br>47.2 or 382.1, as applicable; and (D) “U.S. Special Resolution Regime” means each of (i) the Federal Deposit Insurance Act<br>and the regulations promulgated thereunder and (ii) Title II of the Dodd-Frank Wall Street Reform and Consumer Protection Act and the<br>regulations promulgated thereunder.
---	---

16. INTEGRATION

This Agreement (together with the other agreements and documents being delivered pursuant to or in connection with this Agreement) constitute the entire agreement of the parties hereto with respect to the subject matter hereof and thereof, and supersede all prior agreements and understandings of the parties, oral and written, with respect to the subject matter hereof except as expressly set forth in that certain letter agreement, dated March 6, 2026, among the Company, the Sponsor and the Representative.

17. APPLICABLE LAW

This Agreement will be governed by and construed in accordance with the laws of the State of New York applicable to contracts made and to be performed within the State of New York. Any legal suit, action or proceeding arising out of or based upon this Agreement or the transactions contemplated hereby shall be instituted in the Specified Courts, and each party irrevocably submits to the exclusive jurisdiction (except for proceedings instituted in regard to the enforcement of a judgment of any such court, as to which such jurisdiction is non-exclusive) of such courts in any such suit, action or proceeding. Service of any process, summons, notice or document by mail to such party’s address set forth above shall be effective service of process for any suit, action or other proceeding brought in any such court. The parties irrevocably and unconditionally waive any objection to the laying of venue of any suit, action or other proceeding in the Specified Courts and irrevocably and unconditionally waive and agree not to plead or claim in any such court that any such suit, action or other proceeding brought in any such court has been brought in an inconvenient forum.

18. WAIVER OF JURY TRIAL.

THE COMPANY HEREBY IRREVOCABLY WAIVES, TO THE FULLEST EXTENT PERMITTED BY APPLICABLE LAW, ANY AND ALL RIGHT TO TRIAL BY JURY IN ANY LEGAL PROCEEDING ARISING OUT OF OR RELATING TO THIS AGREEMENT OR THE TRANSACTIONS CONTEMPLATED HEREBY.

19. COUNTERPARTS; ELECTRONIC SIGNATURES.

This Agreement may be signed in one or more counterparts, each of which shall constitute an original and all of which together shall constitute one and the same agreement. Delivery of this Agreement by one party to the other may be made by facsimile, electronic mail (including any electronic signature complying with the New York Electronic Signatures and Records Act (N.Y. State Tech. §§ 301-309), as amended from time to time, or other applicable law) or other transmission method, and the parties hereto agree that any counterpart so delivered shall be deemed to have been duly and validly delivered and be valid and effective for all purposes.

20. HEADINGS.

The section headings used herein are for convenience only and shall not affect the construction hereof.

21. DEFINITIONS.

The terms that follow, when used in this Agreement, shall have the meanings indicated.

“Act” shall mean the Securities Act of 1933, as amended, and the rules and regulations of the Commission promulgated thereunder.

“Applicable Time” shall mean 4:00 p.m. (New York time) on the date of this Agreement.

“Business Day” shall mean any day other than a Saturday, a Sunday or a legal holiday or a day on which banking institutions or trust companies are authorized or obligated by law to close in New York City.

“Commission” shall mean the Securities and Exchange Commission.

“Effective Date” shall mean each date and time that the Registration Statement, any post-effective amendment or amendments thereto and any Rule 462(b) Registration Statement became or becomes effective.

“Exchange Act” shall mean the Securities Exchange Act of 1934, as amended, and the rules and regulations of the Commission promulgated thereunder.

“Execution Time” shall mean the date and time that this Agreement is executed and delivered by the parties hereto.

“Free Writing Prospectus” shall mean a free writing prospectus, as defined in Rule 405.

“Liquidation” shall mean the distributions of the Trust Account to the Public Shareholders in connection with the redemption of Ordinary Shares held by the Public Shareholders pursuant to the terms of the Amended and Restated Memorandum and Articles of Association if the Company fails to consummate a Business Combination.

“Preliminary Prospectus” shall mean any preliminary prospectus referred to in paragraph 1(a) above and any preliminary prospectus included in the Registration Statement at the Effective Date that omits Rule 430A Information.

“Prospectus” shall mean the prospectus relating to the Securities that is first filed pursuant to Rule 424(b) after the Execution Time.

“Registration Statement” shall mean the registration statements referred to in paragraph 1(a) above, including exhibits and financial statements and any prospectus and prospectus supplement relating to the Securities that is filed with the Commission pursuant to Rule 424(b) and deemed part of such registration statement pursuant to Rule 430A, as amended at the Execution Time and, in the event any post-effective amendment thereto or any Rule 462(b) Registration Statement becomes effective prior to the Closing Date, shall also mean such registration statement as so amended or such Rule 462(b) Registration Statement, as the case may be.

“Rule 158”, “Rule 172”, “Rule 405”, “Rule 419”, “Rule 424(b)”, “Rule430A”, “Rule 433”, “Rule 433(h)” and “Rule 462(b)” refer to such rules under the Act.

“Rule 430A Information” shall mean information with respect to the Securities and the offering thereof permitted to be omitted from the Registration Statement when it becomes effective pursuant to Rule 430A.

“Rule 462(b) RegistrationStatement” shall mean a registration statement and any amendments thereto filed pursuant to Rule 462(b) relating to the offering covered by the registration statement referred to in Section 1(a) hereof.

“Statutory Prospectus” shall mean (i) the Preliminary Prospectus dated April 2, 2026, relating to the Securities and (ii) the Time of Delivery Information, if any, set forth on Schedule II hereto.

[remainder of page intentionally left blank]

If the foregoing is in accordance with your understanding of our agreement, please sign and return to us the enclosed duplicate hereof, whereupon it will become a binding agreement among the Company and the several Underwriters in accordance with its terms.

Very truly yours,
JATT II Acquisition Corp
By:	/s/Someit Sidhu
Name:	Someit Sidhu
Title:	Chief Executive Officer

The foregoing Underwriting Agreement is hereby confirmed and accepted as of the date first above written.

Guggenheim Securities, LLC
By:	/s/ Ronald Gerber
Name:	Ronald Gerber
Title:	Senior Managing Director

Schedule I

**<br><br>Underwriters**	Number of<br><br> Underwritten<br><br> Securities to<br><br> be Purchased
Guggenheim Securities, LLC		6,000,000
Total		6,000,000

Schedule II

TIME OF DELIVERY INFORMATION

Time of Delivery Information

1.	The initial price to the public of the Securities: $10.00 per Ordinary Share.
2.	Number of Underwritten Securities offered: 6,000,000.
---	---
3.	The Company has granted an option to the Underwriters to purchase an aggregate of not more than 900,000 Option Securities.
---	---

Schedule III

SCHEDULE OF WRITTEN TESTING-THE-WATERS COMMUNICATIONS

Reference is made to the materials used in the testing the waters presentation made to potential investors by the Company, to the extent such materials are deemed to be a “written communication” within the meaning of Rule 405 under the Act.

Exhibit 3.1

THE COMPANIES ACT (AS REVISED)
OF THE CAYMAN ISLANDS
COMPANY LIMITED BY SHARES
AMENDED AND RESTATEDMEMORANDUM AND<br><br> <br>ARTICLES OF ASSOCIATION
OF<br><br> <br>****
JATT II ACQUISITION CORP<br><br> <br><br><br> <br>(ADOPTED BY WAY OFSPECIAL RESOLUTION<br><br> <br>EFFECTIVE 16 April, 2026)<br><br> <br><br><br> <br><br><br> <br><br><br> <br><br><br> <br><br><br> <br><br><br> <br>

THE COMPANIES ACT (AS REVISED)

OF THE CAYMAN ISLANDS

COMPANY LIMITED BY SHARES

AMENDED AND RESTATED MEMORANDUM OF ASSOCIATION

JATT II ACQUISITION CORP

(ADOPTED BY WAY OF SPECIAL RESOLUTION EFFECTIVE16 April, 2026)

1.	The name of the Company is JATT II Acquisition Corp.
2.	The registered office of the Company will be situated at the offices of Appleby Global Services (Cayman)<br>Limited, Suite 210, 2nd Floor Windward III, Regatta Office Park, PO Box 500, Grand Cayman, Cayman Islands KY1-1106 or at such other place<br>in the Cayman Islands as the Directors may from time to time decide.
---	---
3.	The objects for which the Company is established are unrestricted and the Company shall have full power<br>and authority to carry out any object that is not prohibited by the laws of the Cayman Islands.
---	---
4.	The liability of each Member is limited to the amount, if any, unpaid on such Member’s shares.
---	---
5.	The share capital of the Company is US$20,100.00 divided into 200,000,000 ordinary shares of a par value<br>of US$0.0001 each, and 1,000,000 preference shares of a par value of US$0.0001 each.
---	---
6.	The Company has power to register by way of continuation as a body corporate limited by shares under the<br>laws of any jurisdiction outside the Cayman Islands and to be deregistered in the Cayman Islands.
---	---
7.	Capitalised terms that are not defined in this Amended and Restated Memorandum of Association bear the<br>respective meanings given to them in the Articles of Association of the Company.
---	---

THE COMPANIES ACT (AS REVISED)

OF THE CAYMAN ISLANDS

COMPANY LIMITED BY SHARES

AMENDED AND RESTATED ARTICLES OF ASSOCIATION

JATT II ACQUISITION CORP

(ADOPTED BY WAY OF SPECIAL RESOLUTION EFFECTIVE16 April, 2026)

1.	INTERPRETATION
1.1	In these Articles, Table A in the First Schedule to the Statute does not apply and, unless there is something<br>in the subject or context inconsistent therewith:
---	---

Affiliate: means, with respect to a Person, any other person that, directly or indirectly, through one or more intermediaries, Controls, is Controlled by, or is under common Control with, such Person, and (a) in the case of a natural person, shall include such Person’s spouse, parents, children, siblings, mother-in-law and father-in-law and brothers and sisters-in-law, whether by blood, marriage or adoption or anyone residing in such person’s home, a trust for the benefit of any of the foregoing, or a corporation, a company, a partnership or other entity wholly or jointly owned by any of the foregoing and (b) in the case of an entity, shall include a corporation, a company, a partnership or other entity which directly, or indirectly through one or more intermediaries, Controls, is Controlled by, or is under common Control with, such entity. The term Affiliated has meaning correlative to the foregoing;

Applicable Law: means, with respect to any Person, all applicable provisions of all constitutions, treaties, statutes, laws (including the common law), codes, rules, regulations, ordinances or orders of any Governmental Authority, and any orders, decisions, injunctions, judgments, awards and decrees of or agreements with any Governmental Authority;

Articles: means these amended and restated articles of association of the Company;

Audit Committee: means the audit committee of the board of Directors of the Company formed pursuant to the Articles, or any successor committee;

Auditor: means the Person for the time being performing the duties of auditor of the Company (if any);

Business Combination: means a merger, share exchange, asset acquisition, share purchase, reorganisation or similar business combination involving the Company, with one or more businesses or assets (the target business), which Business Combination: (a) as long as the securities of the Company are listed on a Designated Stock Exchange, must occur with one or more target businesses or assets with a fair market value equal to at least 80 per cent of the net assets held in the Trust Account (net of amounts disbursed to management for working capital purposes, if permitted, and excluding the amount of any deferred underwriting discount held in trust) at the time of signing the definitive agreement to enter into such Business Combination; and (b) must not be effectuated solely with another blank cheque company or a similar company with nominal operations;

business day: means any day other than a Saturday, a Sunday or a legal holiday or a day on which banking institutions or trust companies are authorised or obligated by law to close in New York City;

Clearing House: means a clearing house recognised by the laws of the jurisdiction in which the Shares (or depositary receipts therefor) are listed or quoted on a stock exchange or interdealer quotation system in such jurisdiction;

Company: means the above named company;

Company’s Website: means the website of the Company and/or its web-address or domain name (if any);

Compensation Committee: means the compensation committee of the board of Directors of the Company established pursuant to the Articles, or any successor committee;

Control: means with respect to a Person, the power or authority, whether exercised or not, to direct the business, management and policies of such Person, directly or indirectly, whether through the ownership of voting securities, by contract or otherwise; provided that such power or authority shall conclusively be presumed to exist upon possession of beneficial ownership or power to direct the vote of more than fifty per cent (50%) of the votes entitled to be cast at a meeting of the members or shareholders of such Person or power to control the composition of a majority of the board of directors of such Person. The terms Controlled and Controlling have meanings correlative to the foregoing;

Designated Stock Exchange: means any national securities exchange or automated system on which the Company’s securities are listed for trading, including The Nasdaq Global Market;

Directors: means the directors for the time being of the Company;

Dividend: means any dividend (whether interim or final) resolved to be paid on Shares pursuant to the Articles;

Electronic Communication: means a communication sent by electronic means, including electronic posting to the Company’s Website, transmission to any number, address or internet website (including the website of the United States Securities and Exchange Commission) or other electronic delivery methods as otherwise decided and approved by the Directors;

Electronic Record: has the same meaning as in the Electronic Transactions Act;

Electronic Transactions Act: means the Electronic Transactions Act (2003 Revision) of the Cayman Islands;

Equity-linked Securities: means any debt or equity securities that are convertible, exercisable or exchangeable for Ordinary Shares issued in a financing transaction in connection with a Business Combination, including but not limited to a private placement of equity or debt;

Excise Tax: means the 1% U.S. federal excise tax on share repurchases under Section 3401 of the U.S. Internal Revenue Code of 1986, as amended, enacted by the Inflation Reduction Act of 2022 of the United States;

Founders: means the Sponsor and all Members immediately prior to the consummation of the IPO;

Governmental Authority: means any nation or government or any province or state or any other political subdivision thereof, or any entity, authority or body exercising executive, legislative, judicial, regulatory or administrative functions of or pertaining to government, including any court, tribunal, government authority, agency, department, board, commission or instrumentality or any political subdivision thereof, any court, tribunal or arbitrator, and any self-regulatory organization;

Indemnified Person: has the meaning ascribed to such term in Article 47.1;

Independent Director: has the same meaning as in the rules and regulations of the Designated Stock Exchange and/or the US Exchange Act, as the case may be;

Initial Conversion Ratio: has the meaning ascribed to such term in Article 17.1;

IPO: means the Company’s initial public offering of securities;

IPO Redemption: has the meaning given to it in Article 52.4;

Management: has the meaning given to it in Article 53.1;

Member: has the same meaning as in the Statute;

Memorandum: means the amended and restated memorandum of association of the Company;

Officer: means a person appointed to hold an office in the Company;

Ordinary Resolution: means a resolution:

(a)	passed by a simple majority of the Members as, being entitled to do so, vote in person or, where proxies<br>are allowed, by proxy at a general meeting of the Company and where a poll is taken regard shall be had in computing a majority to the<br>number of votes to which each Member is entitled; or
(b)	approved in writing by all of the Members entitled to vote at a general meeting of the Company in one<br>or more instruments each signed by one or more of the Members;
---	---

Ordinary Shares: means an ordinary share of a par value of US$0.0001 in the share capital of the Company

Over-Allotment Option: means the option of the Underwriter to purchase up to an additional 15 per cent of the units issued in the IPO;

Person: means any individual, corporation, company, limited liability company, partnership, limited partnership, exempted limited partnership, proprietorship, association, joint venture, institution, public benefit corporation, exempted company, firm, trust, estate or other enterprise or entity (whether or not having a separate legal personality) or Governmental Authority or any of them as the context so requires, other than in respect of a Director or Officer of the Company in which circumstances Person shall mean any individual or entity permitted to act as such in accordance with the laws of the Cayman Islands;

Preference Share: means a preference share of a par value of US$0.0001 in the share capital of the Company;

Public Share: means an Ordinary Share issued as part of the units issued in the IPO;

Redemption Notice: means a notice in a form approved by the Company by which a holder of Public Shares is entitled to require the Company to redeem its Public Shares, subject to any conditions contained therein;

Redemption Price: has the meaning given to it in Article 52.4;

Register of Members: means the register of Members maintained in accordance with the Statute and includes (except where otherwise stated) any branch or duplicate register of Members;

Registered Office: means the registered office for the time being of the Company;

Representative: means a representative of the Underwriter;

Seal: means the common seal of the Company and includes every duplicate seal;

SEC: means the United States Securities and Exchange Commission;

Share: means an Ordinary Share or a Preference Share and includes a fraction of a share in the Company;

Share Premium Account: means the share premium account established in accordance with the Articles and the Statute;

Special Resolution: has the same meaning in the Statute, and includes a unanimous written resolution;

Sponsor: JATT Ventures II L.P.;

Statute: means the Companies Act (As Revised) of the Cayman Islands;

Treasury Share: means a Share held in the name of the Company as a treasury share in accordance with the Statute;

Trust Account: means the trust account established by the Company upon the consummation of its IPO and into which a certain amount of the net proceeds of the IPO, together with a certain amount of the proceeds of the private placement simultaneously with the closing date of the IPO, will be deposited;

Underwriter: means an underwriter of the IPO from time to time and any successor underwriter; and

US Exchange Act: means the United States Securities Exchange Act of 1934, as amended, or any similar U.S. federal statute and the rules and regulations of the SEC thereunder, all as the same shall be in effect at the time.

1.2	In these Articles:
(a)	words importing the singular number include the plural number<br>and vice versa;
---	---
(b)	words importing the masculine gender include the feminine<br>gender;
---	---
(c)	words importing persons include corporations and any other<br>legal or natural persons;
---	---
(d)	“written” and “in writing” include all modes of representing or reproducing words<br>in visible form, including in the form of an Electronic Record;
---	---
(e)	“shall” shall be construed as imperative and “may”<br>shall be construed as permissive;
---	---
(f)	references to provisions of any law or regulation shall be construed as references to those provisions<br>as amended, modified, re-enacted or replaced;
---	---

(g)	any phrase introduced by the terms “including”, “include”, “in particular”<br>or any similar expression shall be construed as illustrative and shall not limit the sense of the words preceding those terms;
(h)	the term “and/or” is used herein to mean both “and” as well as “or.”<br>The use of “and/or” in certain contexts in no respects qualifies or modifies the use of the terms “and” or “or”<br>in others. The term “or” shall not be interpreted to be exclusive and the term “and” shall not be interpreted<br>to require the conjunctive (in each case, unless the context otherwise requires);
---	---
(i)	headings are inserted for reference only and shall be ignored<br>in construing the Articles;
---	---
(j)	any requirements as to delivery under the Articles include delivery in the form of an Electronic Record;
---	---
(k)	any requirements as to execution or signature under the Articles including the execution of the Articles<br>themselves can be satisfied in the form of an electronic signature as defined in the Electronic Transactions Act;
---	---
(l)	sections 8 and 19(3) of the Electronic Transactions Act shall<br>not apply;
---	---
(m)	the term “clear days” in relation to the period of a notice means that period excluding the<br>day when the notice is received or deemed to be received and the day for which it is given or on which it is to take effect;
---	---
(n)	the term “holder” in relation to a Share means a Person whose name is entered in the Register<br>of Members as the holder of such Share;
---	---
(o)	reference to any determination by the Directors shall be construed as a determination by the Directors<br>in their sole and absolute discretion and shall be applicable either generally or in any particular case; and
---	---
(p)	reference to a dollar or dollars or USD or US$ or $ and to a cent or cents is reference to dollars and<br>cents of the United States of America.
---	---
2.	COMMENCEMENT OF BUSINESS
---	---
2.1	The business of the Company may be commenced as soon after incorporation of the Company as the Directors<br>shall see fit.
---	---
2.2	The Directors may pay, out of the capital or any other monies of the Company, all expenses incurred in<br>or about the formation and establishment of the Company, including the expenses of registration.
---	---
3.	ISSUE OF SHARES AND OTHER SECURITIES
---	---
3.1	Subject to the provisions, if any, in the Memorandum (and to any direction that may be given by the Company<br>in general meeting) and, where applicable, the rules and regulations of the Designated Stock Exchange, the SEC and/or any other competent<br>regulatory authority or otherwise under Applicable Law, and without prejudice to any rights attached to any existing Shares, the Directors<br>may allot, issue, grant options over or otherwise dispose of Shares (including fractions of a Share) with or without preferred, deferred<br>or other rights or restrictions, whether in regard to Dividends or other distributions, voting, return of capital or otherwise and to<br>such Persons, at such times and on such other terms as they think proper, and may also (subject to the Statute and the Articles) vary<br>such rights.
---	---

3.2	The Company may issue rights, options, warrants or convertible securities or securities of similar nature<br>conferring the right upon the holders thereof to subscribe for, purchase or receive any class of Shares or other securities in the Company,<br>upon such terms as the Directors may from time to time determine and for such purposes the Directors may reserve an appropriate number<br>of Shares for the time being unissued.
3.3	The Company may issue units of securities in the Company, which may be comprised of whole or fractional<br>Shares, rights, options, warrants or convertible securities or securities of similar nature conferring the right upon the holders thereof<br>to subscribe for, purchase or receive any class of Shares or other securities in the Company, upon such terms as the Directors may from<br>time to time determine and for such purposes the Directors may reserve an appropriate number of Shares for the time being unissued. The<br>securities comprising any such units which are issued pursuant to the IPO can only be traded separately from one another on the 52nd day<br>following the date of the prospectus relating to the IPO (or, if such date is not a business day, the following business day) unless the<br>Representative(s) determines that an earlier date is acceptable, subject to the Company having filed a current report on Form 8-K with<br>the SEC and a press release announcing when such separate trading will begin. Prior to such date, the units can be traded, but the securities<br>comprising such units cannot be traded separately from one another.
---	---
3.4	The Company shall not issue Shares to bearer.
---	---
4.	REGISTER OF MEMBERS
---	---
4.1	The Company shall maintain or cause to be maintained the Register of Members in accordance with the Statute.
---	---
4.2	The Directors may determine that the Company shall maintain one or more branch registers of Members in<br>accordance with the Statute. The Directors may also determine which register of Members shall constitute the principal register and which<br>shall constitute the branch register or registers, and to vary such determination from time to time.
---	---
5.	CLOSING OF REGISTER OF MEMBERS OR FIXING RECORD DATE
---	---
5.1	For the purpose of determining Members entitled to notice of, or to vote at any meeting of Members or<br>any adjournment thereof, or Members entitled to receive payment of any Dividend or other distribution, or in order to make a determination<br>of Members for any other purpose, the Directors may, by any means in accordance with the requirements of the Designated Stock Exchange,<br>the SEC and/or any other competent regulatory authority or otherwise under Applicable Law, provide that the Register of Members shall<br>be closed for transfers for a stated period which shall not in any case exceed forty days.
---	---
5.2	In lieu of, or apart from, closing the Register of Members, the Directors may fix in advance or arrears<br>a date as the record date for any such determination of Members entitled to notice of, or to vote at any meeting of the Members or any<br>adjournment thereof, or for the purpose of determining the Members entitled to receive payment of any Dividend or other distribution,<br>or in order to make a determination of Members for any other purpose.
---	---
5.3	If the Register of Members is not so closed and no record date is fixed for the determination of Members<br>entitled to notice of, or to vote at, a meeting of Members or Members entitled to receive payment of a Dividend or other distribution,<br>the date on which notice of the meeting is sent or the date on which the resolution of the Directors resolving to pay such Dividend or<br>other distribution is passed, as the case may be, shall be the record date for such determination of Members. When a determination of<br>Members entitled to vote at any meeting of Members has been made as provided in this Article, such determination shall apply to any adjournment<br>thereof.
---	---

6.	CERTIFICATES FOR SHARES
6.1	A Member shall only be entitled to a share certificate if the Directors resolve that share certificates<br>shall be issued. Share certificates representing Shares, if any, shall be in such form as the Directors may determine. Share certificates<br>shall be signed by one or more Directors or other Person authorised by the Directors. The Directors may authorise certificates to be issued<br>with the authorised signature(s) affixed by mechanical process. All certificates for Shares shall be consecutively numbered or otherwise<br>identified and shall specify the Shares to which they relate. All certificates surrendered to the Company for transfer shall be cancelled<br>and, subject to the Articles, no new certificate shall be issued until the former certificate representing a like number of relevant Shares<br>shall have been surrendered and cancelled.
---	---
6.2	The Company shall not be bound to issue more than one certificate for Shares held jointly by more than<br>one Person and delivery of a certificate to one joint holder shall be a sufficient delivery to all of them.
---	---
6.3	If a share certificate is defaced, worn out, lost or destroyed, it may be renewed on such terms (if any)<br>as to evidence and indemnity and on the payment of such expenses reasonably incurred by the Company in investigating evidence, as the<br>Directors may prescribe, and (in the case of defacement or wearing out) upon delivery of the old certificate.
---	---
6.4	Every share certificate sent in accordance with the Articles will be sent at the risk of the Member or<br>other Person entitled to the certificate. The Company will not be responsible for any share certificate lost or delayed in the course<br>of delivery.
---	---
6.5	Share certificates shall be issued within the relevant time limit as prescribed by the Statute, if applicable,<br>or as the rules and regulations of the Designated Stock Exchange, the SEC and/or any other competent regulatory authority or otherwise<br>under Applicable Law may from time to time determine, whichever is shorter, after the allotment or, except in the case of a Share transfer<br>which the Company is for the time being entitled to refuse to register and does not register, after lodgement of a Share transfer with<br>the Company.
---	---
7.	TRANSFER OF SHARES
---	---
7.1	Subject to the terms of the Articles, any Member may transfer all or any of his Shares by an instrument<br>of transfer provided that such transfer complies with the rules and regulations of the Designated Stock Exchange, the SEC and/or any other<br>competent regulatory authority or otherwise under Applicable Law. If the Shares in question were issued in conjunction with rights, options<br>or warrants issued pursuant to the Articles on terms that one cannot be transferred without the other, the Directors shall refuse to register<br>the transfer of any such Share without evidence satisfactory to them of the like transfer of such option or warrant.
---	---
7.2	The instrument of transfer of any Share shall be in writing in the usual or common form or in a form prescribed<br>by the rules and regulations of the Designated Stock Exchange, the SEC and/or any other competent regulatory authority or otherwise under<br>Applicable Law or in any other form approved by the Directors and shall be executed by or on behalf of the transferor (and if the Directors<br>so require, signed by or on behalf of the transferee) and may be under hand or, if the transferor or transferee is a Clearing House or<br>its nominee(s), by hand or by machine imprinted signature or by such other manner of execution as the Directors may approve from time<br>to time. The transferor shall be deemed to remain the holder of a Share until the name of the transferee is entered in the Register of<br>Members.
---	---

8.	REDEMPTION, REPURCHASE AND SURRENDER OF SHARES
8.1	Subject to the provisions of the Statute and the rules and regulations of the Designated Stock Exchange,<br>the SEC and/or any other competent regulatory authority or otherwise under Applicable Law, the Company may:
---	---
(a)	issue Shares that are to be redeemed or are liable to be redeemed at the option of the Member or the Company<br>in such manner and upon such other terms as the Directors may determine before the issuance of the Shares; and
---	---
(b)	purchase its own Shares (including any redeemable Shares) in such manner and on such other terms as the<br>Directors may determine and agree with the relevant Member.
---	---
8.2	The Company may make a payment in respect of the redemption or purchase of its own Shares in any manner<br>permitted by the Statute, including out of capital.
---	---
8.3	With respect to redeeming or repurchasing the Shares:
---	---
(a)	Members who hold Public Shares are entitled to request the redemption of such Shares in the circumstances<br>described in Article 52;
---	---
(b)	Public Shares shall be repurchased by way of tender offer in the circumstances set out in Article 52;<br>and
---	---
(c)	Ordinary Shares held by the Sponsor shall be surrendered by the Sponsor for no consideration on a pro-rata<br>basis to the extent that the Over-Allotment Option is not exercised in full so that the Founders will own 20 per cent of the Company’s<br>issued Shares after the IPO (exclusive of any securities purchased in private placement simultaneously with the IPO).
---	---
8.4	Subject to the provisions of the Statute, and, where applicable, the rules and regulations of the Designated<br>Stock Exchange, the SEC and/or any other competent regulatory authority or otherwise under Applicable Law, the Company may purchase its<br>own Shares (including any redeemable Shares) in such manner and on such other terms as the Directors may agree with the relevant Member.<br>For the avoidance of doubt, redemptions, repurchases and surrenders of Shares in the circumstances described in the Article above shall<br>not require further approval of the Members.
---	---
8.5	Any Share in respect of which notice of redemption has been given shall not be entitled to participate<br>in the profits of the Company in respect of the period after the date specified as the date of redemption in the Redemption Notice.
---	---
8.6	The redemption, purchase or surrender of any Share shall not be deemed to give rise to the redemption,<br>purchase or surrender of any other Share.
---	---
8.7	The Company may make a payment in respect of the redemption or purchase of its own Shares in any manner<br>permitted by the Statute, including out of capital.
---	---
8.8	The Directors may accept the surrender for no consideration of any fully paid Share (including any redeemable<br>share).
---	---
9.	TREASURY SHARES
---	---
9.1	The Directors may, prior to the purchase, redemption or surrender of any Share, determine that such Share<br>shall be held as a Treasury Share.
---	---
9.2	The Directors may determine to cancel a Treasury Share or transfer a Treasury Share on such terms as they<br>think proper (including, without limitation, for nil consideration).
---	---

10.	VARIATION OF SHARE RIGHTS
10.1	Subject to Article 3.1, if at any time the share capital of the Company is divided into different classes<br>of Shares, all or any of the rights attached to any class (unless otherwise provided by the terms of issue of the Shares of that class)<br>may, whether or not the Company is being wound up, be varied without the consent of the holders of the issued Shares of that class where<br>such variation is considered by the Directors not to have a material adverse effect upon such rights; otherwise, any such variation shall<br>be made only with the consent in writing of the holders of not less than two-thirds of the issued Shares of that class, or with the approval<br>of a resolution passed by a majority of not less than two-thirds of the votes cast at a separate meeting of the holders of the Shares<br>of that class. For the avoidance of doubt, the Directors reserve the right, notwithstanding that any such variation may not have a material<br>adverse effect, to obtain consent from the holders of Shares of the relevant class. To any such meeting all the provisions of the Articles<br>relating to general meetings shall apply mutatis mutandis, except that the necessary quorum shall be one or more Persons holding or representing<br>by proxy at least one-third of the issued Shares of the class (but so that if at any adjourned meeting of such holders a quorum as above<br>defined is not present, those Members who are present shall form a quorum) and that any holder of Shares of the class present in person<br>or by proxy may demand a poll.
---	---
10.2	For the purposes of a separate class meeting, the Directors may treat two or more or all the classes of<br>Shares as forming one class of Shares if the Directors consider that such class of Shares would be affected in the same way by the proposals<br>under consideration, but in any other case shall treat them as separate classes of Shares.
---	---
10.3	The rights conferred upon the holders of the Shares of any class issued with preferred or other rights<br>shall not, unless otherwise expressly provided by the terms of issue of the Shares of that class, be deemed to be varied by the creation<br>or issue of further Shares ranking pari passu therewith or Shares issued with preferred or other rights.
---	---
11.	COMMISSION ON SALES OF SHARES
---	---

The Company may, in so far as the Statute permits, pay a commission to any Person in consideration of his subscribing or agreeing to subscribe (whether absolutely or conditionally) or procuring or agreeing to procure subscriptions (whether absolutely or conditionally) for any Shares. Such commissions may be satisfied by the payment of cash and/or the issue of fully or partly paid-up Shares. The Company may also on any issue of Shares pay such brokerage as may be lawful.

12.	NON-RECOGNITION OF TRUSTS

The Company shall not be bound by or compelled to recognise in any way (even when notified) any equitable, contingent, future or partial interest in any Share, or (except only as is otherwise provided by the Articles or the Statute) any other rights in respect of any Share other than an absolute right to the entirety thereof in the holder.

13.	LIEN ON SHARES
13.1	The Company shall have a first and paramount lien on all Shares (whether fully paid-up or not) registered<br>in the name of a Member (whether solely or jointly with others) for all debts, liabilities or engagements to or with the Company (whether<br>presently payable or not) by such Member or his estate, either alone or jointly with any other Person, whether a Member or not, but the<br>Directors may at any time declare any Share to be wholly or in part exempt from the provisions of this Article. The registration of a<br>transfer of any such Share shall operate as a waiver of the Company’s lien thereon. The Company’s lien on a Share shall also extend to<br>any amount payable in respect of that Share.
---	---

13.

LIEN ON SHARES

13.1

The Company shall have a first and paramount lien on all Shares (whether fully paid-up or not) registered in the name of a Member (whether solely or jointly with others) for all debts, liabilities or engagements to or with the Company (whether presently payable or not) by such Member or his estate, either alone or jointly with any other Person, whether a Member or not, but the Directors may at any time declare any Share to be wholly or in part exempt from the provisions of this Article. The registration of a transfer of any such Share shall operate as a waiver of the Company’s lien thereon. The Company’s lien on a Share shall also extend to any amount payable in respect of that Share.

---

13.2	The Company may sell, in such manner as the Directors think fit, any Shares on which the Company has a<br>lien, if a sum in respect of which the lien exists is presently payable, and is not paid within fourteen clear days after notice has been<br>received or deemed to have been received by the holder of the Shares, or to the Person entitled to it in consequence of the death or bankruptcy<br>of the holder, demanding payment and stating that if the notice is not complied with the Shares may be sold.
13.3	To give effect to any such sale the Directors may authorise any Person to execute an instrument of transfer<br>of the Shares sold to, or in accordance with the directions of, the purchaser. The purchaser or his nominee shall be registered as the<br>holder of the Shares comprised in any such transfer, and he shall not be bound to see to the application of the purchase money, nor shall<br>his title to the Shares be affected by any irregularity or invalidity in the sale or the exercise of the Company’s power of sale under<br>the Articles.
---	---
13.4	The net proceeds of such sale after payment of costs, shall be applied in payment of such part of the<br>amount in respect of which the lien exists as is presently payable and any balance shall (subject to a like lien for sums not presently<br>payable as existed upon the Shares before the sale) be paid to the Person entitled to the Shares at the date of the sale.
---	---
14.	CALLS ON SHARES
---	---
14.1	Subject to the terms of the allotment and issue of any Shares, the Directors may make calls upon the Members<br>in respect of any monies unpaid on their Shares (whether in respect of par value or premium), and each Member shall (subject to receiving<br>at least fourteen clear days’ notice specifying the time or times of payment) pay to the Company at the time or times so specified the<br>amount called on the Shares. A call may be revoked or postponed, in whole or in part, as the Directors may determine. A call may be required<br>to be paid by instalments. A Person upon whom a call is made shall remain liable for calls made upon him notwithstanding the subsequent<br>transfer of the Shares in respect of which the call was made.
---	---
14.2	A call shall be deemed to have been made at the time when the resolution of the Directors authorising<br>such call was passed.
---	---
14.3	The joint holders of a Share shall be jointly and severally<br>liable to pay all calls in respect thereof.
---	---
14.4	If a call remains unpaid after it has become due and payable, the Person from whom it is due shall pay<br>interest on the amount unpaid from the day it became due and payable until it is paid at such rate as the Directors may determine (and<br>in addition all expenses that have been incurred by the Company by reason of such non-payment), but the Directors may waive payment of<br>the interest or expenses wholly or in part.
---	---
14.5	An amount payable in respect of a Share on issue or allotment or at any fixed date, whether on account<br>of the par value of the Share or premium or otherwise, shall be deemed to be a call and if it is not paid all the provisions of the Articles<br>shall apply as if that amount had become due and payable by virtue of a call.
---	---
14.6	The Directors may issue Shares with different terms as to the amount and times of payment of calls, or<br>the interest to be paid.
---	---
14.7	The Directors may, if they think fit, receive an amount from any Member willing to advance all or any<br>part of the monies uncalled and unpaid upon any Shares held by him, and may (until the amount would otherwise become payable) pay interest<br>at such rate as may be agreed upon between the Directors and the Member paying such amount in advance.
---	---

14.8	No such amount paid in advance of calls shall entitle the Member paying such amount to any portion of<br>a Dividend or other distribution payable in respect of any period prior to the date upon which such amount would, but for such payment,<br>become payable.
15.	FORFEITURE OF SHARES
---	---
15.1	If a call or instalment of a call remains unpaid after it has become due and payable the Directors may<br>give to the Person from whom it is due not less than fourteen clear days’ notice requiring payment of the amount unpaid together with<br>any interest which may have accrued and any expenses incurred by the Company by reason of such non-payment. The notice shall specify where<br>payment is to be made and shall state that if the notice is not complied with the Shares in respect of which the call was made will be<br>liable to be forfeited.
---	---
15.2	If the notice is not complied with, any Share in respect of which it was given may, before the payment<br>required by the notice has been made, be forfeited by a resolution of the Directors. Such forfeiture shall include all Dividends, other<br>distributions or other monies payable in respect of the forfeited Share and not paid before the forfeiture.
---	---
15.3	A forfeited Share may be sold, re-allotted or otherwise disposed of on such terms and in such manner as<br>the Directors think fit and at any time before a sale, re-allotment or disposition the forfeiture may be cancelled on such terms as the<br>Directors think fit. Where for the purposes of its disposal a forfeited Share is to be transferred to any Person the Directors may authorise<br>some Person to execute an instrument of transfer of the Share in favour of that Person.
---	---
15.4	A Person any of whose Shares have been forfeited shall cease to be a Member in respect of them and shall<br>surrender to the Company for cancellation the certificate for the Shares forfeited and shall remain liable to pay to the Company all monies<br>which at the date of forfeiture were payable by him to the Company in respect of those Shares together with interest at such rate as the<br>Directors may determine, but his liability shall cease if and when the Company shall have received payment in full of all monies due and<br>payable by him in respect of those Shares.
---	---
15.5	A certificate in writing under the hand of one Director or Officer of the Company that a Share has been<br>forfeited on a specified date shall be conclusive evidence of the facts stated in it as against all Persons claiming to be entitled to<br>the Share. The certificate shall (subject to the execution of an instrument of transfer) constitute a good title to the Share and the<br>Person to whom the Share is sold or otherwise disposed of shall not be bound to see to the application of the purchase money, if any,<br>nor shall his title to the Share be affected by any irregularity or invalidity in the proceedings in reference to the forfeiture, sale<br>or disposal of the Share.
---	---
15.6	The provisions of the Articles as to forfeiture shall apply in the case of non-payment of any sum which,<br>by the terms of issue of a Share, becomes payable at a fixed time, whether on account of the par value of the Share or by way of premium<br>as if it had been payable by virtue of a call duly made and notified.
---	---
16.	TRANSMISSION OF SHARES
---	---
16.1	If a Member dies, the survivor or survivors (where he was a joint holder), or his legal personal representatives<br>(where he was a sole holder), shall be the only Persons recognised by the Company as having any title to his Shares. The estate of a deceased<br>Member is not thereby released from any liability in respect of any Share, for which he was a joint or sole holder.
---	---
16.2	Any Person becoming entitled to a Share in consequence of the death or bankruptcy or liquidation or dissolution<br>of a Member (or in any other way than by transfer) may, upon such evidence being produced as may be required by the Directors, elect,<br>by a notice in writing sent by him to the Company, either to become the holder of such Share or to have some Person nominated by him registered<br>as the holder of such Share. If he elects to have another Person registered as the holder of such Share he shall sign an instrument of<br>transfer of that Share to that Person. The Directors shall, in either case, have the same right to decline or suspend registration as<br>they would have had in the case of a transfer of the Share by the relevant Member before his death or bankruptcy or liquidation or dissolution<br>or any other case than by transfer, as the case may be.
---	---

16.3	A Person becoming entitled to a Share by reason of the death or bankruptcy or liquidation or dissolution<br>of a Member (or in any other case than by transfer) shall be entitled to the same Dividends, other distributions and other advantages<br>to which he would be entitled if he were the holder of such Share. However, he shall not, before becoming a Member in respect of a Share,<br>be entitled in respect of it to exercise any right conferred by membership in relation to general meetings of the Company and the Directors<br>may at any time give notice requiring any such Person to elect either to be registered himself or to have some Person nominated by him<br>be registered as the holder of the Share (but the Directors shall, in either case, have the same right to decline or suspend registration<br>as they would have had in the case of a transfer of the Share by the relevant Member before his death or bankruptcy or liquidation or<br>dissolution or any other case than by transfer, as the case may be). If the notice is not complied with within ninety days of being received<br>or deemed to be received (as determined pursuant to the Articles) the Directors may thereafter withhold payment of all Dividends, other<br>distributions, bonuses or other monies payable in respect of the Share until the requirements of the notice have been complied with.
17.	AMENDMENTS OF MEMORANDUM AND ARTICLES OF ASSOCIATION AND ALTERATION OF CAPITAL
---	---
17.1	The Company may by Ordinary Resolution:
---	---
(a)	increase its share capital by such sum as the Ordinary Resolution shall prescribe and with such rights,<br>priorities and privileges annexed thereto;
---	---
(b)	consolidate and divide all or any of its share capital into Shares of larger amount than its existing<br>Shares;
---	---
(c)	convert all or any of its paid-up Shares into stock, and reconvert that stock into paid- up Shares of<br>any denomination;
---	---
(d)	by subdivision of its existing Shares or any of them divide the whole or any part of its share capital<br>into Shares of smaller amount than is fixed by the Memorandum or into Shares without par value; and
---	---
(e)	cancel any Shares that at the date of the passing of the Ordinary Resolution have not been taken or agreed<br>to be taken by any Person and diminish the amount of its share capital by the amount of the Shares so cancelled.
---	---
17.2	All new Shares created in accordance with the provisions of the preceding Article shall be subject to<br>the same provisions of the Articles with reference to the payment of calls, liens, transfer, transmission, forfeiture and otherwise as<br>the Shares in the original share capital.
---	---
17.3	Subject to the provisions of the Statute, the provisions of the Articles as regards the matters to be<br>dealt with by Ordinary Resolution, the Company may by Special Resolution:
---	---
(a)	change its name;
---	---
(b)	alter or add to the Articles;
---	---

(c)	alter or add to the Memorandum with respect to any objects, powers or other matters specified therein;<br>and
(d)	reduce its share capital or any capital redemption reserve<br>fund.
---	---
18.	OFFICES AND PLACE OF BUSINESS
---	---

Subject to the provisions of the Statute, the Company may by resolution of the Directors change the location of its Registered Office. The Company may, in addition to its Registered Office, maintain such other offices or places of business as the Directors determine.

19.	GENERAL MEETINGS
20.1	All general meetings other than annual general meetings shall be called extraordinary general meetings.
---	---
20.2	The Company may, but shall not (unless required by the Statute or, for so long as any Shares are traded<br>on a Designated Stock Exchange) be obliged to, in each year hold a general meeting as its annual general meeting, and shall specify the<br>meeting as such in the notices calling it. Any annual general meeting shall be held at such time and place as the Directors shall appoint.<br>At these meetings the report of the Directors (if any) shall be presented.
---	---
20.3	The Directors or the chairman of the board of Directors may, whenever they think fit, call general meetings.
---	---
20.4	Members seeking to bring business before the annual general meeting or to nominate candidates for appointment<br>as Directors at the annual general meeting must deliver notice to the principal executive offices of the Company not less than one hundred<br>and twenty calendar days before the date of the Company’s proxy statement released to Members in connection with the previous year’s<br>annual general meeting or, if the Company did not hold an annual general meeting the previous year, or if the date of the current year’s<br>annual general meeting has been changed by more than thirty days from the date of the previous year’s annual general meeting, then<br>the deadline shall be set by the Directors with such deadline being a reasonable time before the Company begins to print and send its<br>related proxy materials.
---	---
21.	NOTICE OF GENERAL MEETINGS
---	---
21.1	At least five clear days’ notice shall be given of any general meeting. Every notice shall specify the<br>place, the day and the hour of the meeting and the general nature of the business to be conducted at the general meeting and shall be<br>given in the manner hereinafter mentioned or in such other manner if any as may be prescribed by the Company by Ordinary Resolution to<br>such Persons as are, under the Articles, entitled to receive such notices from the Company , provided that a general meeting of the Company<br>shall, whether or not the notice specified in this Article has been given and whether or not the provisions of the Articles regarding<br>general meetings have been complied with, be deemed to have been duly convened if it is so agreed:
---	---
(a)	in the case of an annual general meeting, by all of the Members entitled to attend and vote thereat; and
---	---
(b)	in the case of an extraordinary general meeting, by a majority in number of the Members having a right<br>to attend and vote at the meeting, together holding not less than ninety-five per cent in par value of the Shares giving that right.
---	---
21.2	The accidental omission to give notice of a general meeting to, or the non-receipt of notice of a general<br>meeting by, any Person entitled to receive such notice shall not invalidate the proceedings of that general meeting.
---	---

22.	PROCEEDINGS AT GENERAL MEETINGS
22.1	No business shall be transacted at any general meeting unless a quorum is present. Save as otherwise provided<br>by the Articles, one or more Members holding at least one-third of the paid up voting share capital of the Company present in person or<br>by proxy and entitled to vote at that meeting, or if a corporation or other non-natural person by its duly authorized representative or<br>proxy shall form a quorum.
---	---
22.2	A Person may participate at a general meeting by conference telephone, video, a virtual platform or other<br>communications equipment by means of which all the Persons participating in the meeting can communicate with each other. Participation<br>by a Person in a general meeting in this manner is treated as presence in person at that meeting.
---	---
22.3	A resolution (including a Special Resolution) in writing (in one or more counterparts) signed by or on<br>behalf of all of the Members for the time being entitled to receive notice of and to attend and vote at general meetings (or, being corporations<br>or other non-natural persons, signed by their duly authorised representatives) shall be as valid and effective as if the resolution had<br>been passed at a general meeting of the Company duly convened and held.
---	---
22.4	If a quorum is not present within half an hour from the time appointed for the meeting to commence, the<br>meeting shall stand adjourned to the same day in the next week at the same time and/or place or to such other day, time and/or place as<br>the Directors may determine, and if at the adjourned meeting a quorum is not present within half an hour from the time appointed for the<br>meeting to commence, the Members present shall be a quorum.
---	---
22.5	The Directors may, at any time prior to the time appointed for the meeting to commence, appoint any Person<br>to act as chairman of a general meeting of the Company or, if the Directors do not make any such appointment, the chairman, if any, of<br>the board of Directors shall preside as chairman at such general meeting. If there is no such chairman, or if he shall not be present<br>within fifteen minutes after the time appointed for the meeting to commence, or is unwilling to act, the Directors present shall elect<br>one of their number to be chairman of the meeting.
---	---
22.6	If no Director is willing to act as chairman or if no Director is present within fifteen minutes after<br>the time appointed for the meeting to commence, the Members present shall choose one of their number to be chairman of the meeting.
---	---
22.7	The chairman may, with the consent of a meeting at which a quorum is present (and shall if so directed<br>by the meeting) adjourn the meeting from time to time and from place to place, but no business shall be transacted at any adjourned meeting<br>other than the business left unfinished at the meeting from which the adjournment took place.
---	---
22.8	When a general meeting is adjourned for thirty days or more, notice of the adjourned meeting shall be<br>given as in the case of an original meeting. Otherwise it shall not be necessary to give any such notice of an adjourned meeting. All<br>proxy forms submitted for the original general meeting shall remain valid for the postponed meeting. The Directors may postpone a general<br>meeting which has already been postponed.
---	---
22.9	A resolution put to the vote of the meeting shall be decided<br>on a poll.
---	---
22.10	If, prior to a Business Combination, a notice is issued in respect of a general meeting and the Directors,<br>in their absolute discretion, consider that it is impractical or undesirable for any reason to hold that general meeting at the place,<br>the day and the hour specified in the notice calling such general meeting, the Directors may postpone the general meeting to another place,<br>day and/or hour provided that notice of the place, the day and the hour of the rearranged general meeting is promptly given to all Members.<br>No business shall be transacted at any postponed meeting other than the business specified in the notice of the original meeting.
---	---

22.11	A poll shall be taken in such manner as the chairman directs, and the result of the poll shall be deemed<br>to be the resolution of the general meeting at which the poll was demanded.
22.12	In the case of an equality of votes the chairman of the general meeting shall be entitled to a second<br>or casting vote.
---	---
22.13	A poll on the election of a chairman or on a question of adjournment shall be taken forthwith. A poll<br>on any other question shall be taken at such date, time and place as the chairman of the general meeting directs, and any business other<br>than that upon which a poll has been demanded or is contingent thereon may proceed pending the taking of the poll.
---	---
23.	VOTES OF MEMBERS
---	---
23.1	Subject to any rights or restrictions attached to any Shares, every Member who being an individual is<br>present in person or by proxy or, if a corporation or other non-natural person is present by its duly authorised representative or by<br>proxy, shall have one vote for every Share of which he is the holder.
---	---
23.2	In the case of joint holders the vote of the senior holder who tenders a vote, whether in person or by<br>proxy (or, in the case of a corporation or other non-natural person, by its duly authorised representative or proxy), shall be accepted<br>to the exclusion of the votes of the other joint holders, and seniority shall be determined by the order in which the names of the holders<br>stand in the Register of Members.
---	---
23.3	A Member of unsound mind, or in respect of whom an order has been made by any court, having jurisdiction<br>in lunacy, may vote, whether on a show of hands or on a poll, by his committee, receiver, curator bonis, or other Person on such Member’s<br>behalf appointed by that court, and any such committee, receiver, curator bonis or other Person may vote by proxy.
---	---
23.4	No Person shall be entitled to vote at any general meeting unless he is registered as a Member on the<br>record date for such meeting nor unless all calls or other monies then payable by him in respect of Shares have been paid.
---	---
23.5	No objection shall be raised as to the qualification of any voter except at the general meeting or adjourned<br>general meeting at which the vote objected to is given or tendered and every vote not disallowed at the meeting shall be valid. Any objection<br>made in due time in accordance with this Article shall be referred to the chairman whose decision shall be final and conclusive.
---	---
23.6	Votes may be cast either personally or by proxy (or in the case of a corporation or other non- natural<br>person by its duly authorised representative or proxy). A Member may appoint more than one proxy or the same proxy under one or more instruments<br>to attend and vote at a meeting. Where a Member appoints more than one proxy the instrument of proxy shall specify the number of Shares<br>in respect of which each proxy is entitled to exercise the related votes.
---	---
23.7	A Member holding more than one Share need not cast the votes in respect of his Shares in the same way<br>on any resolution and therefore may vote a Share or some or all such Shares either for or against a resolution and/or abstain from voting<br>a Share or some or all of the Shares and, subject to the terms of the instrument appointing him, a proxy appointed under one or more instruments<br>may vote a Share or some or all of the Shares in respect of which he is appointed either for or against a resolution and/or abstain from<br>voting a Share or some or all of the Shares in respect of which he is appointed.
---	---

24.	PROXIES
24.1	The instrument appointing a proxy shall be in writing and shall be executed under the hand of the appointor<br>or of his attorney duly authorised in writing, or, if the appointor is a corporation or other non-natural person, under the hand of its<br>duly authorised representative. A proxy need not be a Member.
---	---
24.2	The Directors may, in the notice convening any meeting or adjourned meeting, or in an instrument of proxy<br>sent out by the Company, specify the manner by which the instrument appointing a proxy shall be deposited and the place and the time (being<br>not later than the time appointed for the commencement of the meeting or adjourned meeting to which the proxy relates) at which the instrument<br>appointing a proxy shall be deposited. In the absence of any such direction from the Directors in the notice convening any meeting or<br>adjourned meeting or in an instrument of proxy sent out by the Company, the instrument appointing a proxy shall be deposited physically<br>at the Registered Office not less than 48 hours before the time appointed for the meeting or adjourned meeting to commence at which the<br>Person named in the instrument proposes to vote.
---	---
24.3	The chairman may in any event at his discretion declare that an instrument of proxy shall be deemed to<br>have been duly deposited. An instrument of proxy that is not deposited in the manner permitted, or which has not been declared to have<br>been duly deposited by the chairman, shall be invalid.
---	---
24.4	The instrument appointing a proxy may be in any usual or common form (or such other form as the Directors<br>may approve) and may be expressed to be for a particular meeting or any adjournment thereof or generally until revoked. An instrument<br>appointing a proxy shall be deemed to include the power to demand or join or concur in demanding a poll.
---	---
24.5	Votes given in accordance with the terms of an instrument of proxy shall be valid notwithstanding the<br>previous death or insanity of the principal or revocation of the proxy or of the authority under which the proxy was executed, or the<br>transfer of the Share in respect of which the proxy is given unless notice in writing of such death, insanity, revocation or transfer<br>was received by the Company at the Registered Office before the commencement of the general meeting, or adjourned meeting at which it<br>is sought to use the proxy.
---	---
25.	CORPORATE MEMBERS
---	---

Any corporation or other non-natural person which is a Member may in accordance with its constitutional documents, or in the absence of such provision by resolution of its directors or other governing body, authorise such Person as it thinks fit to act as its representative at any meeting of the Company or of any class of Members, and the Person so authorised shall be entitled to exercise the same powers on behalf of the corporation which he represents as the corporation could exercise if it were an individual Member.

26.	CLEARING HOUSES

If a Clearing House (or its nominee(s)), being a corporation, is a Member it may authorise such Person or Persons as it thinks fit to act as its representative or representatives at any general meeting of the Company or at any meeting of any class of Members provided that, if more than one Person is so authorised, the authorisation shall specify the number and class of Shares in respect of which each such Person is so authorised. A Person so authorised pursuant to this Article shall be deemed to have been duly authorised without further evidence of the facts and be entitled to exercise the same powers on behalf of the clearing house (or its nominee(s)) which he represents as if such Person was the registered holder of such Shares held by the Clearing House (or its nominee(s)).

27.	SHARES THAT MAY NOT BE VOTED

Shares in the Company that are beneficially owned by the Company shall not be voted, directly or indirectly, at any meeting and shall not be counted in determining the total number of outstanding Shares at any given time.

28.	DIRECTORS
28.1	The Company may by Ordinary Resolution from time to time fix the maximum and minimum number of Directors<br>to be appointed but unless such numbers are fixed as aforesaid the minimum number of Directors shall be one and the maximum number of<br>Directors shall be unlimited.
---	---
29.	POWERS OF DIRECTORS
---	---
29.1	Subject to the provisions of the Statute, the Memorandum and the Articles and to any directions given<br>by Special Resolution, the business of the Company shall be managed by the Directors who may exercise all the powers of the Company. No<br>alteration of the Memorandum or Articles and no such direction shall invalidate any prior act of the Directors which would have been valid<br>if that alteration had not been made or that direction had not been given. A duly convened meeting of the Directors at which a quorum<br>is present may exercise all powers exercisable by the Directors.
---	---
29.2	All cheques, promissory notes, drafts, bills of exchange and other negotiable or transferable instruments<br>and all receipts for monies paid to the Company shall be signed, drawn, accepted, endorsed or otherwise executed, as the case may be,<br>in such manner as the Directors shall determine by resolution.
---	---
29.3	The Directors on behalf of the Company may pay a gratuity or pension or allowance on retirement to any<br>Director who has held any other salaried office or place of profit with the Company or to his widow or dependants and may make contributions<br>to any fund and pay premiums for the purchase or provision of any such gratuity, pension or allowance.
---	---
29.4	The Directors may exercise all the powers of the Company to borrow money and to mortgage or charge its<br>undertaking, property and assets (present and future) and uncalled capital or any part thereof and to issue debentures, debenture stock,<br>mortgages, bonds and other such securities whether outright or as security for any debt, liability or obligation of the Company or of<br>any third party.
---	---
29.5	The Directors shall have the authority to present a winding up petition on behalf of the Company without<br>the sanction of a resolution passed by the Company in general meeting.
---	---
30.	APPOINTMENT AND REMOVAL OF DIRECTORS
---	---
30.1	The Company may by Ordinary Resolution appoint any Person to be a Director or may by Ordinary Resolution<br>remove any Director. The Directors may appoint any Person to be a Director, either to fill a vacancy or as an additional Director, provided<br>that the appointment does not cause the number of Directors to exceed any number fixed by or in accordance with the Articles as the maximum<br>number of Directors.
---	---
30.2	At the time of or following the consummation of a Business Combination, the Company may by Ordinary Resolution<br>appoint any person to be a Director or may by Ordinary Resolution remove any Director.
---	---

31.	VACATION OF OFFICE OF DIRECTOR

The office of a Director shall be vacated if:

(a)	the Director gives notice in writing to the Company that he resigns the office of Director; or
(b)	the Director absents himself from three consecutive meetings of the board of Directors without special<br>leave of absence from the Directors, and the Directors pass a resolution that he has by reason of such absence vacated office; or
---	---
(c)	the Director dies, becomes bankrupt or makes any arrangement or composition with his creditors generally;<br>or
---	---
(d)	the Director is found to be or becomes of unsound mind; or
---	---
(e)	all of the other Directors (being not less than two in number) determine that he should be removed as<br>a Director, either by a resolution passed by all of the other Directors at a meeting of the Directors duly convened and held in accordance<br>with the Articles or by a resolution in writing signed by all of the other Directors; or
---	---
(f)	the Director is removed from office pursuant to any other<br>provision of the Articles.
---	---
32.	PROCEEDINGS OF DIRECTORS
---	---
32.1	The quorum for the transaction of the business of the Directors may be fixed by the Directors, and unless<br>so fixed shall be a majority of the Directors then in office.
---	---
32.2	Subject to the provisions of the Articles, the Directors may regulate their proceedings as they think<br>fit. Questions arising at any meeting of the Directors shall be decided by a majority of votes. In the case of an equality of votes, the<br>chairman shall have a second or casting vote. A Director who is also an alternate Director shall be entitled in the absence of his appointor<br>to a separate vote on behalf of his appointor in addition to his or her own vote.
---	---
32.3	A Person may participate in a meeting of the Directors or any committee of Directors by conference telephone,<br>video, a virtual platform or other communications equipment by means of which all the Persons participating in the meeting can communicate<br>with each other at the same time. Participation by a Person in a meeting in this manner is treated as presence in person at that meeting.<br>Unless otherwise determined by the Directors the meeting shall be deemed to be held at the place where the chairman is located at the<br>start of the meeting.
---	---
32.4	A resolution in writing (in one or more counterparts) signed by all the Directors or all the members of<br>a committee of the Directors or, in the case of a resolution in writing relating to the removal of any Director or the vacation of office<br>by any Director, all of the Directors other than the Director who is the subject of such resolution (an alternate Director being entitled<br>to sign such a resolution on behalf of his appointor and if such alternate Director is also a Director, being entitled to sign such resolution<br>both on behalf of his appointer and in his capacity as a Director) shall be as valid and effectual as if it had been passed at a meeting<br>of the Directors, or committee of Directors as the case may be, duly convened and held.
---	---
32.5	A Director may, or other Officer of the Company on the direction of a Director, call a meeting of the<br>Directors by at least two days’ notice in writing to every Director and alternate Director which notice shall set forth the general nature<br>of the business to be considered unless notice is waived by all the Directors (or their alternates) either at, before or after the meeting<br>is held. To any such notice of a meeting of the Directors all the provisions of the Articles relating to the giving of notices by the<br>Company to the Members shall apply mutatis mutandis.
---	---
32.6	The continuing Directors (or a sole continuing Director, as the case may be) may act notwithstanding any<br>vacancy in their body, but if and so long as their number is reduced below the number fixed by or pursuant to the Articles as the necessary<br>quorum of Directors the continuing Directors or Director may act for the purpose of increasing the number of Directors to be equal to<br>such fixed number, or of summoning a general meeting of the Company, but for no other purpose.
---	---

32.7	The Directors may elect a chairman of their board and determine the period for which he or she is to hold<br>office, but if no such chairman is elected, or if at any meeting the chairman is not present within five minutes after the time appointed<br>for the meeting to commence, the Directors present may choose one of their number to be chairman of the meeting.
32.8	Subject to any regulations imposed on it by the Directors, including where the Directors have designated<br>a chairman of the committee, a committee appointed by the Directors may elect a chairman of its meetings and determine the period for<br>which he is to hold office; but if no such chairman is elected, or if at any meeting the chairman is not present within five minutes after<br>the time appointed for the meeting to commence, the committee members present may choose one of their number to be chairman of the meeting.
---	---
32.9	A committee appointed by the Directors may meet and adjourn as it thinks proper. Subject to any regulations<br>imposed on it by the Directors, questions arising at any committee meeting shall be determined by a majority of votes of the committee<br>members present and in case of an equality of votes the chairman shall have a second or casting vote.
---	---
32.10	All acts done by any meeting of the Directors or of a committee of the Directors (including any Person<br>acting as an alternate Director) shall, notwithstanding that it is afterwards discovered that there was some defect in the appointment<br>of any Director or alternate Director, and/or that they or any of them were disqualified, and/or had vacated their office and/or were<br>not entitled to vote, be as valid as if every such Person had been duly appointed and/or not disqualified to be a Director or alternate<br>Director and/or had not vacated their office and/or had been entitled to vote, as the case may be.
---	---
32.11	A Director but not an alternate Director may be represented at any meetings of the board of Directors<br>by a proxy appointed in writing by him. The proxy shall count towards the quorum and the vote of the proxy shall for all purposes be deemed<br>to be that of the appointing Director.
---	---
33.	PRESUMPTION OF ASSENT
---	---

A Director or alternate Director who is present at a meeting of the board of Directors at which action on any Company matter is taken shall be presumed to have assented to the action taken unless his dissent shall be entered in the minutes of the meeting or unless he shall file his written dissent from such action with the Person acting as the chairman of the meeting before the adjournment thereof or shall forward such dissent by registered post to such Person immediately after the adjournment of the meeting. Such right to dissent shall not apply to a Director or alternate Director who voted in favour of such action.

34.	DIRECTORS’ INTERESTS
34.1	A Director or alternate Director may hold any other office or place of profit under the Company (other<br>than the office of Auditor) in conjunction with his office of Director for such period and on such terms as to remuneration and otherwise<br>as the Directors may determine.
---	---
34.2	A Director or alternate Director may act by himself or by, through or on behalf of his firm, in a professional<br>capacity for the Company and he or his firm shall be entitled to remuneration for professional services as if he were not a Director or<br>alternate Director.
---	---
34.3	A Director or alternate Director may be or become a director or other Officer of or otherwise interested<br>in any company promoted by the Company or in which the Company may be interested as a shareholder, a contracting party or otherwise, and<br>no such Director or alternate Director shall be accountable to the Company for any remuneration or other benefits received by him as a<br>director or Officer of, or from his interest in, such other company.
---	---

34.4	No Person shall be disqualified from the office of Director or alternate Director or prevented by such<br>office from contracting with the Company, either as vendor, purchaser or otherwise, nor shall any such contract or any contract or transaction<br>entered into by or on behalf of the Company in which any Director or alternate Director shall be in any way interested be or be liable<br>to be avoided, nor shall any Director or alternate Director so contracting or being so interested be liable to account to the Company<br>for any profit realised by or arising in connection with any such contract or transaction by reason of such Director or alternate Director<br>holding office or of the fiduciary relationship thereby established. A Director (or his alternate Director in his absence) shall be at<br>liberty to vote in respect of any contract or transaction in which he is interested provided that the nature of the interest of any Director<br>or alternate Director in any such contract or transaction shall be disclosed by him at or prior to its consideration and any vote thereon.
34.5	A general notice that a Director or alternate Director is a shareholder, director, Officer or employee<br>of any specified firm or company and is to be regarded as interested in any transaction with such firm or company shall be sufficient<br>disclosure for the purposes of voting on a resolution in respect of a contract or transaction in which he has an interest, and after such<br>general notice it shall not be necessary to give special notice relating to any particular transaction.
---	---
35.	MINUTES
---	---
35.1	The Directors shall cause minutes to be made in books kept for the purpose of recording all appointments<br>of Officers made by the Directors, all proceedings at meetings of the Company or the holders of any class of Shares and of the Directors,<br>and of committees of the Directors, including the names of the Directors or alternate Directors present at each meeting.
---	---
36.	DELEGATION OF DIRECTORS’ POWERS
---	---
36.1	The Directors may delegate any of their powers, authorities and discretions, including the power to sub-delegate,<br>to any committee consisting of one or more Directors (including, without limitation, the Audit Committee and the Compensation Committee);<br>any committee so formed shall in the exercise of the powers so delegated conform to any conditions that may be imposed on it by the Directors.<br>The Directors may also delegate to any managing director or any Director holding any other executive office such of their powers, authorities<br>and discretions as they consider desirable to be exercised by him provided that an alternate Director may not act as managing director<br>and the appointment of a managing director shall be revoked forthwith if he ceases to be a Director. Any such delegation may be made subject<br>to any conditions the Directors may impose and either collaterally with or to the exclusion of their own powers and any such delegation<br>may be revoked or altered by the Directors. Subject to any such conditions that may be imposed by the Directors, the proceedings of a<br>committee of Directors shall be governed by the Articles regulating the proceedings of Directors, so far as they are capable of applying.
---	---
36.2	The Directors may establish any committees, local boards or agencies or appoint any Person to be a manager<br>or agent for managing the affairs of the Company and may appoint any Person to be a member of such committees, local boards or agencies<br>and such Person need not be a Director or Officer of the Company. Any such appointment may be made subject to any conditions the Directors<br>may impose, and either collaterally with or to the exclusion of their own powers and any such appointment may be revoked or altered by<br>the Directors. Subject to any such conditions that may be imposed by the Directors, the proceedings of any such committee, local board<br>or agency shall be governed by the Articles regulating the proceedings of Directors, so far as they are capable of applying.
---	---

36.3	The Directors may adopt formal written charters for committees and, if so adopted, shall review and assess<br>the adequacy of such formal written charters on an annual basis. Each of these committees shall be empowered to do all things necessary<br>to exercise the rights of such committee set forth in the Articles and shall have such powers as the Directors may delegate pursuant to<br>the Articles and as required by the rules and regulations of the Designated Stock Exchange, the SEC and/or any other competent regulatory<br>authority or otherwise under Applicable Law. Each of the Audit Committee and the Compensation Committee, if established, shall consist<br>of such number of Directors as the Directors shall from time to time determine (or such minimum number as may be required from time to<br>time by the rules and regulations of the Designated Stock Exchange, the SEC and/or any other competent regulatory authority or otherwise<br>under Applicable Law). For so long as any class of Shares is listed on the Designated Stock Exchange, the Audit Committee and the Compensation<br>Committee shall be made up of such number of Independent Directors as is required from time to time by the rules and regulations of the<br>Designated Stock Exchange, the SEC and/or any other competent regulatory authority or otherwise under Applicable Law.
36.4	The Directors may by power of attorney or otherwise appoint any Person to be the agent of the Company<br>on such conditions as the Directors may determine, provided that the delegation is not to the exclusion of their own powers and may be<br>revoked by the Directors at any time.
---	---
36.5	The Directors may by power of attorney or otherwise appoint any company, firm, Person or body of Persons,<br>whether nominated directly or indirectly by the Directors, to be the attorney or authorised signatory of the Company for such purpose<br>and with such powers, authorities and discretions (not exceeding those vested in or exercisable by the Directors under the Articles) and<br>for such period and subject to such conditions as they may think fit, and any such powers of attorney or other appointment may contain<br>such provisions for the protection and convenience of Persons dealing with any such attorneys or authorised signatories as the Directors<br>may think fit and may also authorise any such attorney or authorised signatory to delegate all or any of the powers, authorities and discretions<br>vested in him.
---	---
36.6	The Directors may from time to time appoint any Person, whether or not a Director, to hold such office<br>in the Company as the Directors may think necessary for the administration of the Company (including, for the avoidance of doubt and without<br>limitation, a chairman, chief executive officer, president, chief operating officer, chief financial officer, vice-presidents, secretary,<br>assistant secretaries, treasurer or any other officers as may be determined by the Directors), for such term and at such remuneration<br>(whether by way of salary or commission or participation in profits or partly in one way and partly in another), and with such powers<br>and duties as the Directors may think fit. Any Person so appointed by the Directors may be removed by resolution of the Directors or by<br>the Company by Ordinary Resolution. An Officer of the Company may vacate his office at any time if he gives notice in writing to the Company<br>that he resigns his office.
---	---
37.	NO MINIMUM SHAREHOLDING
---	---

The Company in general meeting may fix a minimum shareholding required to be held by a Director, but unless and until such a shareholding qualification is fixed, a Director is not required to hold Shares.

38.

REMUNERATION OF DIRECTORS

38.1

The remuneration to be paid to the Directors, if any, shall be such remuneration as the Directors shall determine. The Directors shall also be entitled to be paid all travelling, hotel and other expenses properly incurred by them in connection with their attendance at meetings of Directors or committees of Directors, or general meetings of the Company, or separate meetings of the holders of any class of Shares or debentures of the Company, or otherwise in connection with the business of the Company or the discharge of their duties as a Director, or to receive a fixed allowance in respect thereof as may be determined by the Directors, or a combination partly of one such method and partly the other.

---

38.2	The Directors may by resolution approve additional remuneration to any Director for any services which<br>in the opinion of the Directors go beyond his ordinary routine work as a Director. Any fees paid to a Director who is also counsel, attorney<br>or solicitor to the Company, or otherwise serves it in a professional capacity, shall be in addition to his remuneration as a Director.
39.	SEAL
---	---
39.1	The Company may, if the Directors so determine, have a Seal. The Seal shall only be used by the authority<br>of the Directors or of a committee of the Directors authorised by the Directors. Every instrument to which the Seal has been affixed shall<br>be signed by at least one Person who shall be either a Director or Officer of the Company or other Person appointed by the Directors for<br>the purpose.
---	---
39.2	The Company may have for use in any place or places outside the Cayman Islands a duplicate Seal or Seals<br>each of which shall be a facsimile of the common Seal of the Company and, if the Directors so determine, with the addition on its face<br>of the name of every place where it is to be used.
---	---
39.3	A Director or Officer, representative or attorney of the Company may without further authority of the<br>Directors affix the Seal over his signature alone to any document of the Company required to be authenticated by him under seal or to<br>be filed with the Registrar of Companies in the Cayman Islands or elsewhere wheresoever.
---	---
40.	DIVIDENDS, DISTRIBUTIONS AND RESERVE
---	---
40.1	Subject to the Statute and this Article and except as otherwise provided by the rights attached to any<br>Shares, the Directors may resolve to pay Dividends and other distributions on Shares in issue and authorise payment of the Dividends or<br>other distributions out of the funds of the Company lawfully available therefor. A Dividend shall be deemed to be an interim Dividend<br>unless the terms of the resolution pursuant to which the Directors resolve to pay such Dividend specifically state that such Dividend<br>shall be a final Dividend. No Dividend or other distribution shall be paid except out of the realised or unrealised profits of the Company,<br>out of the Share Premium Account or as otherwise permitted by law.
---	---
40.2	Except as otherwise provided by the rights attached to any Shares, all Dividends and other distributions<br>shall be paid according to the par value of the Shares that a Member holds. If any Share is issued on terms providing that it shall rank<br>for Dividend as from a particular date, that Share shall rank for Dividend accordingly.
---	---
40.3	The Directors may deduct from any Dividend or other distribution payable to any Member all sums of money<br>(if any) then payable by him to the Company on account of calls or otherwise.
---	---
40.4	The Directors may resolve that any Dividend or other distribution be paid wholly or partly by the distribution<br>of specific assets and in particular (but without limitation) by the distribution of shares, debentures, or securities of any other company<br>or in any one or more of such ways and where any difficulty arises in regard to such distribution, the Directors may settle the same as<br>they think expedient and in particular may issue fractional Shares and may fix the value for distribution of such specific assets or any<br>part thereof and may determine that cash payments shall be made to any Members upon the basis of the value so fixed in order to adjust<br>the rights of all Members and may vest any such specific assets in trustees in such manner as may seem expedient to the Directors.
---	---

40.5	Except as otherwise provided by the rights attached to any Shares, Dividends and other distributions may<br>be paid in any currency. The Directors may determine the basis of conversion for any currency conversions that may be required and how<br>any costs involved are to be met.
40.6	The Directors may, before resolving to pay any Dividend or other distribution, set aside such sums as<br>they think proper as a reserve or reserves which shall, at the discretion of the Directors, be applicable for any purpose of the Company<br>and pending such application may, at the discretion of the Directors, be employed in the business of the Company.
---	---
40.7	Any Dividend, other distribution, interest or other monies payable in cash in respect of Shares may be<br>paid by wire transfer to the holder or by cheque or warrant sent through the post directed to the registered address of the holder or,<br>in the case of joint holders, to the registered address of the holder who is first named on the Register of Members or to such Person<br>and to such address as such holder or joint holders may in writing direct. Every such cheque or warrant shall be made payable to the order<br>of the Person to whom it is sent. Any one of two or more joint holders may give effectual receipts for any Dividends, other distributions,<br>bonuses, or other monies payable in respect of the Share held by them as joint holders.
---	---
40.8	No Dividend or other distribution shall bear interest against<br>the Company.
---	---
40.9	Any Dividend or other distribution which cannot be paid to a Member and/or which remains unclaimed after<br>six months from the date on which such Dividend or other distribution becomes payable may, in the discretion of the Directors, be paid<br>into a separate account in the Company’s name, provided that the Company shall not be constituted as a trustee in respect of that account<br>and the Dividend or other distribution shall remain as a debt due to the Member. Any Dividend or other distribution which remains unclaimed<br>after a period of six years from the date on which such Dividend or other distribution becomes payable shall be forfeited and shall revert<br>to the Company.
---	---
41.	CAPITALISATION
---	---

The Directors may at any time capitalise any sum standing to the credit of any of the Company’s reserve accounts or funds (including the Share Premium Account and capital redemption reserve fund) or any sum standing to the credit of the profit and loss account or otherwise available for distribution; appropriate such sum to Members in the proportions in which such sum would have been divisible amongst such Members had the same been a distribution of profits by way of Dividend or other distribution; and apply such sum on their behalf in paying up in full unissued Shares for allotment and distribution credited as fully paid-up to and amongst them in the proportion aforesaid. In such event the Directors shall do all acts and things required to give effect to such capitalisation, with full power given to the Directors to make such provisions as they think fit in the case of Shares becoming distributable in fractions (including provisions whereby the benefit of fractional entitlements accrue to the Company rather than to the Members concerned). The Directors may authorise any Person to enter on behalf of all of the Members interested into an agreement with the Company providing for such capitalisation and matters incidental or relating thereto and any agreement made under such authority shall be effective and binding on all such Members and the Company.

42.	SHARE PREMIUM ACCOUNT
42.1	The Directors shall in accordance with the Statute establish a Share Premium Account and shall carry to<br>the credit of such account from time to time a sum equal to the amount or value of the premium paid on the issue of any Share.
---	---
42.2	There shall be debited to any Share Premium Account on the redemption or purchase of a Share the difference<br>between the nominal value of such Share and the redemption or purchase price provided always that at the determination of the Directors<br>such sum may be paid out of the profits of the Company or, if permitted by the Statute, out of capital.
---	---
43.	BOOKS OF ACCOUNT
---	---
43.1	The Directors shall cause proper books of account (including, where applicable, material underlying documentation<br>including contracts and invoices) to be kept with respect to all sums of money received and expended by the Company and the matters in<br>respect of which the receipt or expenditure takes place, all sales and purchases of goods by the Company and the assets and liabilities<br>of the Company. Such books of account must be retained for a minimum period of five years from the date on which they are prepared. Proper<br>books shall not be deemed to be kept if there are not kept such books of account as are necessary to give a true and fair view of the<br>state of the Company’s affairs and to explain its transactions.
---	---
43.2	The Directors shall determine whether and to what extent and at what times and places and under what conditions<br>or regulations the accounts and books of the Company or any of them shall be open to the inspection of Members not being Directors and<br>no Member (not being a Director) shall have any right of inspecting any account or book or document of the Company except as conferred<br>by Statute or authorised by the Directors or by the Company in general meeting.
---	---
43.3	The Directors may cause to be prepared and to be laid before the Company in general meeting profit and<br>loss accounts, balance sheets, group accounts (if any) and such other reports and accounts as may be required by law.
---	---
44.	AUDIT
---	---
44.1	The Directors may appoint an Auditor of the Company who shall hold office on such terms as the Directors<br>determine.
---	---
44.2	If the office of Auditor becomes vacant by resignation or death of the Auditor, or by his becoming incapable<br>of acting by reason of illness or other disability at a time when his services are required, the Directors shall fill the vacancy.
---	---
44.3	Every Auditor of the Company shall have a right of access at all times to the books and accounts and vouchers<br>of the Company and shall be entitled to require from the Directors and Officers of the Company such information and explanation as may<br>be necessary for the performance of the duties of the Auditor.
---	---
44.4	Auditors shall, if so required by the Directors, make a report on the accounts of the Company during their<br>tenure of office at the next annual general meeting following their appointment in the case of a company which is registered with the<br>Registrar of Companies as an ordinary company, and at the next extraordinary general meeting following their appointment in the case of<br>a company which is registered with the Registrar of Companies as an exempted company, and at any other time during their term of office,<br>upon request of the Directors or any general meeting of the Company.
---	---
44.5	Without prejudice to the freedom of the Directors to establish any other committee, if any of the Shares<br>(or depositary receipts therefor) are listed or quoted on a Designated Stock Exchange, and if required by the rules and regulations of<br>the Designated Stock Exchange, the SEC and/or any other compentent regulatory authority or otherwise under Applicable Law, the Directors<br>shall establish and maintain an Audit Committee as a committee of the board of Directors and shall adopt a formal written audit committee<br>charter and review and assess the adequacy of the formal written charter on an annual basis. The composition and responsibilities of the<br>Audit Committee shall comply with the rules and regulations of the SEC and the Designated Stock Exchange and/or any other competent regulatory<br>authority or otherwise under Applicable Law. The Audit Committee (if one exists) shall meet at least once every financial quarter, or<br>more frequently as circumstances dictate.
---	---

44.6	If any of the Shares (or depositary receipts therefor) are listed or quoted on a Designated Stock Exchange,<br>the Company shall conduct an appropriate review of all related party transactions on an ongoing basis and shall utilise the Audit Committee<br>for the review and approval of potential conflicts of interest.
44.7	The remuneration of the Auditor shall be fixed by the Audit Committee (if one exists) or otherwise by<br>the Directors.
---	---
44.8	Any payment made to members of the Audit Committee (if one exists) shall require the review and approval<br>of the Directors, with any Director interested in such payment abstaining from such review and approval.
---	---
45.	NOTICES
---	---
45.1	Notices shall be in writing and may be given by the Company to any Member either personally or by sending<br>it by courier, post, cable, telex, fax or e-mail to him or to his address as shown in the Register of Members (or where the notice is<br>given by e-mail by sending it to the e-mail address provided by such Member). For so long as any of the Shares are traded on a Designated<br>Stock Exchange, notice must also be served in accordance with the requirements of the Designated Stock Exchange. Notice may also be served<br>by Electronic Communication in accordance with the rules and regulations of the Designated Stock Exchange, the SEC and/or any other competent<br>regulatory authority or by placing it on the Company’s Website.
---	---
45.2	Where a notice is sent by:
---	---
(a)	courier, service of the notice shall be deemed to be effected by delivery of the notice to a courier company,<br>and shall be deemed to have been received on the third day (not including Saturdays or Sundays or public holidays) following the day on<br>which the notice was delivered to the courier;
---	---
(b)	post, service of the notice shall be deemed to be effected by properly addressing, pre paying and posting<br>a letter containing the notice, and shall be deemed to have been received on the fifth day (not including Saturdays or Sundays or public<br>holidays in the Cayman Islands) following the day on which the notice was posted;
---	---
(c)	cable, telex or fax, service of the notice shall be deemed to be effected by properly addressing and sending<br>such notice and shall be deemed to have been received on the same day that it was transmitted;
---	---
(d)	e-mail service shall be deemed to be effected by transmitting the e-mail to the e-mail address provided<br>by the intended recipient and shall be deemed to have been received on the same day that it was sent, and it shall not be necessary for<br>the receipt of the e-mail to be acknowledged by the recipient; and
---	---
(e)	placing it on the Company’s Website, service of the notice shall be deemed to have been effected<br>one hour after the notice or document was placed on the Company’s Website.
---	---

45.3	A notice may be given by the Company to the Person or Persons which the Company has been advised are entitled<br>to a Share or Shares in consequence of the death or bankruptcy of a Member in the same manner as other notices which are required to be<br>given under the Articles and shall be addressed to them by name, or by the title of representatives of the deceased, or trustee of the<br>bankrupt, or by any like description at the address supplied for that purpose by the Persons claiming to be so entitled, or at the option<br>of the Company by giving the notice in any manner in which the same might have been given if the death or bankruptcy had not occurred.
45.4	Notice of every general meeting shall be given in any manner authorised by the Articles to every holder<br>of Shares carrying an entitlement to receive such notice on the record date for such meeting except that in the case of joint holders<br>the notice shall be sufficient if given to the joint holder first named in the Register of Members and every Person upon whom the ownership<br>of a Share devolves by reason of his being a legal personal representative or a trustee in bankruptcy of a Member where the Member but<br>for his death or bankruptcy would be entitled to receive notice of the meeting, and no other Person shall be entitled to receive notices<br>of general meetings.
---	---
46.	WINDING UP
---	---
46.1	If the Company shall be wound up, the liquidator shall apply the assets of the Company in satisfaction<br>of creditors’ claims in such manner and order as such liquidator thinks fit. Subject to the rights attaching to any Shares, in a winding<br>up:
---	---
(a)	if the assets available for distribution amongst the Members shall be insufficient to repay the whole<br>of the Company’s issued share capital, such assets shall be distributed so that, as nearly as may be, the losses shall be borne by the<br>Members in proportion to the par value of the Shares held by them; or
---	---
(b)	if the assets available for distribution amongst the Members shall be more than sufficient to repay the<br>whole of the Company’s issued share capital at the commencement of the winding up, the surplus shall be distributed amongst the Members<br>in proportion to the par value of the Shares held by them at the commencement of the winding up subject to a deduction from those Shares<br>in respect of which there are monies due, of all monies payable to the Company for unpaid calls or otherwise.
---	---
46.2	If the Company shall be wound up the liquidator may, subject to the rights attaching to any Shares and<br>with the approval of a Special Resolution of the Company and any other approval required by the Statute, divide amongst the Members in<br>kind the whole or any part of the assets of the Company (whether such assets shall consist of property of the same kind or not) and may<br>for that purpose value any assets and determine how the division shall be carried out as between the Members or different classes of Members.<br>The liquidator may, with the like approval, vest the whole or any part of such assets in trustees upon such trusts for the benefit of<br>the Members as the liquidator, with the like approval, shall think fit, but so that no Member shall be compelled to accept any asset upon<br>which there is a liability.
---	---
47.	INDEMNITY AND INSURANCE
---	---
47.1	Every Director and Officer (which for the avoidance of doubt, shall not include auditors of the Company),<br>together with every former Director and former Officer (each an “Indemnified Person”) shall be indemnified out of the<br>assets of the Company against any liability, action, proceeding, claim, demand, costs, damages or expenses, including legal expenses,<br>whatsoever which they or any of them may incur as a result of any act or failure to act in carrying out their functions other than such<br>liability (if any) that they may incur by reason of their own actual fraud, wilful neglect or wilful default. No Indemnified Person shall<br>be liable to the Company for any loss or damage incurred by the Company as a result (whether direct or indirect) of the carrying out of<br>their functions unless that liability arises through the actual fraud, wilful neglect or wilful default of such Indemnified Person. No<br>person shall be found to have committed actual fraud, wilful neglect or wilful default under this Article unless or until a court of competent<br>jurisdiction shall have made a finding to that effect.
---	---

47.2	The Company shall advance to each Indemnified Person reasonable attorneys’ fees and other costs and expenses<br>incurred in connection with the defence of any action, suit, proceeding or investigation involving such Indemnified Person for which indemnity<br>will or could be sought. In connection with any advance of any expenses hereunder, the Indemnified Person shall execute an undertaking<br>to repay the advanced amount to the Company if it shall be determined by final judgment or other final adjudication that such Indemnified<br>Person was not entitled to indemnification pursuant to this Article. If it shall be determined by a final judgment or other final adjudication<br>that such Indemnified Person was not entitled to indemnification with respect to such judgment, costs or expenses, then such party shall<br>not be indemnified with respect to such judgment, costs or expenses and any advancement shall be returned to the Company (without interest)<br>by the Indemnified Person.
47.3	The Directors, on behalf of the Company, may purchase and maintain insurance for the benefit of any Director<br>or Officer of the Company against any liability which, by virtue of any rule of law, would otherwise attach to such Person in respect<br>of any negligence, default, breach of duty or breach of trust of which such Person may be guilty in relation to the Company.
---	---
48.	FINANCIAL YEAR
---	---

Unless the Directors otherwise prescribe, the financial year of the Company shall end on 31st December in each year and, following the year of incorporation, shall begin on 1st January in each year.

49.	TRANSFER BY WAY OF CONTINUATION
49.1	If the Company is exempted as defined in the Statute, it shall, subject to the provisions of the Statute<br>and with the approval of a Special Resolution, have the power to register by way of continuation as a body corporate under the laws of<br>any jurisdiction outside the Cayman Islands and to be deregistered in the Cayman Islands.
---	---
49.2	At the time of or following the consummation of a Business Combination, if the Company is exempted as<br>defined in the Statute, it shall, subject to the provisions of the Statute and with the approval of a Special Resolution, have the power<br>to register by way of continuation as a body corporate under the laws of any jurisdiction outside the Cayman Islands and to be deregistered<br>in the Cayman Islands.
---	---
50.	MERGERS AND CONSOLIDATIONS
---	---

The Company shall have the power to merge or consolidate with one or more other constituent companies (as defined in the Statute) upon such terms as the Directors may determine and (to the extent required by the Statute) with the approval of a Special Resolution.

51.	DISCLOSURE

The Directors, Officers of the Company or any authorised service providers (including the registered office agent of the Company), shall be entitled to disclose to any regulatory or judicial authority, or to any Designated Stock Exchange on which the Shares may from time to time be listed, any information regarding the affairs of the Company including, without limitation, information contained in the Register of Members and books of the Company.

52.	BUSINESS COMBINATION
52.1	Notwithstanding any other provision of the Articles, this Article shall apply during the period commencing<br>upon the adoption of the Articles and terminating upon the first to occur of the consummation of a Business Combination and the full distribution<br>of the Trust Account pursuant to this Article. In the event of a conflict between this Article and any other Articles, the provisions<br>of this Article shall prevail.
---	---
52.2	Prior to the consummation of any Business Combination, the Company<br>shall either:
---	---
(a)	submit such Business Combination to the Members for approval by way of an Ordinary Resolution; or
---	---
(b)	provide Members with the opportunity to have their Shares repurchased by means of a tender offer for a<br>per-Share repurchase price payable in cash, equal to the aggregate amount then on deposit in the Trust Account, calculated as of two business<br>days prior to the consummation of such Business Combination, including interest earned on the Trust Account (less taxes paid or payable<br>(other than Excise Tax or similar taxes), divided by the number of then issued Public Shares. Such obligation to repurchase Shares is<br>subject to the completion of the proposed Business Combination to which it relates.
---	---
52.3	If the Company initiates any tender offer in accordance with Rule 13e-4 and Regulation 14E of the US Exchange<br>Act in connection with a proposed Business Combination, it shall file tender offer documents with the SEC prior to completing such Business<br>Combination which contain substantially the same financial and other information about such Business Combination and the redemption rights<br>as is required under Regulation 14A of the US Exchange Act. If, alternatively, the Company holds a general meeting to approve a proposed<br>Business Combination, the Company will conduct any redemptions in conjunction with a proxy solicitation pursuant to Regulation 14A of<br>the US Exchange Act, and not pursuant to the tender offer rules, and file proxy materials with the SEC.
---	---
52.4	Any Member holding Public Shares who is not the Sponsor, a Founder, Officer or Director may, in connection<br>with any vote on a Business Combination, elect to have their Public Shares redeemed for cash, in accordance with any applicable requirements<br>provided for in the related proxy materials (the “IPO Redemption”), provided that no such Member acting together with<br>any Affiliate of his or any other person with whom he is acting in concert or as a partnership, limited partnership, syndicate, or other<br>group for the purposes of acquiring, holding, or disposing of Shares may exercise this redemption right with respect to more than 15 per<br>cent of the Public Shares in the aggregate without the prior consent of the Company and provided further that any beneficial holder of<br>Public Shares on whose behalf a redemption right is being exercised must identify itself to the Company in connection with any redemption<br>election in order to validly redeem such Public Shares. If so demanded, the Company shall pay any such redeeming Member, regardless of<br>whether he is voting for or against such proposed Business Combination, a per-Share redemption price payable in cash, equal to the aggregate<br>amount then on deposit in the Trust Account calculated as of two business days prior to the consummation of the Business Combination,<br>including interest earned on the Trust Account (such interest shall be net of taxes payable) and not previously released to the Company<br>to pay its taxes, divided by the number of then issued Public Shares (such redemption price being referred to herein as the “RedemptionPrice”).
---	---
52.5	A Member may not withdraw a Redemption Notice once submitted to the Company unless the Directors determine<br>(in their sole discretion) to permit the withdrawal of such redemption request (which they may do in whole or in part).
---	---

52.6	In the event that the Company does not consummate a Business Combination within 24 months from the consummation<br>of the IPO, or such later time as the Members may approve in accordance with the Articles, the Company shall:
(a)	cease all operations except for the purpose of winding up;
---	---
(b)	as promptly as reasonably possible but not more than ten business days thereafter, redeem the Public Shares,<br>at a per-Share price, payable in cash, equal to the aggregate amount then on deposit in the Trust Account, including interest earned on<br>the funds held in the Trust Account (less taxes paid or payable (other than Excise Tax or similar taxes) and up to $100,000 of interest<br>to pay dissolution expenses) will be used to fund the redemption of the Public Shares in issue, which redemption will completely extinguish<br>public Members’ rights as Members (including the right to receive further liquidation distributions, if any); and
---	---
(c)	as promptly as reasonably possible following such redemption, subject to the approval of the Company’s<br>remaining Members and the Directors, liquidate and dissolve,
---	---

subject in each case to its obligations under Cayman Islands law to provide for claims of creditors and in all cases subject to the other requirements of Applicable Law.

52.7	In the event that any amendment is made to the Articles:
(a)	to modify the substance or timing of the Company’s obligation to allow redemption in connection with a<br>Business Combination or redeem 100 per cent of the Public Shares if the Company does not consummate a Business Combination within 24 months<br>after the date of the closing of the IPO, or such later time as the Members may approve in accordance with the Articles, or
---	---
(b)	with respect to any other provision relating to Members’ rights or pre-Business Combination activity,<br>of the Articles relating to the rights of holders of Ordinary Shares,
---	---

each holder of Public Shares who is not the Sponsor, a Founder, Officer or Director shall be provided with the opportunity to redeem their Public Shares upon the approval or effectiveness of any such amendment at a per-Share price, payable in cash, equal to the aggregate amount then on deposit in the Trust Account, including interest earned on the funds held in the Trust Account and not previously released to the Company to pay its taxes, divided by the number of then outstanding Public Shares.

52.8	A holder of Public Shares shall be entitled to receive distributions from the Trust Account only in the<br>event of an IPO Redemption, a repurchase of Shares by means of a tender offer pursuant to this Article, or a distribution of the Trust<br>Account pursuant to this Article. In no other circumstance shall a holder of Public Shares have any right or interest of any kind in the<br>Trust Account.
52.9	After the issue of Public Shares, and prior to the consummation of a Business Combination, the Company<br>shall not issue additional Shares or any other securities that would entitle the holders thereof to:
---	---
(a)	receive funds from the Trust Account; or
---	---
(b)	vote as a class with Public Shares on a Business Combination.
---	---
52.10	As long as the securities of the Company are listed on a Designated Stock Exchange, the Company must complete<br>one or more Business Combinations having an aggregate fair market value of at least 80 per cent of the assets held in the Trust Account<br>(net of amounts previously disbursed to the Company’s management for taxes or working capital and excluding the amount of deferred<br>underwriting discounts held in the Trust Account) at the time of the Company’s signing a definitive agreement in connection with<br>a Business Combination. A Business Combination must not be effectuated with another blank cheque company or a similar company with nominal<br>operations.
---	---

52.11	A Director may vote in respect of a Business Combination in which such Director has a conflict of interest<br>with respect to the evaluation of such Business Combination. Such Director must disclose such interest or conflict to the other Directors.
52.12	The Company may enter into a Business Combination with a target business that is Affiliated with the Sponsor,<br>a Founder, a Director or an Officer. In the event the Company seeks to consummate a Business Combination with a target that is Affiliated<br>with the Sponsor, a Founder, a Director or an Officer, the Company, or a committee of Independent Directors, will obtain an opinion from<br>an independent investment banking firm or another valuation or appraisal firm that regularly renders fairness opinions on the type of<br>target business the Company is seeking to acquire that is a member of the United States Financial Industry Regulatory Authority or an<br>independent accounting firm that such a Business Combination is fair to the Company from a financial point of view.
---	---
52.13	A Business Combination must be approved by a majority of the board of Directors and a majority of the<br>Independent Directors.
---	---
53.	BUSINESS OPPORTUNITIES
---	---
53.1	To the fullest extent permitted by Applicable Law, no individual serving as a Director or an officer (“Management”)<br>shall have any duty, except and to the extent expressly assumed by contract, to refrain from engaging directly or indirectly in the same<br>or similar business activities or lines of business as the Company. To the fullest extent permitted by Applicable Law, the Company renounces<br>any interest or expectancy of the Company in, or in being offered an opportunity to participate in, any potential transaction or matter<br>which may be a corporate opportunity for Management, on the one hand, and the Company, on the other. Except to the extent expressly assumed<br>by contract, to the fullest extent permitted by Applicable Law, Management shall have no duty to communicate or offer any such corporate<br>opportunity to the Company and shall not be liable to the Company or its Members for breach of any fiduciary duty as a Member, Director<br>and/or officer solely by reason of the fact that such party pursues or acquires such corporate opportunity for itself, himself or herself,<br>directs such corporate opportunity to another person, or does not communicate information regarding such corporate opportunity to the<br>Company.
---	---
53.2	Except as provided elsewhere in this Article, the Company hereby renounces any interest or expectancy<br>of the Company in, or in being offered an opportunity to participate in, any potential transaction or matter which may be a corporate<br>opportunity for both the Company and Management, about which a Director and/or officer who is also a member of Management acquires knowledge.
---	---
53.3	To the extent a court might hold that the conduct of any activity related to a corporate opportunity that<br>is renounced in this Article to be a breach of duty to the Company or its Members, the Company hereby waives, to the fullest extent permitted<br>by Applicable Law, any and all claims and causes of action that the Company may have for such activities. To the fullest extent permitted<br>by Applicable Law, the provisions of this Article apply equally to activities conducted in the future and that have been conducted in<br>the past.
---	---

54.	EXCLUSIVE JURISDICTION AND FORUM
54.1	Unless the Company consents in writing to the selection of an alternative forum, the courts of the Cayman<br>Islands shall have exclusive jurisdiction over any claim or dispute arising out of or in connection with the Memorandum, the Articles<br>or otherwise related in any way to each Member’s shareholding in the Company, including but not limited to:
---	---
(a)	any derivative action or proceeding brought on behalf of the<br>Company;
---	---
(b)	any action asserting a claim of breach of any fiduciary or other duty owed by any current or former Director,<br>Officer or other employee of the Company to the Company or the Members;
---	---
(c)	any action asserting a claim arising pursuant to any provision of the Statute, the Memorandum or the Articles;<br>or
---	---
(d)	any action asserting a claim against the Company governed<br>by the “Internal Affairs Doctrine” (as such concept is recognized under the laws of the United States of America).
---	---
54.2	Each Member irrevocably submits to the exclusive jurisdiction<br>of the courts of the Cayman Islands over all such claims or disputes.
---	---
54.3	Without prejudice to any other rights or remedies that the Company may have, each Member acknowledges<br>that damages alone would not be an adequate remedy for any breach of the selection of the courts of the Cayman Islands as exclusive forum<br>and that accordingly the Company shall be entitled, without proof of special damages, to the remedies of injunction, specific performance<br>or other equitable relief for any threatened or actual breach of the selection of the courts of the Cayman Islands as exclusive forum.
---	---
54.4	This Article 55 shall not apply to any action or suits brought to enforce any liability or duty created<br>by the United States Securities Act of 1933, as amended, the Exchange Act, or any claim for which the federal<br>district courts of the United States of America are, as a matter of the laws of the United States, the sole and exclusive forum for<br>determination of such a claim.
---	---

Exhibit 10.1

April 16, 2026

JATT II Acquisition Corp

153 Central Avenue

C/O 56

Westfield, NJ 07091

Re:	Initial Public Offering

Ladies and Gentlemen:

This letter (this “Letter Agreement”) is being delivered to you in accordance with the Underwriting Agreement (the “Underwriting Agreement”) entered into by and between JATT II Acquisition Corp, a Cayman Islands exempted company (the “Company”) and Guggenheim Securities, LLC, as representative (the “Representative”) of the underwriters named therein (the “Underwriters”), relating to an underwritten initial public offering (the “Public Offering”) of up to 6,900,000 of the Company’s ordinary shares, par value $0.0001 per share (including up to 900,000 shares that may be purchased to cover over-allotments, if any) (the “Ordinary Shares”). The Ordinary Shares will be sold in the Public Offering pursuant to a registration statement on Form S-1 and prospectus (the “Prospectus”) filed by the Company with the U.S. Securities and Exchange Commission (the “Commission”) and the Company has applied to have the Ordinary Shares listed on The Nasdaq Global Market. Certain capitalized terms used herein are defined in paragraph 11 hereof.

In order to induce the Company and the Underwriters to enter into the Underwriting Agreement and to proceed with the Public Offering and for other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, each of JATT Ventures II L.P. (the “Sponsor”) and the undersigned individuals, each of whom is a member of the Company’s board of directors and/or management team, or independent consultant (each of the undersigned individuals, an “Insider” and collectively, the “Insiders”), hereby agrees with the Company as follows:

It is acknowledged and agreed that the Company shall not enter into a definitive agreement regarding a proposed Business Combination without the prior consent of the Sponsor. The Sponsor and each Insider agrees that if the Company seeks shareholder approval of a proposed Business Combination, then in connection with such proposed Business Combination, it, he or she shall (i) vote any Ordinary Shares (as defined below) owned by it, him or her in favor of any proposed Business Combination (except with respect to any such Offering Shares (as defined below) which may not be voted in favor of approving the Business Combination in accordance with the requirements of Rule 14e-5 under the Exchange Act (as defined below) and any Commission interpretations or guidance relating thereto) and (ii) not redeem any Ordinary Shares owned by it, him or her in connection with such shareholder approval. If the Company seeks to consummate a proposed Business Combination by engaging in a tender offer, the Sponsor and each Insider agrees that it, he or she will not sell or tender to the Company any Ordinary Shares owned by it, him or her in connection therewith.

The Sponsor and each Insider hereby agrees that in the event that the Company fails to consummate a Business Combination within 24 months from the closing of the Public Offering, or such later period approved by the Company’s shareholders in accordance with the Company’s amended and restated memorandum and articles of association (as it may be amended from time to time, the “Charter”), the Sponsor and each Insider shall take all reasonable steps to cause the Company to, as promptly as reasonably possible but not more than ten (10) business days thereafter, redeem 100% of the Ordinary Shares in the Public Offering (the “Offering Shares”), at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the Trust Account (as defined below), including interest earned on the funds held in the Trust Account (less taxes paid or payable (other than excise or similar taxes) and up to $100,000 of interest to pay dissolution expenses), divided by the number of then issued and outstanding Offering Shares, which redemption will constitute full and complete payment for the Offering Shares and completely extinguish all Public Shareholders’ (as defined below) rights as shareholders (including the right to receive further liquidating or other distributions, if any), subject to the Company’s obligations under Cayman Islands law to provide for claims of creditors and in all cases subject to the other requirements of applicable law. The Sponsor and each Insider agrees to not propose any amendment to the Charter (A) to modify the substance or timing of the Company’s obligation to allow redemption in connection with a Business Combination or to redeem 100% of the Offering Shares if the Company does not complete a Business Combination within the required time period set forth in the Charter or (B) with respect to any other material provisions relating to shareholders’ rights or pre-initial Business Combination activity, unless the Company provides its Public Shareholders with the opportunity to redeem their Offering Shares upon approval of any such amendment at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the Trust Account, including interest earned on the funds held in the Trust Account (net of taxes paid or payable (other than excise or similar taxes)), divided by the number of then issued and outstanding Offering Shares.

---

The Sponsor and each Insider acknowledges that it, he or she has no right, title, interest or claim of any kind in or to any monies held in the Trust Account with respect to the Founder Shares held by it, him or her. The Sponsor and each Insider hereby further waives, with respect to any Ordinary Shares held by it, him or her, if any, any redemption rights it, he or she may have in connection with (a) the consummation of a Business Combination, including, without limitation, any such rights available in the context of a shareholder vote to approve such Business Combination, or (b) a shareholder vote to approve an amendment to the Charter (A) to modify the substance or timing of the Company’s obligation to allow redemption in connection with a Business Combination or to redeem 100% of the Offering Shares if the Company has not consummated a Business Combination within the time period set forth in the Charter or (B) with respect to any other material provisions relating to shareholders’ rights or pre-initial Business Combination activity or in the context of a tender offer made by the Company to purchase Offering Shares (although the Sponsor, the Insiders and their respective affiliates shall be entitled to redemption and liquidation rights with respect to any Offering Shares it or they hold if the Company fails to consummate a Business Combination within the time period set forth in the Charter).

During the period commencing on the effective date of the Underwriting Agreement and ending 180 days after such date, the Sponsor and each Insider shall not, without the prior written consent of the Representative, (i) sell, offer to sell, contract or agree to sell, hypothecate, pledge, grant any option to purchase or otherwise dispose of or agree to dispose of, directly or indirectly, or establish or increase a put equivalent position or liquidate or decrease a call equivalent position within the meaning of Section 16 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), and the rules and regulations of the Commission promulgated thereunder, with respect to Ordinary Shares (including, but not limited to, Founder Shares) or any securities convertible into, or exercisable, or exchangeable for, Ordinary Shares owned by it, him or her, (ii) enter into any swap or other arrangement that transfers to another, in whole or in part, any of the economic consequences of ownership of Ordinary Shares (including, but not limited to, Founder Shares) or any securities convertible into, or exercisable, or exchangeable for, Ordinary Shares owned by it, him or her, whether any such transaction is to be settled by delivery of such securities, in cash or otherwise, or (iii) publicly announce any intention to effect any transaction specified in clause (i) or (ii). The provisions of this paragraph will not apply to any transfer permitted under paragraph 7(c) hereof or if the release or waiver is effected solely to permit a transfer not for consideration and the transferee has agreed in writing to be bound by the same terms described in this Letter Agreement to the extent and for the duration that such terms remain in effect at the time of the transfer.

4.	In the event of the liquidation of the Trust Account upon the<br>failure of the Company to consummate its initial Business Combination within the time period set forth in the Charter, the Sponsor (the<br>“Indemnitor”) agrees to indemnify and hold harmless the Company against any and all loss, liability, claim,<br>damage and expense whatsoever (including, but not limited to, any and all legal or other expenses reasonably incurred in investigating,<br>preparing or defending against any litigation, whether pending or threatened) to which the Company may become subject as a result of<br>any claim by (i) any third party for services rendered or products sold to the Company (except for the Company’s independent auditors)<br>or (ii) any prospective target business with which the Company has entered into a written letter of intent, confidentiality or other<br>similar agreement, in connection with an extension of the timeframe for the Company to consummate a Business Combination or Business<br>Combination agreement (a “Target”); provided, however, that such indemnification of the Company<br>by the Indemnitor (x) shall apply only to the extent necessary to ensure that such claims by a third party or a Target do not reduce<br>the amount of funds in the Trust Account to below the lesser of (i) $10.00 per Offering Share and (ii) the actual amount per Offering<br>Share held in the Trust Account as of the date of the liquidation of the Trust Account, if less than $10.00 per Offering Share is then<br>held in the Trust Account due to reductions in the value of the trust assets, less taxes payable, (y) shall not apply to any claims by<br>a third party or a Target which executed a waiver of any and all rights to the monies held in the Trust Account (whether or not such<br>waiver is enforceable) and (z) shall not apply to any claims under the Company’s indemnity of the Underwriters against certain<br>liabilities, including liabilities under the Securities Act of 1933, as amended. The Indemnitor shall have the right to defend against<br>any such claim with counsel of its choice reasonably satisfactory to the Company if, within 15 days following written receipt of notice<br>of the claim to the Indemnitor, the Indemnitor notifies the Company in writing that it shall undertake such defense.
5.	To the extent that the Underwriters do not exercise their over-allotment<br>option to purchase up to an additional 900,000 Ordinary Shares within 45 days from the date of the Prospectus (and as further described<br>in the Prospectus), the Sponsor agrees to forfeit, at no cost, a number of Founder Shares equal to 225,000 multiplied by a fraction,<br>(i) the numerator of which is 900,000 minus the number of Ordinary Shares purchased by the Underwriters upon the exercise of their over-allotment<br>option, and (ii) the denominator of which is 900,000. The forfeiture will be adjusted to the extent that the over-allotment option is<br>not exercised in full by the Underwriters so that the Founder Shares will represent an aggregate of 20.0% of the Company’s issued<br>and outstanding Ordinary Shares after the Public Offering (not including the Private Placement Shares (as defined below)). The Initial<br>Shareholders further agree that to the extent that the size of the Public Offering is increased or decreased, the Company will purchase<br>or sell Ordinary Shares or effect a share repurchase or share capitalization, as applicable, immediately prior to the consummation of<br>the Public Offering in such amount as to maintain the number of Founder Shares at 20.0% of its issued and outstanding Ordinary Shares<br>upon the consummation of the Public Offering (not including the Private Placement Shares). In connection with such increase or decrease<br>in the size of the Public Offering, then (A) the references to 900,000 in the numerator and denominator of the formula in the first sentence<br>of this paragraph shall be changed to a number equal to 15% of the number of Ordinary Shares issued in the Public Offering and (B) the<br>reference to 225,000 in the formula set forth in the first sentence of this paragraph shall be adjusted to such number of Founder Shares<br>that the Sponsor would have to surrender to the Company in order for the number of Founder Shares to equal an aggregate of 20.0% of the<br>Company’s issued and outstanding Ordinary Shares after the Public Offering (not including Private Placement Shares).
---	---
6.	The Sponsor and each Insider hereby agrees and acknowledges<br>that: (i) the Underwriters and the Company would be irreparably injured in the event of a breach by such Sponsor or an Insider of its,<br>his or her obligations under paragraphs 1, 2, 3, 4, 5, 7(a), 7(b), and 9, as applicable, of this Letter Agreement, (ii) monetary damages<br>may not be an adequate remedy for such breach and (iii) the non-breaching party shall be entitled to injunctive relief, in addition to<br>any other remedy that such party may have in law or in equity, in the event of such breach.
---	---
7.	(a) The Sponsor and each Insider agrees that it, he or she shall<br>not Transfer any Founder Shares (or any Ordinary Shares issuable upon conversion thereof) until the earlier of (A) 180 days after the<br>completion of the Company’s initial Business Combination and (B) subsequent to the Business Combination, the date on which the<br>Company completes a liquidation, merger, amalgamation, capital stock exchange, reorganization or other similar transaction that results<br>in all of the Company’s Public Shareholders having the right to exchange their Ordinary Shares for cash, securities or other property<br>(the “Founder Shares Lock-up Period”).
---	---

(b) The Sponsor and each Insider agrees that it, he or she shall not Transfer any Private Placement Shares, until 30 days after the completion of a Business Combination (the “Private Placement Shares Lock-up Period”, together with the Founder Shares Lock-up Period, the “Lock-upPeriods”).

(c) Notwithstanding the provisions set forth in paragraphs 7(a) and 7(b), Transfers of the Founder Shares (or any Ordinary Shares issuable upon conversion thereof) or Private Placement Shares that are held by the Sponsor, any Insider or any of their permitted transferees (that have complied with this paragraph 7(c)), are permitted (a) to the Company’s officers or directors, any affiliate or family member of any of the Company’s officers or directors, any members or partners of the Sponsor or their affiliates, any affiliates of the Sponsor, or any employees of such affiliates; (b) in the case of an individual, by gift to a member of such individual’s immediate family or to a trust, the beneficiary of which is a member of such individual’s immediate family, an affiliate of such individual or to a charitable organization; (c) in the case of an individual, by virtue of laws of descent and distribution upon death of such individual; (d) in the case of an individual, pursuant to a qualified domestic relations order; (e) by private sales or transfers made in connection with any forward purchase agreement or similar arrangement or otherwise in connection with the consummation of an initial Business Combination at prices no greater than the price at which the securities were originally purchased; (f) in the event of the Company’s liquidation prior to the completion of an initial Business Combination; (g) by virtue of the laws of the Cayman Islands or the Sponsor’s limited liability company agreement upon dissolution of the Sponsor; or (h) in the event of the Company’s liquidation, merger, capital stock exchange or other similar transaction which results in all of the Company’s shareholders having the right to exchange their Ordinary Shares for cash, securities or other property subsequent to the Company’s completion of an initial Business Combination; provided, however, that in the case of clauses (a) through (e) or (g), these permitted transferees must enter into a written agreement with the Company agreeing to be bound by the transfer restrictions herein and the other restrictions contained in this Agreement (including provisions relating to voting, the Trust Account and liquidating distributions).

The Sponsor and each Insider represents and warrants that it, he or she has never been suspended or expelled from membership in any securities or commodities exchange or association or had a securities or commodities license or registration denied, suspended or revoked. Each Insider’s biographical information furnished to the Company (including any such information included in the Prospectus) is true and accurate in all respects and does not omit any material information with respect to the Insider’s background. The Sponsor and each Insider’s questionnaire furnished to the Company is true and accurate in all respects. The Sponsor and each Insider represents and warrants that: it, he or she is not subject to or a respondent in any legal action for, any injunction, cease-and-desist order or order or stipulation to desist or refrain from any act or practice relating to the offering of securities in any jurisdiction; it, he or she has never been convicted of, or pleaded guilty to, any crime (i) involving fraud, (ii) relating to any financial transaction or handling of funds of another person, or (iii) pertaining to any dealings in any securities and it, he or she is not currently a defendant in any such criminal proceeding.

[Reserved.]

---

10.	The Sponsor and each Insider has full right and power, without<br>violating any agreement to which it is bound (including, without limitation, any non-competition or non-solicitation agreement with any<br>employer or former employer), to enter into this Letter Agreement and, as applicable, to serve as an officer and/or director on the board<br>of directors of the Company and hereby consents to being named in the Prospectus as an officer and/or director of the Company.
11.	As used herein, (i) “Business Combination”<br>shall mean a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination, involving the<br>Company and one or more businesses; (ii) “Founder Shares” shall mean the 1,725,000 Ordinary Shares issued and<br>outstanding (up to 225,000 of which are subject to complete or partial forfeiture if the over-allotment option is not exercised by the<br>Underwriters); (iii) “Initial Shareholders” shall mean the Sponsor and any Insider that holds Founder Shares;<br>(iv) “Private Placement Shares” shall mean the 300,000 Ordinary Shares (or 309,000 Ordinary Shares if the over-allotment<br>option is exercised in full) that the Sponsor has agreed to purchase for an aggregate purchase price of $3,000,000 (or $3,090,000 if<br>the over-allotment option is exercised in full), or $10.00 per share, in a private placement that shall occur simultaneously with the<br>consummation of the Public Offering; (v) “Shares” shall mean the Private Placement Shares and public shares;<br>(vi) “Public Shareholders” shall mean the holders of securities issued in the Public Offering; (vii) “TrustAccount” shall mean the trust fund into which a portion of the net proceeds of the Public Offering and the sale of the<br>Private Placement Shares shall be deposited; and (viii) “Transfer” shall mean the (a) sale of, offer to sell,<br>contract or agreement to sell, hypothecate, pledge, grant of any option to purchase or otherwise dispose of or agreement to dispose of,<br>directly or indirectly, or establishment or increase of a put equivalent position or liquidation with respect to or decrease of a call<br>equivalent position within the meaning of Section 16 of the Exchange Act, and the rules and regulations of the Commission promulgated<br>thereunder with respect to, any security, (b) entry into any swap or other arrangement that transfers to another, in whole or in part,<br>any of the economic consequences of ownership of any security, whether any such transaction is to be settled by delivery of such securities,<br>in cash or otherwise, or (c) public announcement of any intention to effect any transaction specified in clause (a) or (b).
---	---
12.	The Company will maintain an insurance policy or policies providing<br>directors’ and officers’ liability insurance, and each Director shall be covered by such policy or policies, in accordance<br>with its or their terms.
---	---
13.	This Letter Agreement constitutes the entire agreement and understanding<br>of the parties hereto in respect of the subject matter hereof and supersedes all prior understandings, agreements, or representations<br>by or among the parties hereto, written or oral, to the extent they relate in any way to the subject matter hereof or the transactions<br>contemplated hereby. This Letter Agreement may not be changed, amended, modified or waived (other than to correct a typographical error)<br>as to any particular provision, except by a written instrument executed by all parties hereto.
---	---
14.	No party hereto may assign either this Letter Agreement or any<br>of its rights, interests, or obligations hereunder without the prior written consent of the other parties. Any purported assignment in<br>violation of this paragraph shall be void and ineffectual and shall not operate to transfer or assign any interest or title to the purported<br>assignee. This Letter Agreement shall be binding on the Sponsor and each Insider and their respective successors, heirs and assigns and<br>permitted transferees.
---	---
15.	Nothing in this Letter Agreement shall be construed to confer<br>upon, or give to, any person or entity other than the parties hereto any right, remedy or claim under or by reason of this Letter Agreement<br>or of any covenant, condition, stipulation, promise or agreement hereof. All covenants, conditions, stipulations, promises and agreements<br>contained in this Letter Agreement shall be for the sole and exclusive benefit of the parties hereto and their successors, heirs, personal<br>representatives and assigns and permitted transferees.
---	---
16.	This Letter Agreement may be executed in any number of original<br>or facsimile counterparts and each of such counterparts shall for all purposes be deemed to be an original, and all such counterparts<br>shall together constitute but one and the same instrument.
---	---
17.	This Letter Agreement shall be deemed severable, and the invalidity<br>or unenforceability of any term or provision hereof shall not affect the validity or enforceability of this Letter Agreement or of any<br>other term or provision hereof. Furthermore, in lieu of any such invalid or unenforceable term or provision, the parties hereto intend<br>that there shall be added as a part of this Letter Agreement a provision as similar in terms to such invalid or unenforceable provision<br>as may be possible and be valid and enforceable.
---	---

18.	This Letter Agreement shall be governed by and construed and<br>enforced in accordance with the internal laws of the State of New York. The parties hereto (i) all agree that any action, proceeding,<br>claim or dispute arising out of, or relating in any way to, this Letter Agreement shall be brought and enforced in the courts of New<br>York City, in the State of New York, and irrevocably submit to such jurisdiction and venue, which jurisdiction and venue shall be exclusive<br>and (ii) waive any objection to such exclusive jurisdiction and venue or that such courts represent an inconvenient forum.
19.	Any notice, consent or request to be given in connection with<br>any of the terms or provisions of this Letter Agreement shall be in writing and shall be sent by express mail or similar private courier<br>service, by certified mail (return receipt requested), by hand delivery or e-mail transmission.
---	---
20.	This Letter Agreement shall terminate on the earlier of (i)<br>the expiration of the Lock-up Periods or (ii) the liquidation of the Company; provided that this Letter Agreement shall earlier terminate<br>in the event that the Public Offering is not consummated and closed by December 31, 2026; provided further that paragraph 4 of this Letter<br>Agreement shall survive such liquidation.
---	---

[Signature Page Follows]

Sincerely,
JATT Ventures II L.P.
(acting by its general partner, JATT Ventures II Ltd)
By:	/s/ Someit Sidhu
Name:	Someit Sidhu
Title:	Director
By:	/s/ Someit Sidhu
Name:	Someit Sidhu
By:	/s/ Nicholas Fernandez
Name:	Nicholas Fernandez
By:	/s/ Verender S. Badial
Name:	Verender S. Badial
By:	/s/ Christopher Staral
Name:	Christopher Staral
By:	/s/ Arjun Goyal
Name:	Arjun Goyal
By:	/s/ Jonathon Kluft
Name:	Jonathon Kluft
By:	/s/ Brad Middlekauff
Name:	Brad Middlekauff
Acknowledged and Agreed:
---	---
JATT II Acquisition Corp
By:	/s/ Someit Sidhu
Name:	Someit Sidhu
Title:	Chief Executive Officer

[Signature Page to Letter Agreement]

Exhibit 10.2

INVESTMENT MANAGEMENT TRUST AGREEMENT

This Investment Management Trust Agreement (this “Agreement”) is made effective as of April 16, 2026 by and between JATT II Acquisition Corp, a Cayman Islands exempted company (the “Company”), and Continental Stock Transfer & Trust Company, a New York corporation (the “Trustee”).

WHEREAS, the Company’s registration statement on Form S-1, File No. 333-294294 (the “Registration Statement”) and prospectus (the “Prospectus”) for the initial public offering (the “Offering”) of the Company’s Ordinary Shares, par value $0.0001 per share (the “Ordinary Shares”) has been declared effective as of the date hereof by the U.S. Securities and Exchange Commission; and

WHEREAS, the Company has entered into an Underwriting Agreement (the “Underwriting Agreement”) with Guggenheim Securities, LLC, as representative of the underwriters named therein (the “Underwriters”); and

WHEREAS, as described in the Prospectus, $60,000,000 of the gross proceeds of the Offering and sale of the Private Placement Shares (as defined in the Underwriting Agreement) (or $69,000,000 if the Underwriters’ over-allotment option is exercised in full) will be delivered to the Trustee to be deposited and held in a segregated trust account located at all times in the United States (the “Trust Account”) for the benefit of the Company and the holders of the Ordinary Shares issued in the Offering as hereinafter provided (the amount to be delivered to the Trustee (and any interest subsequently earned thereon) is referred to herein as the “Property,” the shareholders for whose benefit the Trustee shall hold the Property will be referred to as the “Public Shareholders,” and the Public Shareholders and the Company will be referred to together as the “Beneficiaries”); and

WHEREAS, pursuant to the Underwriting Agreement, a portion of the Property equal to $1,800,000, or $2,070,000 if the Underwriters’ over-allotment option is exercised in full, is attributable to deferred underwriting discounts and commissions that will be payable by the Company to the Underwriters upon and concurrently with the consummation of the Business Combination (as defined below) (the “Deferred Discount”) and at the Company’s sole and absolute discretion, up to $500,000 of this amount may be paid to third parties not participating in the Company’s Offering that assist the Company in consummating the Business Combination; and

WHEREAS, the Company and the Trustee desire to enter into this Agreement to set forth the terms and conditions pursuant to which the Trustee shall hold the Property.

NOW THEREFORE, IT IS AGREED:

1.	Agreements and Covenants of Trustee. The Trustee hereby<br>agrees and covenants to:

(a) Hold the Property in trust for the Beneficiaries in accordance with the terms of this Agreement in the Trust Account established by the Trustee in the United States at JPMorgan Chase Bank, N.A. (or at another U.S. chartered commercial bank with consolidated assets of $100 billion or more) and at a brokerage institution selected by the Trustee that is reasonably satisfactory to the Company;

(b) Manage, supervise and administer the Trust Account subject to the terms and conditions set forth herein;

(c) In a timely manner, upon the written instruction of the Company, (i) hold the Property as uninvested cash, (ii) deposit the Property into an interest bearing or non-interest bearing demand deposit account at a U.S. chartered commercial bank with consolidated assets of $100 billion or more selected by the Trustee that is satisfactory to the Company, or (iii) invest and reinvest the Property in United States government securities within the meaning of Section 2(a)(16) of the Investment Company Act of 1940, as amended (the “Investment Company Act”), having a maturity of 185 days or less, or in money market funds meeting the conditions of paragraphs (d)(1), (d)(2), (d)(3) and (d)(4) of Rule 2a-7 promulgated under the Investment Company Act (or any successor rule), which invest only in direct U.S. government treasury obligations; the Trustee may not invest in any other securities or assets; it being understood that the Trust Account will earn no interest while account funds are uninvested awaiting the Company’s instructions hereunder and while the account funds are invested or uninvested, the Trustee may earn bank credits or other consideration during such periods;

(d) Collect and receive, when due, all interest or other income arising from the Property, which shall become part of the “Property,” as such term is used herein;

(e) Promptly notify the Company and the Underwriters of all communications received by the Trustee with respect to any Property requiring action by the Company;

(f) Supply any necessary information or documents as may be requested by the Company (or its authorized agents) in connection with the Company’s preparation of the tax returns relating to assets held in the Trust Account or in connection with the preparation of the Company’s financial statements or completion of the audit of the Company’s financial statements by the Company’s auditors;

(g) Participate in any plan or proceeding for protecting or enforcing any right or interest arising from the Property if, as and when instructed by the Company to do so;

(h) Render to the Company monthly written statements of the activities of, and amounts in, the Trust Account reflecting all receipts and disbursements of the Trust Account;

(i) Commence liquidation of the Trust Account only after and promptly after (x) receipt of, and only in accordance with the terms of, a letter from the Company (“Termination Letter”) in a form substantially similar to that attached hereto as either Exhibit A or Exhibit B, as applicable, signed on behalf of the Company by its Chief Executive Officer, Chief Financial Officer, President, Executive Vice President, Vice President, Secretary or Chairman of the board of directors of the Company (the “Board”) or other authorized officer of the Company , and, in the case of Exhibit A, acknowledged and agreed to by the Underwriters, and complete the liquidation of the Trust Account and distribute the Property in the Trust Account, including interest earned on the funds held in the Trust Account (less taxes paid or payable and up to $100,000 of interest to pay dissolution expenses), only as directed in the Termination Letter and the other documents referred to therein, or (y) upon the date which is the later of (1) 24 months after the closing of the Offering and (2) such later date as may be approved by the Company’s shareholders in accordance with the Company’s amended and restated memorandum and articles of association, (as may be amended and/or restated from time to time, the “Articles”) or (z) upon the end of a 30-day cure period after the date any additional amount of funds were required to be deposited in the Trust Account as a condition of any extension of such date approved by the Company’s shareholders but were not deposited, if a Termination Letter has not been received by the Trustee prior to such date, in which case the Trust Account shall be liquidated in accordance with the procedures set forth in the Termination Letter attached as Exhibit B and the Property in the Trust Account, including interest earned on the funds held in the Trust Account (less taxes paid or payable and up to $100,000 of interest to pay dissolution expenses), shall be distributed to the Public Shareholders of record as of such date;

(j) Upon written request from the Company, which may be given from time to time in a form substantially similar to that attached hereto as Exhibit C (a “Tax Payment Withdrawal Instruction”), withdraw from the Trust Account and distribute to the Company the amount of interest earned on the Property requested by the Company to cover any tax obligation owed by the Company as a result of assets of the Company or interest or other income earned on the Property, which amount shall be delivered directly to the Company by electronic funds transfer or other method of prompt payment, and the Company shall forward such payment to the relevant taxing authority so long as there is no reduction in the principal amount per share initially deposited in the Trust Account plus any additional amounts, calculated on a per share basis, required to be deposited for an extension of the last date to complete a business combination as a condition of any extension of such date approved by the Company's shareholders; provided, however, that to the extent there is not sufficient cash in the Trust Account to pay such tax obligation, the Trustee shall liquidate such assets held in the Trust Account as shall be designated by the Company in writing to make such distribution (it being acknowledged and agreed that any such amount in excess of interest income earned on the Property shall not be payable from the Trust Account). The written request of the Company referenced above shall constitute presumptive evidence that the Company is entitled to said funds, and the Trustee shall have no responsibility to look beyond said request;

(k) Upon written request from the Company, which may be given from time to time in a form substantially similar to that attached hereto as Exhibit D (a “Shareholder Redemption Withdrawal Instruction”), the Trustee shall distribute to the Public Shareholders on behalf of the Company the amount requested by the Company to be used to redeem Ordinary Shares from Public Shareholders properly submitted in connection with a shareholder vote to approve an amendment to the Company’s Articles (A) to modify the substance or timing of the Company’s obligation to allow redemption in connection with the Company’s initial business combination or to redeem 100% of the Ordinary Shares sold in the Offering (the “public shares”) if the Company has not consummated an initial Business Combination within such time as is described in the Articles or (B) with respect to any other material provisions relating to shareholders’ rights or pre-initial Business Combination activity. The written request of the Company referenced above shall constitute presumptive evidence that the Company is entitled to distribute said funds, and the Trustee shall have no responsibility to look beyond said request; and

(l) Not make any withdrawals or distributions from the Trust Account other than pursuant to Section 1(i), (j) or (k) above.

2.	Agreements and Covenants of the Company. The Company<br>hereby agrees and covenants to:

(a) Give all instructions to the Trustee hereunder in writing, signed by the Company’s Chairman of the Board, Chief Executive Officer, Chief Financial Officer, President, Executive Vice President, Vice President or Secretary. In addition, except with respect to its duties under Sections 1(i), 1(j) and 1(k) hereof, the Trustee shall be entitled to rely on, and shall be protected in relying on, any verbal or telephonic advice or instruction which it, in good faith and with reasonable care, believes to be given by any one of the persons authorized above to give written instructions, provided that the Company shall promptly confirm such instructions in writing;

(b) Subject to Section 4 hereof, hold the Trustee harmless and indemnify the Trustee from and against any and all expenses, including reasonable counsel fees and disbursements, or losses suffered by the Trustee in connection with any action taken by it hereunder and in connection with any action, suit or other proceeding brought against the Trustee involving any claim, or in connection with any claim or demand, which in any way arises out of or relates to this Agreement, the services of the Trustee hereunder, or the Property or any interest earned on the Property, except for expenses and losses resulting from the Trustee’s gross negligence, fraud or willful misconduct. Promptly after the receipt by the Trustee of notice of demand or claim or the commencement of any action, suit or proceeding, pursuant to which the Trustee intends to seek indemnification under this Section 2(b), it shall notify the Company in writing of such claim (hereinafter referred to as the “Indemnified Claim”). The Trustee shall have the right to conduct and manage the defense against such Indemnified Claim; provided that the Trustee shall obtain the consent of the Company with respect to the selection of counsel, which consent shall not be unreasonably withheld. The Trustee may not agree to settle any Indemnified Claim without the prior written consent of the Company, which such consent shall not be unreasonably withheld. The Company may participate in such action with its own counsel;

(c) Pay the Trustee the fees set forth on Schedule A hereto, including an initial acceptance fee, annual administration fee, and transaction processing fee which fees shall be subject to modification by the parties from time to time. It is expressly understood that the Property shall not be used to pay such fees unless and until it is distributed to the Company pursuant to Sections 1(i) through 1(j) hereof. The Company shall pay the Trustee the initial acceptance fee and the first annual administration fee at the consummation of the Offering. The Company shall not be responsible for any other fees or charges of the Trustee except as set forth in this Section 2(c), Schedule A and as may be provided in Section 2(b) hereof;

(d) In connection with any vote of the Company’s shareholders regarding a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination involving the Company and one or more businesses (the “Business Combination”), provide to the Trustee an affidavit or certificate of the inspector of elections for the shareholder meeting verifying the vote of such shareholders regarding such Business Combination;

(e) Provide the Underwriters with a copy of any Termination Letter(s), Tax Payment Withdrawal Instruction(s), Shareholder Redemption Withdrawal Instruction(s), and/or any other correspondence that is sent to the Trustee with respect to any proposed withdrawal from the Trust Account promptly after it issues the same;

(f) Unless otherwise agreed between the Company and the Underwriters, ensure that any Instruction Letter (as defined in Exhibit A) delivered in connection with a Termination Letter in the form of Exhibit A expressly provides that the Deferred Discount is paid directly to the account or accounts directed by the Underwriters prior to any transfer of the funds held in the Trust Account to the Company or any other person;

(g) Instruct the Trustee to make only those distributions that are permitted under this Agreement, and refrain from instructing the Trustee to make any distributions that are not permitted under this Agreement; and

(h) Within four (4) business days after the Underwriters exercise the over-allotment option (or any unexercised portion thereof) or such over-allotment option expires, provide the Trustee with a notice in writing of the total amount of the Deferred Discount.

3.	Limitations of Liability. The Trustee shall have no<br>responsibility or liability to:

(a) Imply obligations, perform duties, inquire or otherwise be subject to the provisions of any agreement or document other than this Agreement and that which is expressly set forth herein;

(b) Take any action with respect to the Property, other than as directed in Section 1 hereof, and the Trustee shall have no liability to any third party except for liability arising out of the Trustee’s gross negligence, fraud or willful misconduct;

(c) Institute any proceeding for the collection of any principal and income arising from, or institute, appear in or defend any proceeding of any kind with respect to, any of the Property unless and until it shall have received instructions from the Company given as provided herein to do so and the Company shall have advanced or guaranteed to it funds sufficient to pay any expenses incident thereto;

(d) Refund any depreciation in principal of any Property;

(e) Assume that the authority of any person designated by the Company to give instructions hereunder shall not be continuing unless provided otherwise in such designation, or unless the Company shall have delivered a written revocation of such authority to the Trustee;

(f) The other parties hereto or to anyone else for any action taken or omitted by it, or any action suffered by it to be taken or omitted, in good faith and in the Trustee’s best judgment, except for the Trustee’s gross negligence, fraud or willful misconduct. The Trustee may rely conclusively and shall be protected in acting upon any order, notice, demand, certificate, opinion or advice of counsel (including counsel chosen by the Trustee, which counsel may be the Company’s counsel), statement, instrument, report or other paper or document (not only as to its due execution and the validity and effectiveness of its provisions, but also as to the truth and acceptability of any information therein contained) which the Trustee believes, in good faith and with reasonable care, to be genuine and to be signed or presented by the proper person or persons. The Trustee shall not be bound by any notice or demand, or any waiver, modification, termination or rescission of this Agreement or any of the terms hereof, unless evidenced by a written instrument delivered to the Trustee, signed by the proper party or parties and, if the duties or rights of the Trustee are affected, unless it shall give its prior written consent thereto;

(g) Verify the accuracy of the information contained in the Registration Statement;

(h) Provide any assurance that any Business Combination entered into by the Company or any other action taken by the Company is as contemplated by the Registration Statement;

(i) File information returns with respect to the Trust Account with any local, state or federal taxing authority or provide periodic written statements to the Company documenting the taxes payable by the Company, if any, relating to any interest income earned on the Property;

(j) Prepare, execute and file tax reports, income or other tax returns and pay any taxes with respect to any income generated by, and activities relating to, the Trust Account, regardless of whether such tax is payable by the Trust Account or the Company, including, but not limited to, tax obligations, except pursuant to Section 1(j) hereof; or

(k) Verify calculations, qualify or otherwise approve the Company’s written requests for distributions pursuant to Sections 1(i), 1(j) or 1(k) hereof.

Trust Account Waiver. The Trustee has no right of set-off or any right, title, interest or claim of any kind (“Claim”) to, or to any monies in, the Trust Account, and hereby irrevocably waives any Claim to, or to any monies in, the Trust Account that it may have now or in the future. In the event the Trustee has any Claim against the Company under this Agreement, including, without limitation, under Section 2(b) or Section 2(c) hereof, the Trustee shall pursue such Claim solely against the Company and its assets outside the Trust Account and not against the Property or any monies in the Trust Account.
Termination. This Agreement shall terminate as follows:

(a) If the Trustee gives written notice to the Company that it desires to resign under this Agreement, the Company shall use its reasonable efforts to locate a successor trustee, pending which the Trustee shall continue to act in accordance with this Agreement. At such time that the Company notifies the Trustee that a successor trustee has been appointed and has agreed to become subject to the terms of this Agreement, the Trustee shall transfer the management of the Trust Account to the successor trustee, including but not limited to the transfer of copies of the reports and statements relating to the Trust Account, whereupon this Agreement shall terminate; provided, however, that in the event that the Company does not locate a successor trustee within ninety (90) days of receipt of the resignation notice from the Trustee, the Trustee may submit an application to have the Property deposited with any court in the State of New York or with the United States District Court for the Southern District of New York and upon such deposit, the Trustee shall be immune from any liability whatsoever; or

(b) At such time that the Trustee has completed the liquidation of the Trust Account and its obligations in accordance with the provisions of Section 1(i) hereof and distributed the Property in accordance with the provisions of the Termination Letter, this Agreement shall terminate except with respect to Section 2(b).

6.	Miscellaneous.

(a) The Company and the Trustee each acknowledge that the Trustee will follow the security procedures set forth below with respect to funds transferred from the Trust Account. The Company and the Trustee will each restrict access to confidential information relating to such security procedures to authorized persons. Each party must notify the other party immediately if it has reason to believe unauthorized persons may have obtained access to such confidential information, or of any change in its authorized personnel. In executing funds transfers, the Trustee shall rely upon all information supplied to it by the Company, including, account names, account numbers, and all other identifying information relating to a Beneficiary, Beneficiary’s bank or intermediary bank. Except for any liability arising out of the Trustee’s gross negligence, fraud or willful misconduct, the Trustee shall not be liable for any loss, liability or expense resulting from any error in the information or transmission of the funds.

(b) This Agreement shall be governed by and construed and enforced in accordance with the internal laws of the State of New York. This Agreement may be executed in several original or facsimile counterparts, each one of which shall constitute an original, and together shall constitute but one instrument.

(c) This Agreement contains the entire agreement and understanding of the parties hereto with respect to the subject matter hereof. Except for Section 1(i), 1(j) and 1(k) hereof (which sections may not be modified, amended or deleted without the affirmative vote of two-thirds of the then outstanding Ordinary Shares of the Company, which are represented in person or by proxy and are voted at a general meeting of the Company, voting together as a single class; provided that no such amendment will affect any Public Shareholder who has properly elected to redeem his or her Ordinary Shares in connection with a shareholder vote to amend this Agreement (A) to modify the substance or timing of the Company’s obligation to allow redemption in connection with the Company’s initial business combination or to redeem 100% of its public shares if the Company does not complete its initial Business Combination within the time frame specified in the Articles or (B) with respect to any other material provisions relating to shareholders’ rights or pre-initial Business Combination activity), this Agreement or any provision hereof may only be changed, amended or modified (other than to correct a typographical error) by a writing signed by each of the parties hereto.

(d) The parties to this Agreement agree and acknowledge that the Company has no obligation to deposit any funds held outside of the Trust Account into the Trust Account for the benefit of the Beneficiaries following the deposit of the Property in connection with the consummation of the Offering. Holders of Public Shares have no rights to any funds held by the Company outside of the Trust Account upon or following their redemption pursuant to the Articles or this Agreement.

(e) The parties hereto consent to the jurisdiction and venue of any state or federal court located in the City of New York, State of New York, for purposes of resolving any disputes hereunder. AS TO ANY CLAIM, CROSS-CLAIM OR COUNTERCLAIM IN ANY WAY RELATING TO THIS AGREEMENT, EACH PARTY WAIVES THE RIGHT TO TRIAL BY JURY.

(f) Any notice, consent or request to be given in connection with any of the terms or provisions of this Agreement shall be in writing and shall be sent by express mail or similar private courier service, by certified mail (return receipt requested), by hand delivery or by electronic mail:

if to the Trustee, to:

Continental Stock Transfer & Trust Company

1 State Street, 30th Floor

New York, NY 10004

Attn: Francis Wolf & Celeste Gonzalez

Email: fwolf@continentalstock.com

Email: cgonzalez@continentalstock.com

Tel: (212) 845-3233; (212) 845-3248

if to the Company, to:

JATT II Acquisition Corp

153 Central Avenue

C/O 56

Westfield, NJ 07091

Attention: Nicholas Fernandez

Email: nicholas.fernandez@athanorcapital.com

In each case, with copies (which copy shall not constitute notice) to:

Loeb & Loeb LLP

345 Park Avenue

New York, NY 10154

Attention: Giovanni Caruso, Esq

Email: gcaruso@loeb.com

and

Guggenheim Securities, LLC

330 Madison Avenue New York, New York 10017

Attention: Michael Jiang, Senior Managing Director

Email: michael.jiang@guggenheimpartners.com.

and

Davis Polk & Wardwell LLP

450 Lexington Avenue

New York, NY 10017

Attn: Derek Dostal

Email: derek.dostal@davispolk.com

(g) Each of the Company and the Trustee hereby represents that it has the full right and power and has been duly authorized to enter into this Agreement and to perform its respective obligations as contemplated hereunder. The Trustee acknowledges and agrees that it shall not make any claims or proceed against the Trust Account, including by way of set-off, and shall not be entitled to any funds in the Trust Account under any circumstance.

(h) This Agreement is the joint product of the Trustee and the Company and each provision hereof has been subject to the mutual consultation, negotiation and agreement of such parties and shall not be construed for or against any party hereto.

(i) This Agreement may be executed in any number of counterparts, each of which shall be deemed to be an original, but all such counterparts shall together constitute one and the same instrument. Delivery of a signed counterpart of this Agreement by facsimile or electronic transmission shall constitute valid and sufficient delivery thereof.

(j) Each of the Company and the Trustee hereby acknowledges and agrees that the Underwriters are a third-party beneficiaries of this Agreement.

(k) Except as specified herein, no party to this Agreement may assign its rights or delegate its obligations hereunder to any other person or entity without the prior written consent of the other.

[Signature Page Follows]

IN WITNESS WHEREOF, the parties have duly executed this Investment Management Trust Agreement as of the date first written above.

CONTINENTAL STOCK TRANSFER & TRUST COMPANY, as Trustee
By:	/s/ Francis Wolf
Name:	Francis Wolf
Title:	Vice President
JATT II Acquisition Corp
By:	/s/ Someit Sidhu
Name:	Someit Sidhu
Title:	Chief Executive Officer

[Signature Page to Investment Management TrustAgreement]

SCHEDULE A

Fee Item	Time and method of payment	Amount
Initial set-up fee	Initial closing of Offering by wire transfer.	$	2,000
Trustee administration fee	Payable annually. First year fee payable, at initial closing of Offering by wire transfer, thereafter by wire transfer or check.	$	8,000
Transaction processing fee for disbursements to Company under Section 1	Billed to Company following disbursement made to Company under Section 1	$	150
Paying Agent services as required pursuant to Section 1(i), 1(j) and 1(k)	Billed to Company upon delivery of service pursuant to Section 1(i), 1(j) and 1(k)		Prevailing rates

Schedule A-1

EXHIBIT A[Letterhead of Company][Insert date]

Continental Stock Transfer & Trust Company

1 State Street, 30th Floor

New York, New York 10004

Attn: Francis Wolf and Celeste Gonzalez

Re:	Trust Account - Termination Letter

Dear Mr. Wolf and Ms. Gonzalez:

Pursuant to Section 1(i) of the Investment Management Trust Agreement between JATT II Acquisition Corp (the “Company”) and Continental Stock Transfer & Trust Company (“Trustee”), dated as of April 16, 2026 (the “Trust Agreement”), this is to advise you that the Company has entered into an agreement with ___________ (the “Target Business”) to consummate a business combination with Target Business (the “Business Combination”) on or about [insertdate]. The Company shall notify you at least seventy-two (72) hours in advance of the actual date (or such shorter period as you may agree) of the consummation of the Business Combination (the “Consummation Date”). Capitalized terms used but not defined herein shall have the meanings set forth in the Trust Agreement.

In accordance with the terms of the Trust Agreement, the Company hereby authorizes you to commence to liquidate all of the assets of the Trust Account, and to transfer the proceeds to a segregated account held by you on behalf of the Beneficiaries to the effect that, on the Consummation Date, all of the funds held in the Trust Operating Account will be immediately available for transfer to the account or accounts that the Company shall direct on the Consummation Date (including as directed to it by the Underwriters (with respect to the Deferred Discount)).

On the Consummation Date (i) counsel for the Company shall deliver to you written notification that the Business Combination has been consummated, or will be consummated concurrently with your transfer of funds to the accounts as directed by the Company (the “Notification”), and (ii) the Company shall deliver to you (a) a certificate by the Chief Executive Officer, Chief Financial Officer or Chief Legal Officer, which verifies that the Business Combination has been approved by a vote of the Company’s shareholders, if a vote is held and (b) a joint written instruction signed by the Company and the Underwriters with respect to the transfer of the funds held in the Trust Operating Account, including payment of amounts owed to public shareholders who have properly exercised their redemption rights and payment of the Deferred Discount directly to the account or accounts directed by the Underwriters from the Trust Account (the “InstructionLetter”). You are hereby directed and authorized to transfer the funds held in the Trust Account immediately upon your receipt of the Notification and the Instruction Letter, in accordance with the terms of the Instruction Letter. In the event that certain deposits held in the Trust Account may not be liquidated by the Consummation Date without penalty, you will notify the Company in writing of the same and the Company shall direct you as to whether such funds should remain in the Trust Account and be distributed after the Consummation Date to the Company. Upon the distribution of all the funds, net of any payments necessary for reasonable unreimbursed expenses related to liquidating the Trust Account, your obligations under the Trust Agreement shall be terminated.

In the event that the Business Combination is not consummated on the Consummation Date described in the notice thereof and the Company has not notified you on or before the original Consummation Date of a new Consummation Date, then upon receipt by the Trustee of written instructions from the Company, the funds held in the Trust Account shall be reinvested as provided in Section 1(c) of the Trust Agreement on the business day immediately following the Consummation Date as set forth in such notice as soon thereafter as possible.

Exhibit A-1

Very truly yours,

JATT II Acquisition Corp

By:
Name:
Title:

Agreed and acknowledged by:

Guggenheim Securities, LLC

By:
Name:
Title:

Exhibit A-2

EXHIBIT B[Letterhead of Company][Insert date]

Continental Stock Transfer & Trust Company

1 State Street, 30th Floor

New York, New York 10004

Attn: Francis Wolf and Celeste Gonzalez

Re:	Trust Account - Termination Letter

Dear Mr. Wolf and Ms. Gonzalez:

Pursuant to Section 1(i) of the Investment Management Trust Agreement between JATT II Acquisition Corp (the “Company”) and Continental Stock Transfer & Trust Company (the “Trustee”), dated as of April 16, 2026 (the “Trust Agreement”), this is to advise you that the Company has been unable to effect a business combination with a Target Business (the “BusinessCombination”) within the time frame specified in the Articles or on such earlier date as determined by the Company’s Board of Directors, [the Company’s Board of Directors has determined to terminate the period in which the Company must consummate a Business Combination on [●]], as described in the Company’s Prospectus relating to the Offering. Capitalized terms used but not defined herein shall have the meanings set forth in the Trust Agreement.

In accordance with the terms of the Trust Agreement, the Company hereby authorizes you to liquidate all of the assets in the Trust Account and to transfer the total proceeds into a segregated account held by you on behalf of the Beneficiaries to await distribution to the Public Shareholders. The Company has selected __________ as the effective date for the purpose of determining when the Public Shareholders, less taxes payable or owed and up to $100,000 to cover dissolution expenses of the Company. In accordance with the terms of the Trust Agreement, you are hereby directed and authorized to transfer (via wire transfer) such amount for dissolution expenses of $____ promptly upon your receipt of this letter to the Company’s operating account at:

[WIRE INSTRUCTION INFORMATION]

The Company has selected __________^1^ as the effective date for the purpose of determining when the Public Shareholders will be entitled to receive their share of the liquidation proceeds. You. You agree to be the Paying Agent of record and, in your separate capacity as Paying Agent, agree to distribute said funds directly to the Company’s Public Shareholders in accordance with the terms of the Trust Agreement and the Articles. Upon the distribution of all the funds, net of any payments necessary for reasonable unreimbursed expenses related to liquidating the Trust Account, your obligations under the Trust Agreement shall be terminated, except to the extent otherwise provided in Section 1(i) of the Trust Agreement.

Very truly yours,

JATT II Acquisition Corp

By:
Name:
Title:
cc:	Guggenheim Securities, LLC
---	---
^1^	24 months after the closing date of the Offering, such earlier date as the Company’s<br>board of directors may approve, or such later date as the Company’s shareholders may approve.
---	---

Exhibit B-1

EXHIBIT C[Letterhead of Company][Insert date]

Continental Stock Transfer & Trust Company

1 State Street, 30th Floor

New York, New York 10004

Attn: Francis Wolf and Celeste Gonzalez

Re:	Trust Account - Tax Payment Withdrawal Instruction

Dear Mr. Wolf and Ms. Gonzalez:

Pursuant to Section 1(j) of the Investment Management Trust Agreement between JATT II Acquisition Corp (the “Company”) and Continental Stock Transfer & Trust Company (the “Trustee”), dated as of April 16, 2026 (the “Trust Agreement”), the Company hereby requests that you deliver to the Company $_______ of the interest income earned on the Property as of the date hereof. Capitalized terms used but not defined herein shall have the meanings set forth in the Trust Agreement.

The Company needs such funds to pay for the tax obligations. In accordance with the terms of the Trust Agreement, you are hereby directed and authorized to transfer (via wire transfer) such funds promptly upon your receipt of this letter to the Company’s operating account at:

[WIRE INSTRUCTION INFORMATION]

Very truly yours,

JATT II Acquisition Corp

By:
Name:
Title:
cc:	Guggenheim Securities, LLC
---	---

Exhibit C-1

EXHIBIT D[Letterhead of Company][Insert date]

Continental Stock Transfer & Trust Company

1 State Street, 30th Floor

New York, New York 10004

Attn: Francis Wolf & Celeste Gonzalez

Re:	Trust Account - Shareholder Redemption Withdrawal Instruction

Dear Mr. Wolf and Ms. Gonzalez:

Pursuant to Section 1(k) of the Investment Management Trust Agreement between JATT II Acquisition Corp (the “Company”) and Continental Stock Transfer & Trust Company (the “Trustee”), dated as of April 16, 2026 (the “Trust Agreement”), the Company hereby requests that you deliver to the redeeming Public Shareholders of the Company $____ of the principal and interest income earned on the Property as of the date hereof to a segregated account held by you on behalf of the Beneficiaries for distribution to the Public Shareholders who have requested redemption of their Ordinary Shares. Capitalized terms used but not defined herein shall have the meanings set forth in the Trust Agreement.

The Company needs such funds to pay its Public Shareholders who have properly elected to have their Ordinary Shares redeemed by the Company in connection with a shareholder vote to approve an amendment to the Articles (A) to modify the substance or timing of the Company’s obligation to allow redemption in connection with the Company’s initial business combination or to redeem 100% of its public Ordinary Shares if the Company has not consummated an initial Business Combination within such time as is described in the Articles or (B) with respect to any other material provisions relating to shareholders’ rights or pre-initial Business Combination activity. As such, you are hereby directed and authorized to transfer (via wire transfer) such funds to the redeeming Shareholders promptly upon your receipt of this letter in accordance with your customary procedures.

Very truly yours,

JATT II Acquisition Corp

By:
Name:
Title:
cc:	Guggenheim Securities, LLC
---	---

Exhibit D-2

Exhibit 10.3

REGISTRATION RIGHTS AGREEMENT

THIS REGISTRATION RIGHTS AGREEMENT (this “Agreement”), dated as of April 16, 2026, is made and entered into by and between JATT II Acquisition Corp, a Cayman Islands exempted company (the “Company”), JATT Ventures II L.P., a Cayman Islands exempted limited partnership (the “Sponsor”) and each of the undersigned parties listed on the signature page hereto under “Holders” (each such party, together with the Sponsor and any person or entity who hereafter becomes a party to this Agreement pursuant to Section 5.2 of this Agreement, a “Holder” and collectively the “Holders”).

RECITALS

WHEREAS, the Company has 1,725,000 the (“Founder Shares”)ordinary shares of the Company, par value $0.0001 per share (the “OrdinaryShares”), issued and outstanding, up to 225,000 of which will be surrendered to the Company for no consideration depending on the extent to which the underwriters of the Company’s initial public offering exercise their over-allotment option;

WHEREAS, on the date hereof, the Company and the Sponsor entered into that certain Private Placement Shares Purchase Agreement (the “Private PlacementShares Purchase Agreement”), pursuant to which the Sponsor agreed to purchase an aggregate of 300,000 Ordinary Shares (or up to 309,000 Ordinary Shares to the extent that the over-allotment option in connection with the Company’s initial public offering is exercised in full) (the “Private Placement Shares”) in a private placement transaction occurring simultaneously with the closing of the Company’s initial public offering;

WHEREAS, in order to finance the Company’s transaction costs in connection with its search for and consummation of an initial Business Combination (as defined below), the Sponsor, its affiliates or any of the Company’s officers and directors may loan to the Company funds as the Company may require, of which up to $1,500,000 of such loans may be convertible into Ordinary Shares equivalent to Private Placement Shares (“Working Capital Shares”) at a price of $10.00 per share at the option of the lender; and

WHEREAS, the Company and the Holders desire to enter into this Agreement, pursuant to which the Company shall grant the Holders certain registration rights with respect to certain securities of the Company, as set forth in this Agreement.

NOW, THEREFORE, in consideration of the representations, covenants and agreements contained herein, and certain other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the parties hereto, intending to be legally bound, hereby agree as follows:

ARTICLE I

Definitions

1.1	Definitions. The terms defined<br>in this Article I shall, for all purposes of this Agreement, have the respective meanings set forth below:

“Adverse Disclosure” shall mean any public disclosure of material non-public information, which disclosure, in the good faith judgment of the Chief Executive Officer or principal financial officer of the Company, after consultation with counsel to the Company, (i) would be required to be made in any Registration Statement or Prospectus in order for the applicable Registration Statement or Prospectus not to contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements contained therein (in the case of any prospectus and any preliminary prospectus, in the light of the circumstances under which they were made) not misleading, (ii) would not be required to be made at such time if the Registration Statement were not being filed, and (iii) the Company has a bona fide business purpose for not making such information public.

“Agreement” shall have the meaning given in the Preamble.

“Board” shall mean the Board of Directors of the Company.

“Business Combination” shall mean any merger, share exchange, asset acquisition, share purchase, reorganization or other similar business combination with one or more businesses, involving the Company.

“Commission” shall mean the United States Securities and Exchange Commission.

“Company” shall have the meaning given in the Preamble.

“Demand Registration” shall have the meaning given in subsection 2.1.1.

“Demanding Holder” shall have the meaning given in subsection 2.1.1.

“Exchange Act” shall mean the Securities Exchange Act of 1934, as it may be amended from time to time.

“Form S-1” shall have the meaning given in subsection 2.1.1.

“Form S-3” shall have the meaning given in subsection 2.3.

“Founder Shares” shall have the meaning given in the Recitals hereto.

“Founder Shares Lock-upPeriod” shall mean, with respect to the Founder Shares and any Ordinary Shares issuable upon conversion thereof, the period ending on the earlier of (A) 180 days after the completion of the Company’s initial Business Combination and (B) subsequent to the completion of the Business Combination, the date on which the Company completes a liquidation, merger, share exchange, reorganization or other similar transaction that results in all of the Company’s shareholders having the right to exchange their Ordinary Shares for cash, securities or other property.

“Holders” shall have the meaning given in the Preamble.

“Insider Letter” shall mean that certain letter agreement, dated as of the date hereof, by and among the Company, the Sponsor and each of the Company’s officers and directors.

“Maximum Number of Securities” shall have the meaning given in subsection 2.1.4.

“Misstatement” shall mean an untrue statement of a material fact or an omission to state a material fact required to be stated in a Registration Statement or Prospectus, or necessary to make the statements in a Registration Statement or Prospectus (in the light of the circumstances under which they were made) not misleading.

“Ordinary Shares” shall have the meaning given in the Recitals hereto.

“Permitted Transferees” shall mean any person or entity to whom a Holder of Registrable Securities is permitted to transfer such Registrable Securities prior to the expiration of the Founder Shares Lock-up Period, Private Placement Lock-up Period or any other lock-up period, as the case may be, under the Insider Letter, the Private Placement Shares Purchase Agreement, this Agreement and any other applicable agreement between such Holder and the Company, and to any transferee thereafter.

“Piggyback Registration” shall have the meaning given in subsection 2.2.1.

“Private Placement Lock-upPeriod” shall mean, with respect to Private Placement Shares that are held by the initial purchasers of such Private Placement Shares or their Permitted Transferees, the period ending 30 days after the completion of the Company’s initial Business Combination.

“Private Placement Shares” shall have the meaning given in the Recitals hereto.

“Private Placement SharesPurchase Agreement” shall have the meaning given in the Recitals hereto.

“Pro Rata” shall have the meaning given in subsection 2.1.4.

“Prospectus” shall mean the prospectus included in any Registration Statement, as supplemented by any and all prospectus supplements and as amended by any and all post-effective amendments and including all material incorporated by reference in such prospectus.

“Registrable Security” shall mean (a) the Founder Shares, (b) the Private Placement Shares, (c) any outstanding Ordinary Shares or any other equity security (including the Ordinary Shares issued or issuable upon the conversion of any other equity security) of the Company held by a Holder as of the date of this Agreement or acquired by a Holder prior to the consummation of the Business Combination, (d) any equity securities (including the Ordinary Shares issued or issuable upon the exercise of any such equity security) of the Company issuable upon conversion of any working capital loans in an amount up to $1,500,000 made to the Company by a Holder, (e) any equity securities (including the Ordinary Shares issued or issuable upon the exercise of any such equity security) of the Company held by a Holder on or after the date of the Business Combination to the extent that such securities are “restricted securities” (as defined in Rule 144) or are otherwise held by an “affiliate” (as defined in Rule 144) of the Company and (f) any other equity security of the Company issued or issuable with respect to any such Ordinary Share by way of a share capitalization or share sub-division or in connection with a combination of shares, recapitalization, merger, consolidation or reorganization; provided, however, that, as to any particular Registrable Security, such securities shall cease to be Registrable Securities when: (A) a Registration Statement with respect to the sale of such securities shall have become effective under the Securities Act and such securities shall have been sold, transferred, disposed of or exchanged in accordance with such Registration Statement; (B) such securities shall have been otherwise transferred, new certificates for such securities not bearing a legend restricting further transfer shall have been delivered by the Company and subsequent public distribution of such securities shall not require registration under the Securities Act; (C) such securities shall have ceased to be outstanding; (D) such securities may be sold without registration pursuant to Rule 144 promulgated under the Securities Act (or any successor rule promulgated thereafter by the Commission) (but with no volume or other restrictions or limitations including as to manner or timing of sale or current public information requirements); or (E) such securities have been sold to, or through, a broker, dealer or underwriter in a public distribution or other public securities transaction.

“Registration” shall mean a registration effected by preparing and filing a registration statement or similar document in compliance with the requirements of the Securities Act, and the applicable rules and regulations promulgated thereunder, and such registration statement becoming effective.

“Registration Expenses” shall mean the out-of-pocket expenses of a Registration, including, without limitation, the following:

(A)	all registration and filing fees (including fees with respect to filings required to be made with the<br>Financial Industry Regulatory Authority, Inc.) and any securities exchange on which the Ordinary Shares are then listed;
(B)	fees and expenses of compliance with securities or blue sky laws (including reasonable fees and disbursements<br>of counsel for the Underwriters in connection with blue sky qualifications of Registrable Securities);
---	---
(C)	printing, messenger, telephone and delivery expenses;
---	---
(D)	reasonable fees and disbursements of counsel for the Company;
---	---
(E)	reasonable fees and disbursements of all independent registered public accountants of the Company incurred<br>specifically in connection with such Registration; and
---	---

(F)	reasonable fees and expenses of one (1) legal counsel selected by the majority-in-interest of the Demanding<br>Holders initiating a Demand Registration to be registered for offer and sale in the applicable Registration.

“Registration Statement” shall mean any registration statement that covers the Registrable Securities pursuant to the provisions of this Agreement, including the Prospectus included in such registration statement, amendments (including post-effective amendments) and supplements to such registration statement, and all exhibits to and all material incorporated by reference in such registration statement.

“Requesting Holder” shall have the meaning given in subsection 2.1.1.

“Securities Act” shall mean the Securities Act of 1933, as amended from time to time.

“Shelf” shall have the meaning given in subsection 2.3.1.

“Sponsor” shall have the meaning given in the Recitals hereto.

“Subsequent Shelf Registration” shall have the meaning given in subsection 2.3.2.

“Takedown Requesting Holder” shall have the meaning given in subsection 2.3.3.

“Underwriter” shall mean a securities dealer who purchases any Registrable Securities as principal in an Underwritten Offering and not as part of such dealer’s market-making activities.

“Underwritten Registration” or “Underwritten Offering” shall mean a Registration in which securities of the Company are sold to an Underwriter in a firm commitment underwriting for distribution to the public.

“Underwritten Shelf Takedown” shall have the meaning given in subsection 2.3.3.

“Working Capital Shares” shall have the meaning given in the Recitals hereto.

ARTICLE II

registrations

2.1

Demand Registration.

2.1.1

Request for Registration. Subject to the provisions of subsection 2.1.4 and Section 2.4 hereof, at any time and from time to time on or after the date the Company consummates the Business Combination, the Holders of at least fifteen percent (15%) of the then-outstanding number of Registrable Securities (the “Demanding Holders”) may make a written demand for Registration under the Securities Act of all or part of their Registrable Securities, which written demand shall describe the amount and type of securities to be included in such Registration and the intended method(s) of distribution thereof (such written demand a “Demand Registration”). The Company shall, within ten (10) days of the Company’s receipt of the Demand Registration, notify, in writing, all other Holders of Registrable Securities of such demand, and each Holder of Registrable Securities who thereafter wishes to include all or a portion of such Holder’s Registrable Securities in a Registration pursuant to a Demand Registration (each such Holder that includes all or a portion of such Holder’s Registrable Securities in such Registration, a “Requesting Holder”) shall so notify the Company, in writing, within five (5) days after the receipt by the Holder of the notice from the Company. Upon receipt by the Company of any such written notification from a Requesting Holder(s) to the Company, such Requesting Holder(s) shall be entitled to have their Registrable Securities included in a Registration pursuant to a Demand Registration and the Company shall effect, as soon thereafter as practicable, but not more than forty five (45) days immediately after the Company’s receipt of the Demand Registration, the Registration of all Registrable Securities requested by the Demanding Holders and Requesting Holders pursuant to such Demand Registration. Under no circumstances shall the Company be obligated to effect more than an aggregate of three (3) Registrations pursuant to a Demand Registration under this subsection 2.1.1 with respect to any or all Registrable Securities; provided, however, that a Registration shall not be counted for such purposes unless a Form S-1 or any similar long-form registration statement that may be available at such time (“Form S-1”) has become effective and all of the Registrable Securities requested by the Requesting Holders to be registered on behalf of the Requesting Holders in such Form S-1 Registration have been sold, in accordance with Section 3.1 of this Agreement.

---

2.1.2	Effective Registration. Notwithstanding the provisions of subsection 2.1.1 above or any<br>other part of this Agreement, a Registration pursuant to a Demand Registration shall not count as a Registration unless and until (i)<br>the Registration Statement filed with the Commission with respect to a Registration pursuant to a Demand Registration has been declared<br>effective by the Commission and (ii) the Company has complied with all of its obligations under this Agreement with respect thereto; provided,<br>further, that if, after such Registration Statement has been declared effective, an offering of Registrable Securities in a Registration<br>pursuant to a Demand Registration is subsequently interfered with by any stop order or injunction of the Commission, federal or state<br>court or any other governmental agency the Registration Statement with respect to such Registration shall be deemed not to have been declared<br>effective, unless and until, (i) such stop order or injunction is removed, rescinded or otherwise terminated, and (ii) a majority-in-interest<br>of the Demanding Holders initiating such Demand Registration thereafter affirmatively elect to continue with such Registration and accordingly<br>notify the Company in writing, but in no event later than five (5) days, of such election; and provided, further, that the<br>Company shall not be obligated or required to file another Registration Statement until the Registration Statement that has been previously<br>filed with respect to a Registration pursuant to a Demand Registration becomes effective or is subsequently terminated.
2.1.3	Underwritten Offering. Subject to the provisions of subsection 2.1.4 and Section 2.4<br>hereof, if a majority-in-interest of the Demanding Holders so advise the Company as part of their Demand Registration that the offering<br>of the Registrable Securities pursuant to such Demand Registration shall be in the form of an Underwritten Offering, then the right of<br>such Demanding Holder or Requesting Holder (if any) to include its Registrable Securities in such Registration shall be conditioned upon<br>such Holder’s participation in such Underwritten Offering and the inclusion of such Holder’s Registrable Securities in such<br>Underwritten Offering to the extent provided herein. All such Holders proposing to distribute their Registrable Securities through an<br>Underwritten Offering under this subsection 2.1.3 shall enter into an underwriting agreement in customary form with the Underwriter(s)<br>selected for such Underwritten Offering by the majority-in-interest of the Demanding Holders initiating the Demand Registration.
---	---
2.1.4	Reduction of Underwritten Offering. If the managing Underwriter or Underwriters in an Underwritten<br>Registration pursuant to a Demand Registration, in good faith, advises the Company, the Demanding Holders and the Requesting Holders (if<br>any) in writing that the dollar amount or number of Registrable Securities that the Demanding Holders and the Requesting Holders (if any)<br>desire to sell, taken together with all other Ordinary Shares or other equity securities that the Company desires to sell and the Ordinary<br>Shares, if any, as to which a Registration has been requested pursuant to separate written contractual piggy-back registration rights<br>held by any other shareholders who desire to sell, exceeds the maximum dollar amount or maximum number of equity securities that can be<br>sold in the Underwritten Offering without adversely affecting the proposed offering price, the timing, the distribution method, or the<br>probability of success of such offering (such maximum dollar amount or maximum number of such securities, as applicable, the “MaximumNumber of Securities”), then the Company shall include in such Underwritten Offering, as follows: (i) first, the Registrable<br>Securities of the Demanding Holders and the Requesting Holders (if any) (pro rata based on the respective number of Registrable Securities<br>that each Demanding Holder and Requesting Holder (if any) has requested be included in such Underwritten Registration and the aggregate<br>number of Registrable Securities that the Demanding Holders and Requesting Holders have requested be included in such Underwritten Registration<br>(such proportion is referred to herein as “Pro Rata”)) that can be sold without exceeding the Maximum Number<br>of Securities; (ii) second, to the extent that the Maximum Number of Securities has not been reached under the foregoing clause (i), the<br>Registrable Securities of Holders (Pro Rata, based on the respective number of Registrable Securities that each Holder has so requested)<br>exercising their rights to register their Registrable Securities pursuant to subsection 2.2.1 hereof, without exceeding the Maximum<br>Number of Securities; and (iii) third, to the extent that the Maximum Number of Securities has not been reached under the foregoing clauses<br>(i) and (ii), the Ordinary Shares or other equity securities that the Company desires to sell, which can be sold without exceeding the<br>Maximum Number of Securities; and (iv) fourth, to the extent that the Maximum Number of Securities has not been reached under the<br>foregoing clauses (i), (ii) and (iii), the Ordinary Shares or other equity securities of other persons or entities that the Company is<br>obligated to register in a Registration pursuant to separate written contractual arrangements with such persons and that can be sold without<br>exceeding the Maximum Number of Securities.
---	---

2.1.5	Demand Registration Withdrawal. A majority-in-interest of the Demanding Holders initiating a Demand<br>Registration or a majority-in-interest of the Requesting Holders (if any), pursuant to a Registration under subsection 2.1.1 hereof<br>shall have the right to withdraw from a Registration pursuant to such Demand Registration for any or no reason whatsoever upon written<br>notification to the Company and the Underwriter or Underwriters (if any) of their intention to withdraw from such Registration prior to<br>the effectiveness of the Registration Statement filed with the Commission with respect to the Registration of their Registrable Securities<br>pursuant to such Demand Registration. Notwithstanding anything to the contrary in this Agreement, the Company shall be responsible for<br>the Registration Expenses incurred in connection with a Registration pursuant to a Demand Registration prior to its withdrawal under this<br>subsection 2.1.5.
2.2	Piggyback Registration.
---	---
2.2.1	Piggyback Rights. If, at any time on or after the date the Company consummates a Business Combination,<br>the Company proposes to file a Registration Statement under the Securities Act with respect to an offering of equity securities, or securities<br>or other obligations exercisable or exchangeable for, or convertible into equity securities, for its own account or for the account of<br>shareholders of the Company (or by the Company and by the shareholders of the Company including, without limitation, pursuant to Section<br>2.1 hereof), other than a Registration Statement (i) filed in connection with any employee share option or other benefit plan, (ii) for<br>an exchange offer or offering of securities solely to the Company’s existing shareholders, (iii) for an offering of debt that is<br>convertible into equity securities of the Company or (iv) for a dividend reinvestment plan, then the Company shall give written notice<br>of such proposed filing to all of the Holders of Registrable Securities as soon as practicable but not less than ten (10) days before<br>the anticipated filing date of such Registration Statement, which notice shall (A) describe the amount and type of securities to be included<br>in such offering, the intended method(s) of distribution, and the name of the proposed managing Underwriter or Underwriters, if any, in<br>such offering, and (B) offer to all of the Holders of Registrable Securities the opportunity to register the sale of such number of Registrable<br>Securities as such Holders may request in writing within five (5) days after receipt of such written notice (such Registration a “PiggybackRegistration”). The Company shall, in good faith, cause such Registrable Securities to be included in such Piggyback Registration<br>and shall use its best efforts to cause the managing Underwriter or Underwriters of a proposed Underwritten Offering to permit the Registrable<br>Securities requested by the Holders pursuant to this subsection 2.2.1 to be included in a Piggyback Registration on the same terms<br>and conditions as any similar securities of the Company included in such Registration and to permit the sale or other disposition of such<br>Registrable Securities in accordance with the intended method(s) of distribution thereof. All such Holders proposing to distribute their<br>Registrable Securities through an Underwritten Offering under this subsection 2.2.1 shall enter into an underwriting agreement<br>in customary form with the Underwriter(s) selected for such Underwritten Offering by the Company.
---	---
2.2.2	Reduction of Piggyback Registration. If the managing Underwriter or Underwriters in an Underwritten<br>Registration that is to be a Piggyback Registration, in good faith, advises the Company and the Holders of Registrable Securities participating<br>in the Piggyback Registration in writing that the dollar amount or number of the Ordinary Shares that the Company desires to sell, taken<br>together with (i) the Ordinary Shares, if any, as to which Registration has been demanded pursuant to separate written contractual arrangements<br>with persons or entities other than the Holders of Registrable Securities hereunder (ii) the Registrable Securities as to which registration<br>has been requested pursuant to Section 2.2 hereof, and (iii) the Ordinary Shares, if any, as to which Registration has been requested<br>pursuant to separate written contractual piggy-back registration rights of other shareholders of the Company, exceeds the Maximum Number<br>of Securities, then:
---	---
(a)	If the Registration is undertaken for the Company’s account, the Company shall include in any such<br>Registration (A) first, the Ordinary Shares or other equity securities that the Company desires to sell, which can be sold without exceeding<br>the Maximum Number of Securities; (B) second, to the extent that the Maximum Number of Securities has not been reached under the foregoing<br>clause (A), the Registrable Securities of Holders exercising their rights to register their Registrable Securities pursuant to subsection<br>2.2.1 hereof (pro rata based on the respective number of Registrable Securities that such Holder has requested be included in such<br>Registration), which can be sold without exceeding the Maximum Number of Securities; and (C) third, to the extent that the Maximum Number<br>of Securities has not been reached under the foregoing clauses (A) and (B), the Ordinary Shares, if any, as to which Registration has<br>been requested pursuant to written contractual piggy-back registration rights of other shareholders of the Company, which can be sold<br>without exceeding the Maximum Number of Securities;
---	---

(b)	If the Registration is pursuant to a request by persons or entities other than the Holders of Registrable<br>Securities, then the Company shall include in any such Registration (A) first, the Ordinary Shares or other equity securities, if any,<br>of such requesting persons or entities, other than the Holders of Registrable Securities, which can be sold without exceeding the Maximum<br>Number of Securities; (B) second, to the extent that the Maximum Number of Securities has not been reached under the foregoing clause<br>(A), the Registrable Securities of Holders exercising their rights to register their Registrable Securities pursuant to subsection<br>2.2.1 hereof, pro rata based on the number of Registrable Securities that each Holder has requested be included in such Registration<br>and the aggregate number of Registrable Securities that the Holders have requested to be included in such Registration, which can be sold<br>without exceeding the Maximum Number of Securities; (C) third, to the extent that the Maximum Number of Securities has not been reached<br>under the foregoing clauses (A) and (B), the Ordinary Shares or other equity securities that the Company desires to sell, which can be<br>sold without exceeding the Maximum Number of Securities; and (D) fourth, to the extent that the Maximum Number of Securities has not been<br>reached under the foregoing clauses (A), (B) and (C), the Ordinary Shares or other equity securities for the account of other persons<br>or entities that the Company is obligated to register pursuant to separate written contractual arrangements with such persons or entities,<br>which can be sold without exceeding the Maximum Number of Securities.
2.2.3	Any Holder of Registrable Securities shall have the right to withdraw from a Piggyback Registration for<br>any or no reason whatsoever upon written notification to the Company and the Underwriter or Underwriters (if any) of his, her or its intention<br>to withdraw from such Piggyback Registration prior to the effectiveness of the Registration Statement filed with the Commission with respect<br>to such Piggyback Registration. The Company (whether on its own good faith determination or as the result of a request for withdrawal<br>by persons pursuant to separate written contractual obligations) may withdraw a Registration Statement filed with the Commission in connection<br>with a Piggyback Registration at any time prior to the effectiveness of such Registration Statement. Notwithstanding anything to the contrary<br>in this Agreement, the Company shall be responsible for the Registration Expenses incurred in connection with the Piggyback Registration<br>prior to its withdrawal under this subsection 2.2.3.
---	---
2.2.4	Unlimited Piggyback Registration Rights. For purposes of clarity, any Registration effected pursuant<br>to Section 2.2 hereof shall not be counted as a Registration pursuant to a Demand Registration effected under Section 2.1<br>hereof.
---	---
2.3	Shelf Registration.
---	---
2.3.1	The Holders of Registrable Securities may at any time, and from time to time, request in writing that<br>the Company, pursuant to Rule 415 under the Securities Act (or any successor rule promulgated thereafter by the Commission), register<br>the resale of any or all of their Registrable Securities on Form S-3 or any similar short form registration statement that may be available<br>at such time (“Form S-3”), or if the Company is ineligible to use Form S-3, on Form S-1; a registration statement<br>filed pursuant to this subsection 2.3.1 (a “Shelf”) shall provide for the resale of the Registrable Securities<br>included therein pursuant to any method or combination of methods legally available to, and requested by, any Holder. Within five (5)<br>days of the Company’s receipt of a written request from a Holder or Holders of Registrable Securities for a Registration on a Shelf,<br>the Company shall promptly give written notice of the proposed Registration to all other Holders of Registrable Securities, and each Holder<br>of Registrable Securities who thereafter wishes to include all or a portion of such Holder’s Registrable Securities in such Registration<br>on a Shelf shall so notify the Company, in writing, within ten (10) days after the receipt by the Holder of the notice from the Company.<br>As soon as practicable thereafter, but not more than twelve (12) days after the Company’s initial receipt of such written request<br>for a Registration on Form S-3, the Company shall register all or such portion of such Holder’s Registrable Securities as are specified<br>in such written request, together with all or such portion of Registrable Securities of any other Holder or Holders joining in such request<br>as are specified in the written notification given by such Holder or Holders; provided, however, that the Company shall<br>not be obligated to effect any such Registration pursuant to this subsection 2.3.1 if the Holders of Registrable Securities, together<br>with the Holders of any other equity securities of the Company entitled to inclusion in such Registration, propose to sell the Registrable<br>Securities and such other equity securities (if any) at any aggregate price to the public of less than $10,000,000. The Company shall<br>maintain each Shelf in accordance with the terms hereof, and shall prepare and file with the SEC such amendments, including post-effective<br>amendments, and supplements as may be necessary to keep such Shelf continuously effective, available for use and in compliance with the<br>provisions of the Securities Act until such time as there are no longer any Registrable Securities included on such Shelf. In the event<br>the Company files a Shelf on Form S-1, the Company shall use its commercially reasonable efforts to convert the Form S-1 to a Form S-3<br>as soon as practicable after the Company is eligible to use Form S-3.
---	---

2.3.2

If any Shelf ceases to be effective under the Securities Act for any reason at any time while Registrable Securities included thereon are still outstanding, the Company shall use its commercially reasonable efforts to as promptly as is reasonably practicable cause such Shelf to again become effective under the Securities Act (including obtaining the prompt withdrawal of any order suspending the effectiveness of such Shelf), and shall use its commercially reasonable efforts to as promptly as is reasonably practicable amend such Shelf in a manner reasonably expected to result in the withdrawal of any order suspending the effectiveness of such Shelf or file an additional registration statement (a “Subsequent Shelf Registration”) registering the resale of all Registrable Securities including on such Shelf, and pursuant to any method or combination of methods legally available to, and requested by, any Holder. If a Subsequent Shelf Registration is filed, the Company shall use its commercially reasonable efforts to (i) cause such Subsequent Shelf Registration to become effective under the Securities Act as promptly as is reasonably practicable after the filing thereof and (ii) keep such Subsequent Shelf Registration continuously effective, available for use and in compliance with the provisions of the Securities Act until such time as there are no longer any Registrable Securities included thereon. Any such Subsequent Shelf Registration shall be on Form S-3 to the extent that the Company is eligible to use such form. Otherwise, such Subsequent Shelf Registration shall be on another appropriate form. In the event that any Holder holds Registrable Securities that are not registered for resale on a delayed or continuous basis, the Company, upon request of a Holder shall promptly use its commercially reasonable efforts to cause the resale of such Registrable Securities to be covered by either, at the Company’s option, a Shelf (including by means of a post-effective amendment) or a Subsequent Shelf Registration and cause the same to become effective as soon as practicable after such filing and such Shelf or Subsequent Shelf Registration shall be subject to the terms hereof; provided, however, the Company shall only be required to cause such Registrable Securities to be so covered once annually after inquiry of the Holders.

2.3.3

At any time and from time to time after a Shelf has been declared effective by the Commission, the Sponsor and Holders may request to sell all or any portion of its Registrable Securities in an underwritten offering that is registered pursuant to the Shelf (each, an “Underwritten Shelf Takedown”); provided that the Company shall only be obligated to effect an Underwritten Shelf Takedown if such offering shall include securities with a total offering price (including piggyback securities and before deduction of underwriting discounts) reasonably expected to exceed, in the aggregate, $10,000,000. All requests for Underwritten Shelf Takedowns shall be made by giving written notice to the Company at least 48 hours prior to the public announcement of such Underwritten Shelf Takedown, which shall specify the approximate number of Registrable Securities proposed to be sold in the Underwritten Shelf Takedown and the expected price range (net of underwriting discounts and commissions) of such Underwritten Shelf Takedown. The Company shall include in any Underwritten Shelf Takedown the securities requested to be included by any holder (each a “Takedown Requesting Holder”) at least 24 hours prior to the public announcement of such Underwritten Shelf Takedown pursuant to written contractual piggyback registration rights of such holder (including to those set forth herein). The Sponsor and Holders shall have the right to select the underwriter(s) for such offering (which shall consist of one or more reputable nationally recognized investment banks), subject to the Company’s prior approval which shall not be unreasonably withheld, conditioned or delayed. For purposes of clarity, any Registration effected pursuant to this subsection 2.3.3 shall not be counted as a Registration pursuant to a Demand Registration effected under Section 2.1 hereof.

---

2.3.4	If the managing Underwriter or Underwriters in an Underwritten Shelf Takedown, in good faith, advises<br>the Company, the Sponsor, Holders and the Takedown Requesting Holders (if any) in writing that the dollar amount or number of Registrable<br>Securities that the Sponsor and the Takedown Requesting Holders (if any) desire to sell, taken together with all other Ordinary Shares<br>or other equity securities that the Company desires to sell, exceeds the Maximum Number of Securities, then the Company shall include<br>in such Underwritten Shelf Takedown, as follows: (i) first, the Registrable Securities of the Sponsor and the Holders that can be sold<br>without exceeding the Maximum Number of Securities, determined Pro Rata based on the respective number of Registrable Securities that<br>each such Holder has so requested to be included in such Underwritten Shelf Takedown; (ii) second, to the extent that the Maximum Number<br>of Securities has not been reached under the foregoing clause (i), the Ordinary Shares or other equity securities that the Company desires<br>to sell, which can be sold without exceeding the Maximum Number of Securities; and (iii) third, to the extent that the Maximum Number<br>of Securities has not been reached under the foregoing clauses (i) and (ii), the Ordinary Shares or other equity securities of the Takedown<br>Requesting Holders, if any, that can be sold without exceeding the Maximum Number of Securities, determined Pro Rata based on the respective<br>number of Registrable Securities that each Takedown Requesting Holder has so requested to be included in such Underwritten Shelf Takedown.
2.3.5	The Sponsor and Holders shall have the right to withdraw from an Underwritten Shelf Takedown for any or<br>no reason whatsoever upon written notification to the Company and the Underwriter or Underwriters (if any) of its intention to withdraw<br>from such Underwritten Shelf Takedown prior to the public announcement of such Underwritten Shelf Takedown. Notwithstanding anything to<br>the contrary in this Agreement, the Company shall be responsible for the Registration Expenses incurred in connection with an Underwritten<br>Shelf Takedown prior to a withdrawal under this subsection 2.3.5.
---	---
2.4	Restrictions on Registration Rights.<br>If (A) during the period starting with the date sixty (60) days prior to the Company’s good faith estimate of the date of the filing<br>of, and ending on a date one hundred and twenty (120) days after the effective date of, a Company initiated Registration and provided<br>that the Company has delivered written notice to the Holders prior to receipt of a Demand Registration pursuant to subsection 2.1.1<br>hereof and it continues to actively employ, in good faith, all reasonable efforts to cause the applicable Registration Statement to become<br>effective; (B) the Holders have requested an Underwritten Registration and the Company and the Holders are unable to obtain the commitment<br>of underwriters to firmly underwrite the offer; or (C) in the good faith judgment of the Board such Registration would be seriously detrimental<br>to the Company and the Board concludes as a result that it is essential to defer the filing of such Registration Statement at such time,<br>then in each case the Company shall furnish to such Holders a certificate signed by the Chairperson of the Board stating that in the good<br>faith judgment of the Board it would be seriously detrimental to the Company for such Registration Statement to be filed in the near future<br>and that it is therefore essential to defer the filing of such Registration Statement. In such event, the Company shall have the right<br>to defer such filing for a period of not more than thirty (30) days; provided, however, that the Company shall not defer<br>its obligation in this manner more than once in any 12-month period.
---	---
2.5	Legends. In connection with<br>any sale or other disposition of the Registrable Securities by a Holder pursuant to Rule 144 promulgated under the Securities Act (or<br>any successor rule promulgated thereafter by the Commission) and upon compliance by the Holder with the requirements of this Section 2.5,<br>if requested by the Holder, the Company shall cause the transfer agent for the Registrable Securities (the “Transfer Agent”)<br>to remove any restrictive legends related to the book entry account holding such Registrable Securities and make a new, unlegended entry<br>for such book entry shares sold or disposed of without restrictive legends within two (2) trading days of any such request therefor from<br>the Holder; provided that the Company and the Transfer Agent have timely received from the Holder customary representations and other<br>documentation reasonably acceptable to the Company and the Transfer Agent in connection therewith. Subject to receipt from the Holder<br>by the Company and the Transfer Agent of customary representations and other documentation reasonably acceptable to the Company and the<br>Transfer Agent in connection therewith, the Holder may request that the Company remove any legend from the book entry position evidencing<br>its Registrable Securities and the Company will, if required by the Transfer Agent, use its commercially reasonable efforts cause an opinion<br>of the Company’s counsel be provided, in a form reasonably acceptable to the Transfer Agent, to the effect that the removal of such<br>restrictive legends in such circumstances may be effected under the Securities Act, following the earliest of such time as such Registrable<br>Securities (i) are subject to or have been or are about to be sold pursuant to an effective registration statement or (ii) have<br>been or are about to be sold pursuant to Rule 144 promulgated under the Securities Act (or any successor rule promulgated thereafter by<br>the Commission). If restrictive legends are no longer required for such Registrable Securities pursuant to the foregoing, the Company<br>shall, in accordance with the provisions of this section and within two (2) trading days of any request therefor from the Holder accompanied<br>by such customary and reasonably acceptable representations and other documentation referred to above establishing that restrictive legends<br>are no longer required, deliver to the Transfer Agent irrevocable instructions that the Transfer Agent shall make a new, unlegended entry<br>for such book entry shares. The Company shall be responsible for the fees of its Transfer Agent, its legal counsel and all DTC fees associated<br>with such issuance.
---	---

ARTICLE III

COMPANY PROCEDURES

3.1	General Procedures. If at any time<br>on or after the date the Company consummates a Business Combination the Company is required to effect the Registration of Registrable<br>Securities, the Company shall use its best efforts to effect such Registration to permit the sale of such Registrable Securities in accordance<br>with the intended plan of distribution thereof, and pursuant thereto the Company shall, as expeditiously as possible:
3.1.1	prepare and file with the Commission as soon as practicable a Registration Statement with respect to such<br>Registrable Securities and use its reasonable best efforts to cause such Registration Statement to become effective and remain effective<br>until all Registrable Securities covered by such Registration Statement have been sold;
---	---
3.1.2	prepare and file with the Commission such amendments and post-effective amendments to the Registration<br>Statement, and such supplements to the Prospectus, as may be requested by the Holders or any Underwriter of Registrable Securities or<br>as may be required by the rules, regulations or instructions applicable to the registration form used by the Company or by the Securities<br>Act or rules and regulations thereunder to keep the Registration Statement effective until all Registrable Securities covered by such<br>Registration Statement are sold in accordance with the intended plan of distribution set forth in such Registration Statement or supplement<br>to the Prospectus;
---	---
3.1.3	prior to filing a Registration Statement or Prospectus, or any amendment or supplement thereto, furnish<br>without charge to the Underwriters, if any, and the Holders of Registrable Securities included in such Registration, and such Holders’<br>and Underwriters’ legal counsel, copies of such Registration Statement as proposed to be filed, each amendment and supplement to<br>such Registration Statement (in each case including all exhibits thereto and documents incorporated by reference therein), the Prospectus<br>included in such Registration Statement (including each preliminary Prospectus), and such other documents as the Underwriters and the<br>Holders of Registrable Securities included in such Registration or the legal counsel for any such Holders and Underwriters may request<br>in order to facilitate the disposition of the Registrable Securities owned by such Holders;
---	---
3.1.4	prior to any public offering of Registrable Securities, use its best efforts to (i) register or qualify<br>the Registrable Securities covered by the Registration Statement under such securities or “blue sky” laws of such jurisdictions<br>in the United States as the Holders of Registrable Securities included in such Registration Statement (in light of their intended plan<br>of distribution) may request and (ii) take such action necessary to cause such Registrable Securities covered by the Registration Statement<br>to be registered with or approved by such other governmental authorities as may be necessary by virtue of the business and operations<br>of the Company and do any and all other acts and things that may be necessary or advisable to enable the Holders of Registrable Securities<br>included in such Registration Statement to consummate the disposition of such Registrable Securities in such jurisdictions; provided,<br>however, that the Company shall not be required to qualify generally to do business in any jurisdiction where it would not otherwise be<br>required to qualify or take any action to which it would be subject to general service of process or taxation in any such jurisdiction<br>where it is not then otherwise so subject;
---	---

3.1.5	cause all such Registrable Securities to be listed on each securities exchange or automated quotation<br>system on which similar securities issued by the Company are then listed;
3.1.6	provide a transfer agent and registrar for all such Registrable Securities no later than the effective<br>date of such Registration Statement;
---	---
3.1.7	advise each seller of such Registrable Securities, promptly after it shall receive notice or obtain knowledge<br>thereof, of the issuance of any stop order by the Commission suspending the effectiveness of such Registration Statement or the initiation<br>or threatening of any proceeding for such purpose and promptly use its reasonable best efforts to prevent the issuance of any stop order<br>or to obtain its withdrawal if such stop order should be issued;
---	---
3.1.8	at least five (5) days prior to the filing of any Registration Statement or Prospectus or any amendment<br>or supplement to such Registration Statement or Prospectus furnish a copy thereof to each seller of such Registrable Securities and its<br>counsel, including, without limitation, providing copies promptly upon receipt of any comment letters received with respect to any such<br>Registration Statement or Prospectus;
---	---
3.1.9	notify the Holders at any time when a Prospectus relating to such Registration Statement is required to<br>be delivered under the Securities Act, of the happening of any event as a result of which the Prospectus included in such Registration<br>Statement, as then in effect, includes a Misstatement, and then to correct such Misstatement as set forth in Section 3.4 hereof;
---	---
3.1.10	permit a representative of the Holders (such representative to be selected by a majority of the participating<br>Holders), the Underwriters, if any, and any attorney or accountant retained by such Holders or Underwriter to participate, at each such<br>person’s own expense, in the preparation of the Registration Statement, and cause the Company’s officers, directors and employees<br>to supply all information reasonably requested by any such representative, Underwriter, attorney or accountant in connection with the<br>Registration; provided, however, that such representatives or Underwriters enter into a confidentiality agreement, in form<br>and substance reasonably satisfactory to the Company, prior to the release or disclosure of any such information; and provided further,<br>the Company may not include the name of any Holder or Underwriter or any information regarding any Holder or Underwriter in any Registration<br>Statement or Prospectus, any amendment or supplement to such Registration Statement or Prospectus, any document that is to be incorporated<br>by reference into such Registration Statement or Prospectus, or any response to any comment letter, without the prior written consent<br>of such Holder or Underwriter and providing each such Holder or Underwriter a reasonable amount of time to review and comment on such<br>applicable document, which comments the Company shall include unless contrary to applicable law;
---	---
3.1.11	obtain a “cold comfort” letter from the Company’s independent registered public accountants<br>in the event of an Underwritten Registration which the participating Holders may rely on, in customary form and covering such matters<br>of the type customarily covered by “cold comfort” letters as the managing Underwriter may reasonably request, and reasonably<br>satisfactory to a majority-in-interest of the participating Holders;
---	---
3.1.12	on the date the Registrable Securities are delivered for sale pursuant to such Registration, obtain an<br>opinion, dated such date, of counsel representing the Company for the purposes of such Registration, addressed to the Holders, the placement<br>agent or sales agent, if any, and the Underwriters, if any, covering such legal matters with respect to the Registration in respect of<br>which such opinion is being given as the Holders, placement agent, sales agent, or Underwriter may reasonably request and as are customarily<br>included in such opinions and negative assurance letters, and reasonably satisfactory to a majority in interest of the participating Holders;
---	---
3.1.13	in the event of any Underwritten Offering, enter into and perform its obligations under an underwriting<br>agreement, in usual and customary form, with the managing Underwriter of such offering;
---	---
3.1.14	make available to its security holders, as soon as reasonably practicable, an earnings statement covering<br>the period of at least twelve (12) months beginning with the first day of the Company’s first full calendar quarter after the effective<br>date of the Registration Statement which satisfies the provisions of Section 11(a) of the Securities Act and Rule 158 thereunder<br>(or any successor rule promulgated thereafter by the Commission);
---	---

3.1.15	if the Registration involves the Registration of Registrable Securities involving gross proceeds in excess<br>of $25,000,000, use its reasonable efforts to make available senior executives of the Company to participate in customary “road<br>show” presentations that may be reasonably requested by the Underwriter in any Underwritten Offering; and
3.1.16	otherwise, in good faith, cooperate reasonably with, and take such customary actions as may reasonably<br>be requested by the Holders, in connection with such Registration.
---	---
3.2	Registration Expenses. The Registration<br>Expenses of all Registrations shall be borne by the Company. It is acknowledged by the Holders that the Holders shall bear all incremental<br>selling expenses relating to the sale of Registrable Securities, such as Underwriters’ commissions and discounts, brokerage fees,<br>Underwriter marketing costs and, other than as set forth in the definition of “Registration Expenses,” all reasonable fees<br>and expenses of any legal counsel representing the Holders.
---	---
3.3	Requirements for Participation in Underwritten<br>Offerings. No person may participate in any Underwritten Offering for equity securities of the Company pursuant to a Registration<br>initiated by the Company hereunder unless such person (i) agrees to sell such person’s securities on the basis provided in any underwriting<br>arrangements approved by the Company and (ii) completes and executes all customary questionnaires, powers of attorney, indemnities, lock-up<br>agreements, underwriting agreements and other customary documents as may be reasonably required under the terms of such underwriting arrangements.
---	---
3.4	Suspension of Sales; Adverse Disclosure.<br>Upon receipt of written notice from the Company that a Registration Statement or Prospectus contains a Misstatement, each of the Holders<br>shall forthwith discontinue disposition of Registrable Securities until he, she or it has received copies of a supplemented or amended<br>Prospectus correcting the Misstatement (it being understood that the Company hereby covenants to prepare and file such supplement or amendment<br>as soon as practicable after the time of such notice), or until he, she or it is advised in writing by the Company that the use of the<br>Prospectus may be resumed. If the filing, initial effectiveness or continued use of a Registration Statement in respect of any Registration<br>at any time would require the Company to make an Adverse Disclosure or would require the inclusion in such Registration Statement of financial<br>statements that are unavailable to the Company for reasons beyond the Company’s control, the Company may, upon giving prompt written<br>notice of such action to the Holders, delay the filing or initial effectiveness of, or suspend use of, such Registration Statement for<br>the shortest period of time, but in no event more than thirty (30) days, determined in good faith by the Company to be necessary for such<br>purpose. In the event the Company exercises its rights under the preceding sentence, the Holders agree to suspend, immediately upon their<br>receipt of the notice referred to above, their use of the Prospectus relating to any Registration in connection with any sale or offer<br>to sell Registrable Securities. The Company shall immediately notify the Holders of the expiration of any period during which it exercised<br>its rights under this Section 3.4.
---	---
3.5	Reporting Obligations. As long<br>as any Holder shall own Registrable Securities, the Company, at all times while it shall be a reporting company under the Exchange Act,<br>covenants to file timely (or obtain extensions in respect thereof and file within the applicable grace period) all reports required to<br>be filed by the Company after the date hereof pursuant to Sections 13(a) or 15(d) of the Exchange Act and to promptly furnish<br>the Holders with true and complete copies of all such filings. The Company further covenants that it shall take such further action as<br>any Holder may reasonably request, all to the extent required from time to time to enable such Holder to sell Ordinary Shares held by<br>such Holder without registration under the Securities Act within the limitation of the exemptions provided by Rule 144 promulgated under<br>the Securities Act (or any successor rule promulgated thereafter by the Commission), including providing any legal opinions. Upon the<br>request of any Holder, the Company shall deliver to such Holder a written certification of a duly authorized officer as to whether it<br>has complied with such requirements.
---	---

ARTICLE IV

indemnification and contribution

4.1	Indemnification.
4.1.1	The Company agrees to indemnify, to the extent permitted by law, each Holder of Registrable Securities,<br>its officers and directors and each person who controls such Holder (within the meaning of the Securities Act) against all losses, claims,<br>damages, liabilities and expenses (including attorneys’ fees) caused by any untrue or alleged untrue statement of material fact<br>contained in any Registration Statement, Prospectus or preliminary Prospectus or any amendment thereof or supplement thereto or any omission<br>or alleged omission of a material fact required to be stated therein or necessary to make the statements therein not misleading, except<br>insofar as the same are caused by or contained in any information furnished in writing to the Company by such Holder expressly for use<br>therein. The Company shall indemnify the Underwriters, their officers and directors and each person who controls such Underwriters (within<br>the meaning of the Securities Act) to the same extent as provided in the foregoing with respect to the indemnification of the Holder.
---	---
4.1.2	In connection with any Registration Statement in which a Holder of Registrable Securities is participating,<br>such Holder shall furnish to the Company in writing such information and affidavits as the Company reasonably requests for use in connection<br>with any such Registration Statement or Prospectus and, to the extent permitted by law, shall indemnify the Company, its directors and<br>officers and agents and each person who controls the Company (within the meaning of the Securities Act) against any losses, claims, damages,<br>liabilities and expenses (including without limitation reasonable attorneys’ fees) resulting from any untrue statement of material<br>fact contained in the Registration Statement, Prospectus or preliminary Prospectus or any amendment thereof or supplement thereto or any<br>omission of a material fact required to be stated therein or necessary to make the statements therein not misleading, but only to the<br>extent that such untrue statement or omission is contained in any information or affidavit so furnished in writing by such Holder expressly<br>for use therein; provided, however, that the obligation to indemnify shall be several, not joint and several, among such Holders of Registrable<br>Securities, and the liability of each such Holder of Registrable Securities shall be in proportion to and limited to the net proceeds<br>received by such Holder from the sale of Registrable Securities pursuant to such Registration Statement. The Holders of Registrable Securities<br>shall indemnify the Underwriters, their officers, directors and each person who controls such Underwriters (within the meaning of the<br>Securities Act) to the same extent as provided in the foregoing with respect to indemnification of the Company.
---	---
4.1.3	Any person entitled to indemnification herein shall (i) give prompt written notice to the indemnifying<br>party of any claim with respect to which it seeks indemnification (provided that the failure to give prompt notice shall not impair any<br>person’s right to indemnification hereunder to the extent such failure has not materially prejudiced the indemnifying party) and<br>(ii) unless in such indemnified party’s reasonable judgment a conflict of interest between such indemnified and indemnifying parties<br>may exist with respect to such claim, permit such indemnifying party to assume the defense of such claim with counsel reasonably satisfactory<br>to the indemnified party. If such defense is assumed, the indemnifying party shall not be subject to any liability for any settlement<br>made by the indemnified party without its consent (but such consent shall not be unreasonably withheld). An indemnifying party who is<br>not entitled to, or elects not to, assume the defense of a claim shall not be obligated to pay the fees and expenses of more than one<br>counsel (plus local counsel) for all parties indemnified by such indemnifying party with respect to such claim, unless in the reasonable<br>judgment of any indemnified party a conflict of interest may exist between such indemnified party and any other of such indemnified parties<br>with respect to such claim. No indemnifying party shall, without the consent of the indemnified party, consent to the entry of any judgment<br>or enter into any settlement which cannot be settled in all respects by the payment of money (and such money is so paid by the indemnifying<br>party pursuant to the terms of such settlement) or which settlement does not include as an unconditional term thereof the giving by the<br>claimant or plaintiff to such indemnified party of a release from all liability in respect to such claim or litigation.
---	---

4.1.4	The indemnification provided for under this Agreement shall remain in full force and effect regardless<br>of any investigation made by or on behalf of the indemnified party or any officer, director or controlling person of such indemnified<br>party and shall survive the transfer of securities. The Company and each Holder of Registrable Securities participating in an offering<br>also agrees to make such provisions as are reasonably requested by any indemnified party for contribution to such party in the event the<br>Company’s or such Holder’s indemnification is unavailable for any reason.
4.1.5	If the indemnification provided under Section 4.1 hereof from the indemnifying party is unavailable<br>or insufficient to hold harmless an indemnified party in respect of any losses, claims, damages, liabilities and expenses referred to<br>herein, then the indemnifying party, in lieu of indemnifying the indemnified party, shall contribute to the amount paid or payable by<br>the indemnified party as a result of such losses, claims, damages, liabilities and expenses in such proportion as is appropriate to reflect<br>the relative fault of the indemnifying party and the indemnified party, as well as any other relevant equitable considerations. The relative<br>fault of the indemnifying party and indemnified party shall be determined by reference to, among other things, whether any action in question,<br>including any untrue or alleged untrue statement of a material fact or omission or alleged omission to state a material fact, was made<br>by, or relates to information supplied by, such indemnifying party or indemnified party, and the indemnifying party’s and indemnified<br>party’s relative intent, knowledge, access to information and opportunity to correct or prevent such action; provided, however,<br>that the liability of any Holder under this subsection 4.1.5 shall be limited to the amount of the net proceeds received by such<br>Holder in such offering giving rise to such liability. The amount paid or payable by a party as a result of the losses or other liabilities<br>referred to above shall be deemed to include, subject to the limitations set forth in subsections 4.1.1, 4.1.2 and 4.1.3<br>above, any legal or other fees, charges or expenses reasonably incurred by such party in connection with any investigation or proceeding.<br>The parties hereto agree that it would not be just and equitable if contribution pursuant to this subsection 4.1.5 were determined<br>by pro rata allocation or by any other method of allocation, which does not take account of the equitable considerations referred to in<br>this subsection 4.1.5. No person guilty of fraudulent misrepresentation (within the meaning of Section 11(f) of the Securities<br>Act) shall be entitled to contribution pursuant to this subsection 4.1.5 from any person who was not guilty of such fraudulent<br>misrepresentation.
---	---
4.2	Waiver of Medallion Guaranty. The<br>Company agrees to use commercially reasonable efforts to enter into an indemnification agreement in customary form, in favor of Continental<br>Stock Transfer & Trust Company (or any successor transfer agent or warrant agent of the Company) in connection with the waiver of<br>any requirement to provide a medallion guarantee in connection with any Transfer of any equity securities of the Company by the Sponsor,<br>the Representative or any of their Permitted Transferees.
---	---

ARTICLE V

MISCELLANEOUS

5.1	Notices. Any notice or communication<br>under this Agreement must be in writing and given by (i) deposit in the United States mail, addressed to the party to be notified, postage<br>prepaid and registered or certified with return receipt requested, (ii) delivery in person or by courier service providing evidence of<br>delivery, or (iii) transmission by hand delivery, electronic mail, telecopy, telegram or facsimile. Each notice or communication<br>that is mailed, delivered, or transmitted in the manner described above shall be deemed sufficiently given, served, sent, and received,<br>in the case of mailed notices, on the third business day following the date on which it is mailed and, in the case of notices delivered<br>by courier service, hand delivery, electronic mail, telecopy, telegram or facsimile, at such time as it is delivered to the addressee<br>(with the delivery receipt or the affidavit of messenger) or at such time as delivery is refused by the addressee upon presentation. Any<br>notice or communication under this Agreement must be addressed, if to the Company, to: 153 Central Avenue, C/O 56, Westfield, NJ 07091,<br>and, if to any Holder, at such Holder’s address or contact information as set forth in the Company’s books and records. Any<br>party may change its address for notice at any time and from time to time by written notice to the other parties hereto, and such change<br>of address shall become effective thirty (30) days after delivery of such notice as provided in this Section 5.1.
5.2	Assignment; No Third-Party Beneficiaries.
---	---
5.2.1	This Agreement and the rights, duties and obligations of the Company hereunder may not be assigned or<br>delegated by the Company in whole or in part.
---	---

5.2.2	Prior to the expiration of the Founder Shares Lock-up Period or the Private Placement Lock-up Period,<br>as the case may be, no Holder may assign or delegate such Holder’s rights, duties or obligations under this Agreement, in whole<br>or in part, except in connection with a transfer of Registrable Securities by such Holder to a Permitted Transferee but only if such Permitted<br>Transferee agrees to become bound by the transfer restrictions set forth in this Agreement.
5.2.3	This Agreement and the provisions hereof shall be binding upon and shall inure to the benefit of each<br>of the parties and its successors and the permitted assigns of the Holders, which shall include Permitted Transferees.
---	---
5.2.4	This Agreement shall not confer any rights or benefits on any persons that are not parties hereto, other<br>than as expressly set forth in this Agreement and Section 5.2 hereof.
---	---
5.2.5	No assignment by any party hereto of such party’s rights, duties and obligations hereunder shall<br>be binding upon or obligate the Company unless and until the Company shall have received (i) written notice of such assignment as provided<br>in Section 5.1 hereof and (ii) the written agreement of the assignee, in a form reasonably satisfactory to the Company, to be bound<br>by the terms and provisions of this Agreement (which may be accomplished by an addendum or certificate of joinder to this Agreement).<br>Any transfer or assignment made other than as provided in this Section 5.2 shall be null and void.
---	---
5.3	Counterparts. This Agreement may<br>be executed in multiple counterparts (including facsimile or PDF counterparts), each of which shall be deemed an original, and all of<br>which together shall constitute the same instrument, but only one of which need be produced.
---	---
5.4	Governing Law; Venue. NOTWITHSTANDING<br>THE PLACE WHERE THIS AGREEMENT MAY BE EXECUTED BY ANY OF THE PARTIES HERETO, THE PARTIES EXPRESSLY AGREE THAT THIS AGREEMENT SHALL BE<br>GOVERNED BY AND CONSTRUED UNDER THE LAWS OF THE STATE OF NEW YORK AS APPLIED TO AGREEMENTS AMONG NEW YORK RESIDENTS ENTERED INTO AND TO<br>BE PERFORMED ENTIRELY WITHIN NEW YORK, WITHOUT REGARD TO THE CONFLICT OF LAW PROVISIONS OF SUCH JURISDICTION. ANY LEGAL SUIT, ACTION OR<br>PROCEEDING ARISING OUT OF OR BASED UPON THIS AGREEMENT OR THE TRANSACTIONS CONTEMPLATED HEREBY MAY BE INSTITUTED IN THE FEDERAL COURTS<br>OF THE UNITED STATES OR THE COURTS OF THE STATE OF NEW YORK IN EACH CASE LOCATED IN THE CITY OF NEW YORK, AND EACH PARTY IRREVOCABLY SUBMITS<br>TO THE EXCLUSIVE JURISDICTION OF SUCH COURTS IN ANY SUCH SUIT, ACTION OR PROCEEDING.
---	---
5.5	Amendments and Modifications. Upon<br>the written consent of the Company and the Holders of at least a majority in interest of the Registrable Securities at the time in question,<br>compliance with any of the provisions, covenants and conditions set forth in this Agreement may be waived, or any of such provisions,<br>covenants or conditions may be amended or modified; provided, however, that notwithstanding the foregoing, any amendment<br>hereto or waiver hereof that adversely affects one Holder, solely in his, her or its capacity as a holder of the capital shares of the<br>Company, in a manner that is materially different from the other Holders (in such capacity) shall require the consent of the Holder so<br>affected. No course of dealing between any Holder or the Company and any other party hereto or any failure or delay on the part of a Holder<br>or the Company in exercising any rights or remedies under this Agreement shall operate as a waiver of any rights or remedies of any Holder<br>or the Company. No single or partial exercise of any rights or remedies under this Agreement by a party shall operate as a waiver or preclude<br>the exercise of any other rights or remedies hereunder or thereunder by such party.
---	---
5.6	Other Registration Rights. The<br>Company represents and warrants that no person, other than a Holder of Registrable Securities, has any right to require the Company to<br>register any securities of the Company for sale or to include such securities of the Company in any Registration filed by the Company<br>for the sale of securities for its own account or for the account of any other person. Further, the Company represents and warrants that<br>this Agreement supersedes any other registration rights agreement or agreement with similar terms and conditions and in the event of a<br>conflict between any such agreement or agreements and this Agreement, the terms of this Agreement shall prevail.
---	---
5.7	Term. This Agreement shall terminate<br>upon the earlier of (i) the tenth anniversary of the date of this Agreement or (ii) the date as of which (A) all of the Registrable Securities<br>have been sold pursuant to a Registration Statement (but in no event prior to the applicable period referred to in Section 4(a)(3) of<br>the Securities Act and Rule 174 thereunder (or any successor rule promulgated thereafter by the Commission)) or (B) the Holders of<br>all Registrable Securities are permitted to sell the Registrable Securities without registration pursuant to Rule 144 (or any similar<br>provision) under the Securities Act with no volume or other restrictions or limitations. The provisions of Section 3.5 and ArticleIV hereof shall survive any termination.
---	---

[Signature Page Follows]

IN WITNESS WHEREOF, the undersigned have caused this Agreement to be executed as of the date first written above.

COMPANY:
JATT II Acquisition Corpa Cayman Islands exempted company
By:	/s/ Someit Sidhu
Name:	Someit Sidhu
Title:	Chief Executive Officer
HOLDERS
---	---
JATT Ventures II L.P.
(acting by its general partner, JATT Ventures II Ltd)
By:	/s/ Someit Sidhu
Name:	Someit Sidhu
Title:	Director

[Signature Page to Registration Rights Agreement]

Exhibit 10.4

PRIVATE PLACEMENT SHARES PURCHASE AGREEMENT

THIS PRIVATE PLACEMENT SHARES PURCHASE AGREEMENT, dated as of April 16, 2026, (as it may from time to time be amended, this “Agreement”), is entered into by and between JATT II Acquisition Corp, a Cayman Islands exempted company (the “Company”), and JATT Ventures II L.P., a Cayman Islands exempted limited partnership (the “Purchaser”).

WHEREAS, the Company intends to consummate an initial public offering (the “Public Offering”) of shares of the Company’s Ordinary Shares, par value $0.0001 per share (the “Shares”). The Purchaser has agreed to purchase an aggregate of 300,000 Shares (or 309,000 in the aggregate if the over-allotment option in connection with the Public Offering is exercised in full) (the “PrivatePlacement Shares”).

NOW THEREFORE, in consideration of the mutual promises contained in this Agreement and other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the parties to this Agreement hereby, intending legally to be bound, agree as follows:

AGREEMENT

Section 1 Authorization,Purchase and Sale; Terms of the Private Placement Shares.

A.	Authorization of the Private Placement Shares.<br>The Company has duly authorized the issuance and sale of the Private Placement Shares to the Purchaser.
B.	Purchase and Sale of the Private Placement<br>Shares.
---	---
(i)	On the date of the consummation of the Public Offering or on such earlier time and date as may be mutually<br>agreed by the Purchaser and the Company (the “Initial Closing Date”), the Company shall issue and sell to the<br>Purchaser, and the Purchaser shall purchase from the Company, an aggregate of 300,000 Private Placement Shares at a price of $10.00 per<br>share for an aggregate purchase price of $3,000,000 (the “Purchase Price”), which shall be paid by wire transfer<br>of immediately available funds to the Company at least one business day prior to the Initial Closing Date in accordance with the Company’s<br>wiring instructions. On the Initial Closing Date, upon the payment by the Purchaser of the Purchase Price, the Company, at its option,<br>shall deliver a certificate evidencing the Private Placement Shares purchased by the Purchaser on such date duly registered in the Purchaser’s<br>name to the Purchaser, or effect such delivery in book-entry form.
---	---
(ii)	On the date of the consummation of the closing of the over-allotment option in connection with the Public<br>Offering or on such earlier time and date as may be mutually agreed by the Purchaser and the Company (each such date, an “Over-AllotmentClosing Date”, and each Over-Allotment Closing Date (if any) and the Initial Closing Date being sometimes referred to herein<br>as a “Closing Date”), the Company shall issue and sell to the Purchaser, and the Purchaser shall purchase from<br>the Company, up to an aggregate of 9,000 additional Private Placement Shares at a price of $10.00 per share for an aggregate purchase<br>price of up to $90,000 (if the over-allotment option in connection with the Public Offering is exercised in full) (the “Over-AllotmentPurchase Price”). The Purchaser shall pay the Over-Allotment Purchase Price by wire transfer of immediately available funds<br>to the Company at least one business day prior to the Over-Allotment Closing Date in accordance with the Company’s wiring instructions.<br>On the Over-Allotment Closing Date, upon the payment by the Purchaser of the Over-Allotment Purchase Price, the Company shall, at its<br>option, deliver a certificate evidencing the Private Placement Shares purchased by the Purchaser on such date duly registered in the Purchaser’s<br>name to the Purchaser, or effect such delivery in book-entry form.
---	---
C.	Terms of the Private Placement Shares.
---	---
(i)	The Private Placement Shares shall be subject to a letter agreement, dated as of the date hereof, by and<br>among the Purchaser, the Company and certain of the Company’s directors and officers (a “Letter Agreement”).
---	---
(ii)	At the time of the Initial Closing Date, the Company and the Purchaser shall enter into a registration<br>rights agreement (the “Registration Rights Agreement”) pursuant to which the Company will grant certain registration<br>rights to the Purchaser relating to the Private Placement Shares.
---	---

Section 2 Representationsand Warranties of the Company. As a material inducement to the Purchaser to enter into this Agreement and purchase the Private Placement Shares, the Company hereby represents and warrants to the Purchaser (which representations and warranties shall survive the Closing Date) that:

A.	Incorporation and Corporate Power.<br>The Company is an exempted company duly incorporated, validly existing and in good standing under the laws of the Cayman Islands and is<br>qualified to do business in every jurisdiction in which the failure to so qualify would reasonably be expected to have a material adverse<br>effect on the financial condition, operating results or assets of the Company. The Company possesses all requisite corporate power and<br>authority necessary to carry out the transactions contemplated by this Agreement and the Letter Agreement.
B.	Authorization; No Breach.
---	---
(i)	The execution, delivery and performance of this Agreement and the Private Placement Shares have been duly<br>authorized by the Company as of the Closing Date. This Agreement constitutes the valid and binding obligation of the Company, enforceable<br>in accordance with its terms.
---	---
(ii)	The execution and delivery by the Company of this Agreement and the Private Placement Shares, the issuance<br>and sale of the Private Placement Shares and the fulfillment of, and compliance with, the respective terms hereof and thereof by the Company,<br>do not and will not as of the Closing Date (a) conflict with or result in a breach of the terms, conditions or provisions of, (b) constitute<br>a default under, (c) result in the creation of any lien, security interest, charge or encumbrance upon the Company’s equity or assets<br>under, (d) result in a violation of, or (e) require any authorization, consent, approval, exemption or other action by or notice or declaration<br>to, or filing with, any court or administrative or governmental body or agency pursuant to the Amended and Restated Memorandum and Articles<br>of Association of the Company in effect on the date hereof or as may be amended prior to completion of the contemplated Public Offering,<br>or any material law, statute, rule or regulation to which the Company is subject, or any agreement, order, judgment or decree to which<br>the Company is subject, except for any filings required after the date hereof under federal or state securities laws.
---	---
C.	Title to Securities. Upon issuance<br>in accordance with, and payment pursuant to, the terms hereof, the Private Placement Shares will be duly and validly issued, fully paid<br>and nonassessable. Upon issuance in accordance with, and payment pursuant to, the terms hereof, and upon registration in the Company’s<br>register of members, the Purchaser will have good title to the Private Placement Shares, free and clear of all liens, claims and encumbrances<br>of any kind, other than (i) transfer restrictions hereunder and under the other agreements contemplated hereby, (ii) transfer restrictions<br>under federal and state securities laws, and (iii) liens, claims or encumbrances imposed due to the actions of the Purchaser.
---	---

D.	Governmental Consents. No permit,<br>consent, approval or authorization of, or declaration to or filing with, any governmental authority is required in connection with the<br>execution, delivery and performance by the Company of this Agreement or the consummation by the Company of any other transactions contemplated<br>hereby.
E.	Regulation D Qualification. Neither<br>the Company nor, to its knowledge, any of its affiliates, members, officers, directors or beneficial shareholders of 20% or more of its<br>outstanding securities, has experienced a disqualifying event as enumerated pursuant to Rule 506(d) of Regulation D under the Securities<br>Act of 1933, as amended (the “Securities Act”).
---	---

Section 3 Representationsand Warranties of the Purchaser. As a material inducement to the Company to enter into this Agreement and issue and sell the Private Placement Shares to the Purchaser, the Purchaser hereby represents and warrants to the Company (which representations and warranties shall survive each Closing Date) that:

A.	Organization and Requisite Authority.<br>The Purchaser possesses all requisite power and authority necessary to carry out the transactions contemplated by this Agreement.
B.	Authorization; No Breach.
---	---
(i)	This Agreement constitutes a valid and binding obligation of the Purchaser, enforceable in accordance<br>with its terms, subject to bankruptcy, insolvency, fraudulent conveyance, reorganization, moratorium and other laws of general applicability<br>relating to or affecting creditors’ rights and to general equitable principles (whether considered in a proceeding in equity or<br>law).
---	---
(ii)	The execution and delivery by the Purchaser of this Agreement and the fulfillment of and compliance with<br>the terms hereof by the Purchaser does not and shall not as of each Closing Date conflict with or result in a breach by the Purchaser<br>of the terms, conditions or provisions of any agreement, instrument, order, judgment or decree to which the Purchaser is subject.
---	---
C.	Investment Representations.
---	---
(i)	The Purchaser is acquiring the Private Placement Shares (the “Securities”),<br>for the Purchaser’s own account, for investment purposes only and not with a view towards, or for resale in connection with, any<br>public sale or distribution thereof.
---	---
(ii)	The Purchaser is an “accredited investor” as such term is defined in Rule 501(a)(3) of Regulation<br>D, and the Purchaser has not experienced a disqualifying event as enumerated pursuant to Rule 506(d) under the Securities Act.
---	---
(iii)	The Purchaser understands that the Securities are being offered and will be sold to it in reliance on<br>specific exemptions from the registration requirements of the United States federal and state securities laws and that the Company is<br>relying upon the truth and accuracy of, and the Purchaser’s compliance with, the representations and warranties of the Purchaser<br>set forth herein in order to determine the availability of such exemptions and the eligibility of the Purchaser to acquire such Securities.
---	---

(iv)	The Purchaser did not decide to enter into this Agreement as a result of any general solicitation or general<br>advertising within the meaning of Rule 502(c) of Regulation D under the Securities Act.
(v)	The Purchaser has been furnished with all materials relating to the business, finances and operations<br>of the Company and materials relating to the offer and sale of the Securities which have been requested by the Purchaser. The Purchaser<br>has been afforded the opportunity to ask questions of the executive officers and directors of the Company. The Purchaser understands that<br>its investment in the Securities involves a high degree of risk and it has sought such accounting, legal and tax advice as it has considered<br>necessary to make an informed investment decision with respect to the acquisition of the Securities.
---	---
(vi)	The Purchaser understands that no United States federal or state agency or any other government or governmental<br>agency has passed on or made any recommendation or endorsement of the Securities or the fairness or suitability of the investment in the<br>Securities by the Purchaser nor have such authorities passed upon or endorsed the merits of the offering of the Securities.
---	---
(vii)	The Purchaser understands that: (a) the Securities have not been and are not being registered under the<br>Securities Act or any state securities laws, and may not be offered for sale, sold, assigned or transferred unless (1) subsequently registered<br>thereunder or (2) sold in reliance on an exemption therefrom; and (b) except as specifically set forth in the Registration Rights Agreement,<br>neither the Company nor any other person is under any obligation to register the Securities under the Securities Act or any state securities<br>laws or to comply with the terms and conditions of any exemption thereunder. While the Purchaser understands that Rule 144 is not available<br>for the resale of securities initially issued by shell companies (other than business combination related shell companies) or issuers<br>that have been at any time previously a shell company, the Purchaser understands that Rule 144 includes an exception to this prohibition<br>if the following conditions are met: (i) the issuer of the securities that was formerly a shell company has ceased to be a shell company;<br>(ii) the issuer of the securities is subject to the reporting requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934,<br>as amended (the “Exchange Act”); (iii) the issuer of the securities has filed all Exchange Act reports and material<br>required to be filed, as applicable, during the preceding 12 months (or such shorter period that the issuer was required to file such<br>reports and materials), other than Form 8-K reports; and (iv) at least one year has elapsed from the time that the issuer filed current<br>Form 10 type information with the U.S. Securities and Exchange Commission (the “SEC”) reflecting its status<br>as an entity that is not a shell company.
---	---
(viii)	The Purchaser has such knowledge and experience in financial and business matters, knows of the high degree<br>of risk associated with investments in the securities of companies in the development stage such as the Company, is capable of evaluating<br>the merits and risks of an investment in the Securities and is able to bear the economic risk of an investment in the Securities in the<br>amount contemplated hereunder for an indefinite period of time. The Purchaser has adequate means of providing for its current financial<br>needs and contingencies and will have no current or anticipated future needs for liquidity which would be jeopardized by the investment<br>in the Securities. The Purchaser can afford a complete loss of its investment in the Securities.
---	---

Section 4 Conditionsof the Purchaser’s Obligations. The obligation of the Purchaser to purchase and pay for the Private Placement Shares is subject to the fulfillment, on or before each Closing Date, of each of the following conditions:

A.	Representations and Warranties.<br>The representations and warranties of the Company contained in Section 2 hereof shall be true and correct at and as of such Closing Date<br>as though then made.
B.	Performance. The Company shall<br>have performed and complied with all agreements, obligations and conditions contained in this Agreement that are required to be performed<br>or complied with by it on or before such Closing Date.
---	---
C.	No Injunction. No litigation, statute,<br>rule, regulation, executive order, decree, ruling or injunction shall have been enacted, entered, promulgated or endorsed by or in any<br>court or governmental authority of competent jurisdiction or any self-regulatory organization having authority over the matters contemplated<br>hereby, which prohibits the consummation of any of the transactions contemplated by this Agreement or the Letter Agreement.
---	---
D.	Letter Agreement and Registration Rights Agreement.<br>The Company shall have entered into the Letter Agreement and the Registration Rights Agreement, each on terms satisfactory to the Purchaser.
---	---

Section 5 Conditionsof the Company’s Obligations. The obligations of the Company to the Purchaser under this Agreement are subject to the fulfillment, on or before each Closing Date, of each of the following conditions:

A.	Representations and Warranties.<br>The representations and warranties of the Purchaser contained in Section 3 hereof shall be true and correct at and as of such Closing<br>Date as though then made.
B.	Performance. The Purchaser shall<br>have performed and complied with all agreements, obligations and conditions contained in this Agreement that are required to be performed<br>or complied with by the Purchaser on or before such Closing Date.
---	---
C.	Corporate Consents. The Company<br>shall have obtained the consent of its Board of Directors authorizing the execution, delivery and performance of this Agreement and the<br>Letter Agreement and the issuance and sale of the Private Placement Shares hereunder.
---	---
D.	No Injunction. No litigation, statute,<br>rule, regulation, executive order, decree, ruling or injunction shall have been enacted, entered, promulgated or endorsed by or in any<br>court or governmental authority of competent jurisdiction or any self-regulatory organization having authority over the matters contemplated<br>hereby, which prohibits the consummation of any of the transactions contemplated by this Agreement or the Letter Agreement.
---	---
E.	Letter Agreement. The Company shall<br>have entered into the Letter Agreement on terms satisfactory to the Company.
---	---

Section 6 Termination. This Agreement may be terminated at any time after June 30, 2026 upon the election by either the Company or the Purchaser upon written notice to the other party if the closing of the Public Offering does not occur prior to such date.

Section 7 Survivalof Representations and Warranties. All of the representations and warranties contained herein shall survive each Closing Date.

Section 8 Definitions. Terms used but not otherwise defined in this Agreement shall have the meaning assigned to such terms in the registration statement on Form S-1 the Company has filed with the SEC under the Securities Act.

Section 9 Miscellaneous.

A.	Successors and Assigns. Except<br>as otherwise expressly provided herein, all covenants and agreements contained in this Agreement by or on behalf of any of the parties<br>hereto shall bind and inure to the benefit of the respective successors of the parties hereto whether so expressed or not. Notwithstanding<br>the foregoing or anything to the contrary herein, the parties may not assign this Agreement, other than assignments by the Purchaser to<br>affiliates thereof (including, without limitation one or more of its members).
B.	Severability. Whenever possible,<br>each provision of this Agreement shall be interpreted in such manner as to be effective and valid under applicable law, but if any provision<br>of this Agreement is held to be prohibited by or invalid under applicable law, such provision shall be ineffective only to the extent<br>of such prohibition or invalidity, without invalidating the remainder of this Agreement.
---	---
C.	Counterparts. This Agreement may<br>be executed simultaneously in two or more counterparts, none of which need contain the signatures of more than one party, but all such<br>counterparts taken together shall constitute one and the same agreement.
---	---
D.	Descriptive Headings; Interpretation.<br>The descriptive headings of this Agreement are inserted for convenience only and do not constitute a substantive part of this Agreement.<br>The use of the word “including” in this Agreement shall be by way of example rather than by limitation.
---	---
E.	Governing Law. This Agreement shall<br>be deemed to be a contract made under the laws of the State of New York and for all purposes shall be construed in accordance with the<br>internal laws of the State of New York.
---	---
F.	Amendments. This Agreement may<br>not be amended, modified or waived as to any particular provision, except by a written instrument executed by all parties hereto.
---	---

[Signature Page Follows]

IN WITNESS WHEREOF, the parties hereto have executed this Agreement to be effective as of the date first set forth above.

COMPANY
JATT II Acquisition Corp
a Cayman Islands exempted company
By:	/s/ Someit Sidhu
Name:	Someit Sidhu
Title:	Chief Executive Officer
PURCHASER
JATT Ventures II L.P.
(acting by its general partner, JATT Ventures II Ltd)
By:	/s/ Someit Sidhu
Name:	Someit Sidhu
Title:	Director

[Signature Page to Private Placement SharesPurchase Agreement]

Exhibit 10.5

JATT II Acquisition Corp

153 Central Avenue

C/O 56

Westfield, NJ 07091

April 16, 2026

JATT Ventures II L.P.

153 Central Avenue

C/O 56

Westfield, NJ 07091

Re:	Administrative Services and Indemnification Agreement

Ladies and Gentlemen:

This letter agreement (this “Agreement”) by and between JATT II Acquisition Corp (the “Company”) and JATT Ventures II L.P. (the “Sponsor”), dated as of the date hereof, will confirm our agreement that, commencing on the date the securities of the Company are first listed on the Nasdaq Global Market (the “Listing Date”), pursuant to a Registration Statement on Form S-1 and prospectus filed with the U.S. Securities and Exchange Commission (the “RegistrationStatement”) and continuing until the earlier of the consummation by the Company of an initial business combination (“BusinessCombination”) or the Company’s liquidation (in each case as described in the Registration Statement) (such earlier date hereinafter referred to as the “Termination Date”):

1.	The Sponsor shall make available, or cause to be made available, to the Company, at 153 Central Avenue,<br>C/O 56, Westfield, NJ 07091 (or any successor location), officer compensation and administrative services as may be reasonably required<br>by the Company. In exchange therefor, the Company shall pay the Sponsor $20,000 per month on the Listing Date and continuing monthly thereafter<br>until the Termination Date.
2.	The Company agrees to indemnify and hold harmless the Sponsor, its directors, officers, employees, principals,<br>managers, partners, members, shareholders, equityholders, control persons, affiliates, agents, advisors, consultants and representatives<br>(the “Indemnitees”) from any claims, losses, liabilities, obligations, causes of action, proceedings (whether pending or threatened),<br>investigations, damages, awards, settlements, judgments, decrees, fees, costs, penalties, amounts paid in settlement or expenses (including<br>interest, assessments and other charges in connection therewith and reasonable fees and disbursements of attorneys and other professional<br>advisors and costs of suit) arising out of or relating to any pending or threatened claim, action, suit, proceeding or investigation against<br>any of them or in which any of them may be a participant or may otherwise be involved (including as a witness) that arises out of or relates<br>to (i) the Offering or the Company’s operations or conduct of its business (including, for the avoidance of doubt, a Business Combination),<br>or (ii) any claim against the Sponsor alleging any expressed or implied management or endorsement by the Sponsor of any activities of<br>the Company or any express or implied association between the Sponsor, on the one hand, and the Company or any of its affiliates, on the<br>other hand. The Indemnitee will promptly notify the Company in writing of any indemnified claim, provided that failure or delay to give<br>such notice shall not relieve the Company of its indemnification obligations hereunder. The Company will, at its expense, undertake the<br>defense of such claim with attorneys of its own choosing reasonably satisfactory in all respects to such Indemnitee, subject to the right<br>of such Indemnitee to undertake such defense as hereinafter provided. An Indemnitee may participate in such defense with counsel of such<br>Indemnitee’s choosing at the expense of the Company. In the event that the Company does not undertake the defense of any claim within<br>a reasonable time after such Indemnitee has given the notice thereof, or in the event that such Indemnitee shall in good faith determine<br>that the defense of any claim by the Company is inadequate or may conflict with the interest of any Indemnitee, such Indemnitee may, at<br>the expense of the Company and after giving notice to the Company of such action, undertake the defense of the claim and compromise or<br>settle the claim, all for the account of and at the risk of the Company. The Company shall pay all costs and expenses (including, without<br>limitation, attorneys’ fees and costs of experts) incurred by the Indemnitee in connection with Indemnitee’s defense of any<br>such claim promptly (and in any event within 10 days) after receipt of any statement therefor. In the defense of any claim against an<br>Indemnitee, the Company shall not, except with the prior written consent of such Indemnitee, consent to entry of any judgment or enter<br>into any settlement that includes any injunctive or other non-monetary relief or any payment of money by such Indemnitee, or that does<br>not include as an unconditional term thereof the giving by the person or persons asserting such claim to such Indemnitee of an unconditional<br>release from all liability on any of the matters that are the subject of such Claim and an acknowledgement that such Indemnitee denies<br>all wrongdoing in connection with such matters. The Company shall not be obligated to indemnify an Indemnitee against amounts paid in<br>settlement of a claim if such settlement is effected by such Indemnitee without the prior written consent of the Company, which shall<br>not be unreasonably withheld or delayed. If the indemnification provided for in this paragraph is for any reason not available to an Indemnitee<br>as a matter of law in respect of any losses, claims, damages or liabilities referred to herein, then, in lieu of indemnifying such Indemnitee<br>therefor, the Company shall contribute to the amount paid or payable by such Indemnitee as a result of such losses, claims, damages or<br>liabilities (and expenses relating thereto) (a) in such proportion as is appropriate to reflect the relative benefits to the Indemnitee,<br>on the one hand, and the Company, on the other hand, of the subject matter of this Agreement or (b) if the allocation provided by clause<br>(a) above is not available, in such proportion as is appropriate to reflect not only the relative benefits referred to in such clause<br>(a) but also the relative fault of each of such Indemnitee and the Company, as well as any other relevant equitable considerations. Notwithstanding<br>anything to the contrary set forth herein or otherwise, the Company acknowledges and agrees that each Indemnitee shall be an express third-party<br>beneficiary of the provisions of this paragraph 2 and any related provision hereof that is or may extend rights to such Indemnitee. For<br>the avoidance of doubt, the Company’s indemnification obligations contained in this paragraph 2 shall survive the Company’s<br>consummation of a Business Combination.
---	---
3.	The Sponsor hereby irrevocably waives any and all right, title, interest, causes of action and claims<br>of any kind as a result of, or arising out of, this Agreement (each, a “Claim”) in or to, and any and all right<br>to seek payment of any amounts due to it out of, the trust account established for the benefit of the public shareholders of the Company<br>and into which substantially all of the proceeds of the Company’s initial public offering will be deposited (the “TrustAccount”), and hereby irrevocably waives any Claim it may have in the future as a result of, or arising out of, this Agreement,<br>which Claim would reduce, encumber or otherwise adversely affect the Trust Account or any monies or other assets in the Trust Account,<br>and further agrees not to seek recourse, reimbursement, payment or satisfaction of any Claim against the Trust Account or any monies or<br>other assets in the Trust Account for any reason whatsoever.
---	---

This Agreement constitutes the entire agreement and understanding of the parties hereto in respect of its subject matter and supersedes all prior understandings, agreements, or representations by or among the parties hereto, written or oral, to the extent they relate in any way to the subject matter hereof or the transactions contemplated hereby.

This Agreement may not be amended, modified or waived as to any particular provision, except by a written instrument executed by the parties hereto.

No party hereto may assign either this Agreement or any of its rights, interests, or obligations hereunder without the prior written approval of the other party. Any purported assignment in violation of this paragraph shall be void and ineffectual and shall not operate to transfer or assign any interest or title to the purported assignee.

This Agreement shall be governed by and construed in accordance with the laws of the State of New York for agreements made and to be wholly performed within such state, without regards to the conflicts of laws principles thereof.

[Signature Page Follows]

Very truly yours,
JATT II Acquisition Corp
By:	/s/ Someit Sidhu
Name:	Someit Sidhu
Title:	Chief Executive Officer
AGREED AND ACCEPTED BY:
JATT Ventures II L.P.
(acting by its general partner, JATT Ventures II Ltd)
By:	/s/ Someit Sidhu
Name:	Someit Sidhu
Title:	Chief Executive Officer

[Signature Page to Administrative Services andIndemnification Agreement]

Exhibit 99.1

JATT II Acquisition Corp Announces Pricing of$60,000,000 Initial Public Offering

Westfield, New Jersey, United States, April16, 2026 (GLOBE NEWSWIRE) – JATT II Acquisition Corp (the “Company”), a newly organized special purpose acquisition company formed as a Cayman Islands exempted company, today announced the pricing of its initial public offering of 6,000,000 ordinary shares at an offering price of $10.00 per ordinary share. The ordinary shares are expected to trade on the Nasdaq Global Market (“NASDAQ”) under the ticker symbol “JATT” beginning April 17, 2026. The offering is expected to close on April 20, 2026, subject to customary closing conditions.

Guggenheim Securities, LLC is acting as sole book-running manager. The Company has granted the underwriters a 45-day option to purchase up to 900,000 additional ordinary shares at the initial public offering price to cover over-allotments, if any.

A registration statement relating to the securities sold in the initial public offering was declared effective by the U.S. Securities and Exchange Commission (the “SEC”) on April 16, 2026 (the “Effective Date”). The public offering is being made only by means of a prospectus. When available, copies of the prospectus relating to the offering may be obtained from Guggenheim Securities, LLC, Attn: Equity Syndicate Department, 330 Madison Avenue, 8th Floor, New York, NY 10017, by telephone at (212) 518-9544, or by email at GSEquityProspectusDelivery@guggenheimpartners.com.

This press release shall not constitute an offer to sell or a solicitation of an offer to buy, nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.

About JATT II Acquisition Corp

JATT II Acquisition Corp is a newly incorporated blank check company incorporated as a Cayman Islands exempted company and formed for the purpose of entering into a merger, amalgamation, share exchange, asset acquisition, share purchase, recapitalization, reorganization or similar business combination with one or more businesses. The Company has not selected any specific business combination target and has not, nor has anyone on its behalf, engaged in any substantive discussions, directly or indirectly, with any business combination target with respect to an initial business combination with the Company. While the Company may pursue an initial business combination in any business or industry, the Company intends to focus its search on healthcare and healthcare-related businesses, with a primary emphasis on biotechnology and broader life sciences. In particular, the Company intends to seek businesses that can benefit from the clinical, scientific, operational, strategic and capital markets experience of the management team and board of directors and, in many cases, from access to the public markets as a means of funding continued development, executing strategic transactions and increasing visibility with investors and potential partners. The Company expects to focus particularly, though not exclusively, on businesses applying data-driven approaches, including machine learning, computational biology, structure-based drug design and related technologies, to improve the therapeutic discovery and development process. The Company is sponsored by JATT Ventures II L.P. and is led by Dr. Someit Sidhu, Chief Executive Officer and Chairman of the Board, and Nicholas Fernandez, Chief Financial Officer. The Company’s Board of Directors also includes Verender S. Badial, Arjun Goyal, Jonathon Kluft and Christopher Staral, bringing extensive experience across biotechnology investing, company architecture, and public and private capital markets.

Forward-Looking Statements

This press release contains statements that constitute “forward-looking statements,” including with respect to the Company’s initial public offering (“IPO”) including the gross proceeds of the IPO, the anticipated use of the net proceeds from the IPO and the search for an initial business combination. No assurance can be given that the offering discussed above will be completed on the terms described, or that the net proceeds of the offering will be used as indicated or that the Company will ultimately complete a business combination transaction in the sectors it is targeting or at all. Forward-looking statements are subject to numerous conditions, many of which are beyond the control of JATT II Acquisition Corp, including those set forth in the Risk Factors section of JATT II Acquisition Corp’s registration statement and preliminary prospectus for the IPO filed with the SEC. Copies are available on the SEC’s website, www.sec.gov. JATT II Acquisition Corp undertakes no obligation to update these statements for revisions or changes after the date of this release, except as required by law.

Contacts:

Nicholas Fernandez

Chief Financial Officer

153 Central Avenue

C/O 56

Westfield, NJ 07091

201-688-0364

Exhibit 99.2

JATT II Acquisition Corp Announces Closing of

$60,000,000 Initial Public Offering

Westfield, New Jersey, United States, April20, 2026 (GLOBE NEWSWIRE) — JATT II Acquisition Corp (the “Company”) announced the closing of its initial public offering of 6,000,000 ordinary shares at an offering price of $10.00 per ordinary share on April 20, 2026. Total gross proceeds from the offering were $60,000,000 before deducting underwriting discounts and commissions and other offering expenses payable by the Company.

The ordinary shares began trading on the Nasdaq Global Market (“NASDAQ”) under the ticker symbol “JATT” on April 17, 2026.

A registration statement relating to the securities sold in the initial public offering was declared effective by the U.S. Securities and Exchange Commission (the “SEC”) on April 16, 2026. The public offering is being made only by means of a prospectus. Copies of the prospectus relating to the offering may be obtained from Guggenheim Securities, LLC, Attn: Equity Syndicate Department, 330 Madison Avenue, 8th Floor, New York, NY 10017, by telephone at (212) 518-9544, or by email at GSEquityProspectusDelivery@guggenheimpartners.com.

About JATT II Acquisition Corp

Forward-Looking Statements

This press release contains statements that constitute “forward-looking statements,” including with respect to the Company’s initial public offering (“IPO”) including the gross proceeds of the IPO, the anticipated use of the net proceeds from the IPO and the search for an initial business combination. No assurance can be given that the offering discussed above will be completed on the terms described, or that the net proceeds of the offering will be used as indicated or that the Company will ultimately complete a business combination transaction in the sectors it is targeting or at all. Forward-looking statements are subject to numerous conditions, many of which are beyond the control of JATT II Acquisition Corp, including those set forth in the Risk Factors section of JATT II Acquisition Corp’s registration statement and prospectus for the IPO filed with the SEC. Copies are available on the SEC’s website, www.sec.gov. JATT II Acquisition Corp undertakes no obligation to update these statements for revisions or changes after the date of this release, except as required by law.

Contacts:

Nicholas Fernandez

Chief Financial Officer

153 Central Avenue

C/O 56

Westfield, NJ 07091

201-688-0364